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Resumo 
 
 
Graças aos desenvolvimentos na área da síntese de nanomaterais e às
potentes técnicas de caracterização à nanoescala conseguimos hoje visualizar
uma nanopartícula (NP) como um dispositivo de elevado potencial terapêutico.
A melhoria da sua efectividade terapêutica requer no entanto o
aprofundamento e sistematização de conhecimentos, ainda muito incipientes,
sobre toxicidade, selectividade, efeitos colaterais e sua dependência das
próprias características físico-químicas da NP em análise. O presente trabalho,
elegendo como alvo de estudo uma substância considerada biocompatível e
não tóxica, a hidroxiapatite (Hap), pretende dar um contributo para esta área
do conhecimento. Definiram-se como metas orientadoras deste trabalho (i)
estudar a síntese de nanoparticulas de Hap (Hap NP), e a modificação das
características físico-químicas e morfológicas das mesmas através da
manipulação das condições de síntese; (ii) estudar a funcionalização das Hap
NP com nanoestruturas de ouro e com ácido fólico, para lhes conferir
capacidades acrescidas de imagiologia e terapêuticas, particularmente
interessantes em aplicações como o tratamento do cancro (iii) estudar a
resposta celular a materiais nanométricos, com propriedades físico-químicas
diversificadas.  
No que se refere à síntese de Hap NP, comparam-se dois métodos de síntese
química distintos, a precipitação química a temperatura fisiológica (WCS) e a
síntese hidrotérmica (HS), em meios aditivados com ião citrato. A síntese WCS
originou partículas de tamanho nanométrico, com uma morfologia de agulha,
pouco cristalinas e elevada área superficial especifica. A síntese HS à
temperatura de 180ºC permitiu obter partículas de dimensões também
nanométricas mas com área específica inferior, com morfologia de bastonete
prismático com secção recta hexagonal e elevada cristalinidade. Com o
objectivo de aprofundar o papel de algumas variáveis experimentais na
definição das características finais das partículas de hidroxiapatite,
designadamente o papel do ião citrato (Cit), variou-se a razão molar [Cit/Ca] da
solução reagente e o tempo de síntese. Demonstrou-se que o ião citrato e
outras espécies químicas resultantes da sua decomposição nas condições
térmicas (180ºC) de síntese tem um papel preponderante na velocidade de
nucleação e de crescimento dessas mesmas partículas e por conseguinte nas
características físico-químicas das mesmas. Elevadas razões [Cit/Ca] originam
partículas de dimensão micrométrica cuja morfologia é discutida no contexto
do crescimento com agregação. 
 
 
  
  
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Com o objectivo de avaliar a citotoxicidade in vitro das nanopartículas
sintetizadas procedeu-se à esterilização das mesmas. O método de
esterilização escolhido foi a autoclavagem a 121º C. Avaliou-se o impacto do
processo de esterilização nas características das partículas, verificando-se
contrariamente às partículas WCS, que as partículas HS não sofrem
alterações significativas de morfologia, o que se coaduna com as condições de
síntese das mesmas, que são mais severas do que as de esterilização. As
partículas WCS sofrem processos de dissolução e recristalização que se
reflectem em alterações significativas de morfologia. Este estudo demonstrou
que a etapa de esterilização de nanopartículas para aplicações biomédicas,
por autoclavagem, pode alterar substancialmente as propriedades das
mesmas, sendo pois criticamente importante caracterizar os materiais após
esterilização. Os estudos citotoxicológicos para dois tipos de partículas
esterilizadas (HSster e WCSster) revelaram que ambas apresentam baixa
toxicidade e possuem potencial para a modelação do comportamento de
células osteoblásticas.  
Tendo em vista a funcionalização da superfície das Hap NP para multifunções
de diagnóstico e terapia exploraram-se condições experimentais que
viabilizassem o acoplamento de nanopartículas de ouro à superfície das
nanopartículas de Hidroxiapatite (Hap-AuNP). Tirando partido da presença de
grupos carboxílicos adsorvidos na superfície das nanopartículas de Hap foi
possível precipitar partículas nanométricas de ouro (1,5 a 2,5 nm) na superfície
das mesmas adaptando o método descrito por Turkevich. No presente trabalho
as nanopartículas de Hap funcionaram assim como um template redutor do
ouro iónico de solução, propiciando localmente, na superfície das próprias
nanopartículas de Hap, a sua redução a ouro metálico. A nucleação do ouro é
assim contextualizada pelo papel redutor das espécies químicas adsorvidas,
designadamente os grupos carboxílicos derivados de grupos citratos que
presidiram à síntese das próprias nanopartículas de Hap. Estudou-se também
a funcionalização das Hap NP com ácido fólico (FA), uma molécula
biologicamente interessante por ser de fácil reconhecimento pelos receptores
existentes em células cancerígenas. Os resultados confirmaram a ligação do
ácido fólico à superfície das diferentes partículas produzidas HS e Hap-AuNPs.
Graças às propriedades ópticas do ouro nanométrico (efeito plasmão)
avaliadas por espectroscopia vis-UV e às potencialidades de hipertermia local
por conversão fototérmica, as nanoestruturas Hap-AuNPs produzidas
apresentam-se com elevado interesse enquanto nanodispositivos capazes de
integrar funções de quimio e terapia térmica do cancro e imagiologia.  
 
 
 
  
  
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
O estudo da resposta celular aos diversos materiais sintetizados no presente
trabalho foi alvo de análise na tentativa de se caracterizar a toxicidade dos
mesmos bem como avaliar o seu desempenho em aplicações terapêuticas.
Demonstrou-se que as Hap NP não afectam a proliferação das células para
concentrações até 500 g/ml, observando-se um aumento na expressão
genética da BMP-2 e da fosfatase alcalina. Verificou-se também que as Hap
NP são susceptíveis de internalização por células osteoblásticas MG63,
apresentando uma velocidade de dissolução intracelular relativamente
reduzida. A resposta celular às Hap-AuNP confirmou a não citotoxicidade
destas partículas e revelou que a presença do ouro na superfície das Hap NP
aumenta a taxa proliferação celular, bem como a expressão de parâmetros
osteogénicos. No seu conjunto os resultados sugerem que os vários tipos de
partículas sintetizadas no presente estudo apresentam também
comportamentos interessantes para aplicações em engenharia de tecido
ósseo.  
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Abstract 
 
 
Thanks to the last developments in the field of nanomaterials synthesis and to
the powerful characterization techniques at the nanoscale, a nanoparticle (NP)
can now be viewed as a device of high therapeutic potential. The improvement
of its therapeutic effectiveness however still requires the deepening and
systematization of important knowledge, still very incipient, on critical related
issues including toxicity, selectivity, side effects and their own dependence on
the physicochemical characteristics of the NP under analysis. The awareness
of this need has framed the present work whose material target is a substance
currently considered as biocompatible and nontoxic, hydroxyapatite (Hap),
aiming to contribute to the referred pool of knowledge. The guiding goals of this
work are here stated as: (i) to study the synthesis of nanoparticles Hap (Hap
NP) for understanding the control of particle physico-chemical characteristics
through the manipulation of its synthesis conditions, (ii) to study the
functionalization of Hap NP with gold and with folic acid in order to impart both
imaging and therapy abilities to the synthesized NP thus addressing their
usefulness for particular applications related to the treatment of cancer, (iii) to
examine the cellular response to nanosized materials having diverse physico-
chemical properties.  
For the study of Hap synthesis a hydrothermal synthesis (HS) technique
assisted by citric acid additive was followed. The potential of citrate ion (Cit) for
tailoring the synthesized particle morphology was exploited by varying the
molar ratio [Cit:Ca] of the starting precursor solution. It was demonstrated that
the citrate ion and/or other chemical species resulting from citrate
decomposition at the used synthesis temperature (180°C) has a major role on
nucleation and growth processes of the resulting Hap particles and on their
final physico-chemical characteristics. Prismatic Hap particles with hexagonal
cross section but with nanometric dimensions were obtained for a low [Cit:Ca]
ratio while increasing ratios originated micrometer-sized particles composed by
assembled fiber-like or sheet-like particles whose morphology may be
discussed in the framework of an aggregation assisted growth. The evaluation
of the biological performance of the produced nanometric Hap particles was the
natural step in the present study. However, for the goal of comparing the
impact of Hap NP morphology variations on cell response, a second chemical
precipitation method (WCS) at physiological temperature and using the same
additive was also adopted to produce thinner Hap NP. The physico-chemical
characteristics of the two precipitated particles, i.e. HS and WCS Hap NP, were
comparatively discussed, being found that thin needle-like particles of very high
specific surface area (170 m2/g) are obtained from WCS as compared to the
prismatic HS particles of lower specific surface area (55 m2/g) but of higher
crystallinity. Moreover, as in vitro studies require sterilized materials, the
particles were autoclaved at 121º C and the sterilization impact  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
on the particles properties was evaluated as well. Contrarily to WCS particles
no significant changes are observed on HS morphology, consistently with the
high synthesis temperature conditions for HS NP that exceed largely
autoclaving condition. WCS particles undergo dissolution and recrystallization
processes which are reflected on significant changes of WCS NP morphology.
These results demonstrate that autoclaving sterilization may substantially alter
the properties of NP intended for biomedical applications being thus critically
important to characterize the materials after sterilization. The in vitro
cytotoxicity studies on both type of sterilised particles (HSster and WCSster)
revealed that they present low toxicity and have potential for the modulation of
the osteoblastic cell behaviour.  
The possibility of functionalizing Hap NP surface for multifunction purposes
(diagnosis and therapy, for instance) was also exploited in the present work.
Taking advantage from the presence of adsorbed carboxylic groups left by the
synthesis process, HS NP surfaces could be used as a kind of template for
gold precipitation, thus providing a new approach to Turkevich method for gold
precipitation. Gold nanoparticles with an average diameter of 1.5 to 2.5 nm
were effectively precipitated on HS nanoparticles facets as revealed by
transmission electron microscopy (TEM). The reducing ability of the species
adsorbed on HS surface including carboxylate compounds derived from citrate
was thus confirmed as gold ions supplied by the neighbouring gold solution
underwent a local reduction giving place to metallic gold spots and hence to
nanostructured hydroxyapatite-gold nanoparticles (Hap-AuNPs). The
functionalization of Hap NP with folic acid (FA), a molecule with high biological
interest due to its easy recognition by the receptors on tumor cells, was also
studied. The results confirmed the conjugation of FA to the surface of HS and
Hap-AuNPs nanoparticles. Thanks to the optical properties of Hap-AuNPs
imparted by the nanometric gold (plasmon effect) as confirmed by UV-vis
spectroscopy and to the hyperthermia effect reported for metallic nanometric
gold, the Hap-AuNPs here produced show a great potential as nanodevices
able to integrate functions of chemical and thermal therapy for cancer and
imaging. The cellular response to the various nanomaterials synthesized in this
work was also analysed in an attempt to characterize their toxicity and to
assess their biological performance aiming to identify potential therapeutic
applications. It was demonstrated that Hap NP do not affect MG63 cell
proliferation until concentrations up to 500 g/ml, as indicated by BMP-2 and
alkaline phosphatase expression. It was also found that Hap NP undergo
internalization by MG63 osteoblast cells, suffering a relatively low intracellular
dissolution rate.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
The cellular response to Hap AuNPs confirmed their non-cytotoxicity while
showing that the presence of gold at the surface of Hap NP increases the cell
proliferation rate and the expression of osteogenic parameters. Altogether the
in vitro results suggest that the behavior of the various types of particles
synthesized in this study addresses a potential interest for applications in hard
tissue engineering. 
  
 
 
  
 
 
 
 
 
 
 
 
 
Ao meu marido Bruno 
e às minhas filhas, Adriana e Filipa 
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The precise architectural manipulation of nano or microcrystals with well-defined 
morphologies and tunable sizes remains a research focus and a challenging issue 
in the materials science field because it is well-known that the properties of the 
materials are closely interconnected with geometrical factors such as shape, 
dimensionality and size 1. Consequently remarkable efforts have been dedicated 
to develop new fabrication methods of a range of high-quality inorganic 
nanoparticles. Furthermore, the emergence of novel nanoparticles (NPs) is 
expected to contribute as well to considerable improvements of bioanalytical 
measurements as to cause a substantial progress in vitro and in vivo diagnostics 
and therapies 2.  
Despite the remarkable therapeutic potential of nanoparticles in medicine, the 
fundamental information regarding the physico-chemical interaction between NPs 
and cells is still relatively limited. It is known that cellular uptake of nanoparticles is 
modulated by size, shape and effective surface charge and surface 
functionalization 2. Depending on the nature of the NPs, cell membrane may 
exhibit different penetration and cytotoxic response. It is thus important to develop 
new NPs and to correlate their physicochemical properties with the cellular 
response for enlarging the pool of knowledge in this field.  
Nowadays one of the major challenges related to NP is to combine therapeutic 
ability with a molecular imaging approach in order to provide coupled diagnosis 
and therapeutic functionalities to NP thus enhancing their biomedical usefulness. 
An ideal solution would imply the development of a simple system that could 
simultaneously present biocompatible properties and work as contrast agent 
allowing image enhancement by imaging techniques. Several metallic NPs such 
as gold are being exploited as contrast agent to achieve this goal. Moreover for 
certain applications like cancer treatment, nanometric sized noble metal particles 
may further enable the possibility of photothermal therapy which would reinforce 
the NP therapeutic potential.  
The awareness of these demanding issues has framed the present work which is 
centred on a material target currently considered as biocompatible and nontoxic, 
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i.e. hydroxyapatite (Hap), aiming to contribute to the development of novel 
biomedical applications and to deepen its underlying scientific knowledge. This 
general objective will be guided by the following specific goals: (1) to study the 
synthesis of Hap nanoparticles (Hap NP) for understanding the dependence of 
nanoparticle physicochemical characteristics on its specific synthesis conditions, 
(2) to study the functionalization of Hap NP with gold and with folic acid in order to 
impart the possibility of both imaging and therapy abilities to the synthesized NP 
thus addressing their usefulness for particular applications related to the treatment 
of cancer and (3) to examine the cellular response to the synthesized nanosized 
materials having diverse physicochemical attributes.  
Therefore, the first objective of this work will be pursued through the study of Hap 
particle size and shape evolutions under the variations of the experimental 
parameters of an hydrothermal synthesis method assisted by citrate ion (Cit). The 
understanding of this organic additive role as tailoring tool of the various nano and 
micro sized morphologies of the obtained Hap particles will be attempted. 
Furthermore, in order to access the effects of Hap nanoparticles (Hap NP) 
morphological features on the elicited biological response, Hap NP produced by 
two different methods hence displaying distinct attributes (size shape and 
crystallinity) will be also addressed either “as prepared” or after the sterilization 
step prior to in vitro studies.  
The functionalization of Hap nanoparticles with nanometric metallic gold (Au0) will 
be also exploited through a novel synthesis approach which revisits the classical 
Turkevich method for gold precipitation. The properties of the newly obtained 
nanostructured materials (Hap-NPs with Au) will be discussed envisaging potential 
applications of (Hap-NPs with Au) that might benefit from coupled therapeutic and 
contrasting properties. Finally the conjugation of the produced particles with a 
vitamine such as folic acid (FA) which is claimed as a tumour targeting moiety, is 
also studied. The functionalization studies are complemented by in vitro essays 
aiming to access the cytotoxity and gene expression induced by the synthesized 
particles on MG63 osteoblastic cells.  
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The present thesis is organized in 5 chapters. Chapter 1 is dedicated to literature 
review aiming to bring up to date the reader with the state of the art. Literature 
review will cover the fundamental characteristics of Hap particles, its synthesis 
approaches and then Hap particles medical applications. Finally the advantages of 
the functionalization of Hap-NPs surface for diagnostic and therapeutic purposes 
will be also reviewed. 
In chapter 2 the experimental procedures used for the synthesis of both Hap and 
Hap-Au nanoparticles and for particles functionalization with FA are detailed. The 
characterization techniques used throughout this work for accessing the various 
properties of the synthesized materials will be also introduced. 
The following chapters will present, analyse and discuss the experimental results 
obtained in the work under analysis. The results regarding the hydrothermal 
synthesis of Hap nano and microparticles with a controllable size and morphology 
are discussed in chapter 3. Hap crystals properties including microstructure, 
crystalline phase and functional groups are comparatively judged for particles 
precipitated under different amounts of organic additive (Cit) and after different 
growth time. Chapter 4 discusses the interaction with cells of Hap-NPs with distinct 
morphology obtained by two different methods. Cell proliferation, alkaline 
phosphatase and genetic markers were used in the assessment of the cellular 
responses. 
The functionalization of Hap-NPs is presented and discussed in the last chapter 
(chapter 5) in which gold precipitation on Hap surface and FA conjugation are 
focused. Metallic particles morphology analysis is based on transmission electron 
microscopy and UV spectroscopy and FA functionalization accessed by Fourier 
transforms infrared spectroscopy analyses. This chapter is complemented by in 
vitro studies which examine MG63 osteoblastic cells response to the different 
produced Hap nanoparticles. 
The final chapter presents the main conclusions and suggest future work to 
complement the studies undertaken in this thesis as well.  
Introduction 
6 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Chapter 1  
Background on hydroxyapatite 
nanoparticles synthesis and 
functionalization 
 
 
 
 
Chapter 1       Background on hydroxyapatite nanoparticles synthesis and functionalization 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter 1       Background on hydroxyapatite nanoparticles synthesis and functionalization 
9 
1.1. Introduction 
It is the objective of this chapter to provide an overall survey of the basic concepts 
and up-to-date literature results concerning the use of hydroxyapatite and 
functionalized hydroxyapatite nanoparticles for medical applications. It includes a 
brief description of the crystal structure and important properties of hydroxyapatite, 
and a review of the current methodologies of hydroxyapatite synthesis. Finally the 
applications of hydroxyapatite particles in various areas of medicine are also 
described. 
Metallic nanoparticles in special gold are currently receiving a great attention, 
mainly due to their excellent optical, imaging and therapeutic properties. For that 
reason, they were considered as good candidates to be targeted on 
hydroxyapatite nanoparticles. The main characteristics, synthesis methods and 
applications of gold nanoparticles will be also surveyed.  
Finally, in order to optimize the potentialities of hydroxyapatite nanoparticles for 
medical applications, the main properties of a recognized vitamine, folic acid, and 
its potential to be attached to hydroxyapatite nanoparticles will be addressed. 
1.2. Hydroxyapatite (Hap): an overview 
1.2.1. Hap as the main inorganic constituent of bone 
Calcium phosphate, in particular hydroxyapatite (Hap), has a high potential for 
healthcare applications due to its high biocompatibility which reflects the fact of 
being the inorganic mineral of mammalian bone and teeth 3,4.  
Bone provides the basic mechanical support to the body by transferring forces that 
are involved in locomotion but has also other functions 3. It has now been 
established that bone not only acts as a reservoir for minerals, primarily calcium 
and phosphate related ones, which circulate through blood in supersaturated 
concentrations, but also stores growth factors, fatty acids, heavy metals, and other 
toxic elements, besides being further involved in blood buffering by controlled 
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release of alkaline salts 3. Bones also provide physical protection to vital internal 
organs and some bones also act as production plant of red and white blood cells 3. 
Bone performance comes not only from the synergetic combination of its mineral 
and organic components properties, but also from its hierarchical, superstructural 
organization 3. Figure 1.1 shows the hierarchical architecture of bone, detailing its 
different hierarchical levels. The shape of the bone as it is known macroscopically 
in our body is shown in the first picture (figure 1.1 (a)). A deeper analysis and 
depending on the bone position it is possible to observe the spongy and cortical 
bone (figure 1.1 (b)) which is composed by cylindrical structures called osteons. In 
the center osteons (figure 1.1 (c)) large blood vessels are found 3,5. The cylindrical 
structures called of osteons are formed by fibril bundles that are organized in 
arrays of lamellar structures with thickness of 3–7 m 6 (figure 1.1 (d) and (e)). 
These arrays are mineralized collagen fibrils, linked by a protein phase (figure 1.1 
(f) and (g)). The mineral phase present in collagen fibrils is composed by 
hydroxyapatite nanoparticles (Hap-NPs) 3,5. Hap-NPs are responsible for imparting 
appropriate compressive strength, so that collagen fibers, able to dissipate energy 
effectively, provide superior elastic properties, thus improving the brittleness of the 
Hap 3. In an effort to develop systems that promote the development of bone 
tissue, several groups have studied the effect of scaffolds based on a combination 
of natural bone with the information provided to cells by the extracellular matrix 
(ECM) and hydroxyapatite, showing that there is an improvement in the growth of 
osteoblasts adhesion and stimuli for the mineralization, compared to matrices 
without hydroxyapatite. In the most recent years, scaffolds containing 
hydroxyapatite particles with various shapes and sizes have been produced and 
their bioactivity investigated 7. It was found that a nanocomposite scaffold coated 
with needle-shaped hydroxyapatite particles showed the strongest osteoblast 
differentiation profile compared with round spherical shaped particles 7.  
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Figure 1.1- Hierarchical multiscale structure of bone, showing the different hierarchical 
levels (adapted from 6).  
Biological mineralization (or biomineralization) is a process of in vivo formation of 
inorganic minerals. In the biomineralization processes, organized assemblies of 
organic macromolecules regulate nucleation, growth, morphology and assembly of 
inorganic crystals. Biologically calcium phosphates (biological apatite) formed in 
vivo under mild conditions are always nanodimensional and nanocrystalline. Two 
forms of Hap crystals can be distinguished in dentin and bone depending on their 
localization: extrafibrillar and intrafibrillar (figure 1.2) 3. According to many reports, 
at the nanostructural level, tiny plate-like crystals of biological apatite occur in 
bone within the discrete spaces of collagen fibrils and grow with a specific 
crystalline orientation along the c axis, which align roughly parallel to the 
longitudinal axis of the collagen fibrils 4. The apatite growth is somehow limited by 
the small intercollagenous spaces, which are approximately 50 nm in length, 25 
nm in width and 2–3 nm thick 5,8. Y. Cai et al. report a new model of ‘‘bricks and 
mortar’’ regarding the biological aggregation of apatite nanoparticles. According to 
their report an inorganic phase, amorphous calcium phosphate (ACP), acts as 
‘‘mortar’’ to cement the crystallized ‘‘bricks’’ of nano-Hap. Meanwhile, biological 
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molecules control the nano-construction. For that is using Hap nanospheres as the 
building blocks, highly ordered enamel like and bone-like apatite are hierarchically 
constructed in the presence of glycine (Gly) and glutamate (Glu), respectively as 
observed in figure 1.2.  
They also produce enamel-likel apatites using bovine amelogenin. For that they 
use a concentration of 1.25 M of amelogenin, and large enamel-like Hap 
mesocrystals were formed after 3 days, they observed that enamel-like apatites 
formation is about 20 times faster than with 10 M glycine. This shows that this 
protein, a well-known effective modifier during in vivo tooth enamel formation, can 
dramatically accelerate the kinetics of nano-assembly and promote the formation 
of elongate apatite microstructures 9. 
Figure 1.2- A schematic model of apatite evolution via the conglutination of ‘‘bricks (Hap) 
and mortar (ACP)’’. Under the control of biological components such as glycine and 
glutamate, the Hap subunits can be re-organized (adapted from 9). 
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1.2.2. Hydroxyapatite crystal structure issues  
Owing to its chemical similarity to the calcium phosphate phase of human bone 
together with its biological performance, synthetic hydroxyapatite (Hap 
Ca10(PO4)6(OH)2) has been recognized as an important bone substitute material in 
orthopaedics, dentistry and artificial implants. Moreover its biodegradation 
products, Ca2+ and PO43-, are found in relatively high concentrations (about 1–5 
mM) in the bloodstream 10. Hap ceramics due to their natural occurrence, are 
classified as biocompatible and safe systems by the US food and drug 
administration (FDA) 10 and are widely used in pharmaceutical technology 11,12 
being recommended by the World Health Organization and the European 
Pharmacopoeia 10. 
Calcium phosphate minerals can adopt numerous crystal structures depending on 
stoichiometry and conditions of formation and thus a number of other calcium 
phosphate minerals are known in addition to Hap (table 1.1) which details will not 
be analysed in this thesis.  
Table 1.1- calcium phosphate minerals biologically relevant (adapted from 3,13,14)  
 
Mineral Chemical formula Ca/P ratio 
Crystallographic 
characteristics 
Solubility 
product 
(pKsp) 
Monocalcium phosphate 
monohydrate (MCPM) Ca(H2PO4)2H2O 0,5 Triclinic P1 
Highly 
soluble 
Dicalcium phosphate 
dehydrate (DCPD) (brushite) CaHPO4.H2O 1.0 Monoclinic C2/c -6.4 
Octacalcium phosphate 
(OCP) Ca8H2(PO4)6.5H2O 1.33 Triclinic P1 -46.9 
Tricalcium phosphate (TCP)  and  –Ca3(PO4)2 1.5 =rhombohedral R3c -29.5 
Hydroxyapatite (Hap) Ca10(PO4)6(OH)2 1.67 Hexagonal P63/m -114.0 
Fluoroapatite Ca10(PO4)6F2 1.67 Hexagonal P63/m -118.0 
 
Chapter 1       Background on hydroxyapatite nanoparticles synthesis and functionalization 
14 
Hap is a mineral from the family of apatites, with general formula Ca10(PO4)6X2, 
where X is typically OH- (hydroxyapatite Hap), F- (fluorapatite), Cl- (chlorapatite)15. 
In biological conditions, Hap can be subjected to an extensive substitution of ions. 
Thus human bone apatite is best described as (Ca,Z)10(PO4,Y)6(OH,X)2, where Z= 
Na+, Mg2+, K+, Sr2+, and so forth, Y = CO32-, HPO42-, and X = Cl-, F- 3,15. In fact 
most of these impurities, except fluoride, contribute to the solubility increase of the 
resulting nonstoichiometric apatite. According to the literature, CO32- is the most 
common impurity (3-8 wt %) in biological apatites, and the synthetic carbonated 
Hap is shown to have an improved bioactivity as compared with pure Hap, which 
has been attributed to the greater solubility of the carbonated phase 3. The 
presence of CO32- ions in the Hap crystal structure has also been shown to have a 
retarding effect on the crystal growth since it induces a reduction of symmetry, a 
decrease in the crystallite size and increased degree of distortion 3.  
The basic apatite crystal structure was published nearly simultaneously by Náray-
Szabó and Mehmel in 1930 15. The most frequently encountered structure of Hap 
belongs to a hexagonal system with P63/m space group16,17 where the dimensions 
of the unit cell of the pure material were reported to range from a=b= 9.398 Ǻ to 
9.438 Ǻ and c= 6.868 Ǻ to 6.887 Ǻ, with α=β= 90º and γ=120º 18. A less common 
symmetry of Hap lattice is described by P21/b space group within the monoclinic 
crystal system 3. The two possible structural models of hydroxyapatite differ in the 
arrangement of the OH- ions 19. Furthermore, several substitution has an effect on 
the lattice parameters 3. These changes in crystal lattice parameters are often 
correlated with changes in crystallinity, thermal stability, morphology, solubility and 
other physicochemical and biological properties of the material 3. Biological Hap 
crystal surface is rarely smooth, and the reason is related to its biological 
application. The roughness of biological Hap, specially its surface irregularities, 
allow further adsorption of proteins and other biological molecules on its surface 
which benefits the biomineralization process 3. Previous studies have shown that a 
rough surface improves the biocompatibility of the material and has a positive 
effect on inflammatory reactions, whereas the viability of monocytes seeded on flat 
surfaces tends to be far less 3. Also, cells are constantly creating and 
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decomposing Hap in bone, and rougher surfaces provide conditions for an easier 
anchoring of cells.  
The overall crystal structure of hydroxyapatite is indicated in figure 1.3. The 
optimized structure of hexagonal P63 Hap is characterized by two formula units per 
cell (Z = 2) and contains 44 atoms per unit cell 17. In the basal plane it is built up of 
a framework of PO4 tetrahedra, where two oxygen atoms are located on a 
horizontal plane (with respect to the c-axis) and the other two are positioned on an 
axis parallel to the c-direction. Within the unit cell the PO4 tetrahedra are situated 
in two layers, at a height of ¼ and ¾ of the unit cell respectively, and distributed in 
such a way that they form two types of channels perpendicular to the basal plane 
16. The first type has a diameter of 2 Ǻ and is occupied by calcium ions Ca (I) 
where each unit cell contains two of these channels each containing two calcium 
ions, at heights of 0 and ½ of the unit cell. The second type of channel (diameter 
3-3,5 Ǻ) has its walls formed by oxygen atoms and by Ca (II) ions, located at 
heights of ¼ and ¾, which constitute two equilateral triangles perpendicular to the 
c-axis, offset from each other by a rotation of 60º. As a result, the overall shape of 
this second type of channel is hexagonal and it is here that the OH- groups are 
located, although different anions (O, F, Cl) or impurities can be found in these 
channels as well 16,20.  
Figure 1.3- Crystal structure of Hap showing its c-axis perpendicular to 3 a-axes lying at 
120ºC angles to each other (adapted from 3). 
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The Hap morphology usually is needle-like, as resulting from an oriented growth 
along the c-axis 17, which is thermodynamically favoured. The Hap crystal faces 
are responsible for the macroscopic crystal morphology as shown in Figure 1.4. 
Figure 1.4- Crystal form of hydroxyapatite mineral (re-printed from 17). 
It has been observed that during bio-mineralization of teeth hard tissues (dentine 
and enamel) crystal growth occurs mainly perpendicular to the (001) plane, i.e. 
along the c-axis 17. Still, these faces ((010) and (100)) appear during the 
uninhibited growth of the Hap crystal and determine a morphology transformation 
from needles to plates. It is clear that, because Hap crystals are elongated along 
the c direction in bones and during bio-mineralization of tooth hard tissue, the 
(100) plane is the most developed, being responsible for the interaction with 
molecule 17.  
Nowadays several studies based on computational calculations have been carried 
out aiming to contribute for a better understanding of the interaction between 
molecules and the surface of minerals, including hydroxyapatite 18,20-23. From 
these studies, it is possible to estimate which surface has a lower energy and 
which are the cleavage planes. Most of the works published refer the {0001}, 
{1010} and {1011} planes as hydroxyapatite cleavage plane based on 
experimental evidence that these faces act as the binding surface for many 
anionic species, including small molecules, polymers and anionically modified cell 
surfaces 18,20. Considering the computational models developed by P.B. Ray et al. 
in 2002, and the experimental results obtained by W.A. Rachinger in 1982 it was 
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found that the cleavage plane for apatite is (100) 21,24. The presence of a cleavage 
plane is important, since the highest defect density is concentrated in that plane 
and it is possible to predict the growth of the hydroxyapatite particles along this 
cleavage plane. 
1.2.3. Synthesis methodologies of Hydroxyapatite nanoparticles 
Nanosized and nanocrystalline bioceramics clearly represent a promising class of 
orthopaedic and dental implant formulations as well as drug delivery systems with 
improved biological and biomechanical properties when compared with other class 
of materials. In general, nanostructured materials offer improved performances as 
compared to their larger sized counterparts due to their larger surface-to-volume 
ratios which turn them a kind of bridge between single molecules and bulk material 
systems5. Recently, numerous efforts have been devoted to the development of 
synthesis approaches of nanostructures able to ensure a close size and shape 
control. Chronological data regarding the synthesis of nanosized apatites are 
presented in Table 1.2 5,25. In general, the shape, size and specific surface area of 
the apatite nanoparticles appear to be very sensitive to both the reaction 
temperature and the reactant mode addition.  
Table 1.2- Chronological data on nano-hydroxyapatite synthesis.  
Year  Synthesis Process 
1995 Synthesis of nanocrystalline hydroxyapatite (particle size ∼20 nm) for the first 
time using calcium nitrate and ammonium hydrophosphate as precursors by 
solution spray dry method 26 
2000 Synthesis of biomimetic nano-sized Ca-hydroxyapatite powders (∼50 nm) at 
37°C and pH of 7.4 from calcium nitrate tetrahydrate and diammonium 
hydrogen phosphate salts in synthetic body fluid (SBF) using novel chemical 
precipitation technique 25  
2002 Preparation of nano-sized hydroxyapatite particles and hydroxyapatite/chitosan 
nano-composite 27 
2002 Direct precipitation from dilute calcium chloride and sodium phosphate 
solutions 28 
2003 Radio frequency (rf) plasma spray process employing fine spray dried (SD) 
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Hap powders (average size ∼15 μm) as feedstock 29 
2003 Sol–gel process using equimolar solutions of Ca (NO3)2·4H2O and (NH4)2HPO4 
dissolved in ethanol solvent 30 
2003 Chemical precipitation through aqueous solutions of calcium chloride and 
ammonium hydrogen phosphate 31 
2003 Mechanochemical synthesis of nano-Hap and TCP powders using calcium 
hydrogen phosphate (CaHPO4·2H2O) and calcium oxide (CaO) as starting 
materials 25 
2003 Synthesis of Hap nano-powders via sucrose-templated sol–gel method using 
calcium nitrate and ammonium hydrogen phosphate as precursor chemicals 32 
2004 Hydrolysis method by hydrolysis of dicalcium phosphate dihydrate 
(CaHPO4·2H2O, DCPD) and CaCO3 with 2.5 M NaOH (aq) 33 
2004 Citric acid sol–gel combustion process using calcium nitrate, diammonium 
hydrogen phosphate and citric acid 25 
The synthesis of calcium phosphate nanostructures where Hap-NPs are included, 
can be performed by using a wide variety of methods, such as: wet chemical 
precipitation 34,35, sol-gel processing 5, co-precipitation, emulsion technique, 
hydrothermal process, mechanochemical method, ultrasonic technique, template 
method, microwave processing, emulsion hydrothermal combination, and 
microwave hydrothermal combination 25. Table 1.3 summarizes the synthesis 
methods of calcium phosphate (CaP) nanostructures as well as their own 
advantages and disadvantages 36. Using these methods, a variety of nanoscale 
calcium phosphate particles with different structures and morphologies have been 
synthesized, including needle-like, spherical, fibrous, mesoporous nanocrystals, 
nanorods, hollow nanospheres, layer nanostructures and flowers 34,37-39. In this 
thesis, a particular attention will be paid to two synthesis methods, the wet 
chemical method and the hydrothermal method. Both are relatively simple and low 
cost methods easy to be controlled.  
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Table 1.3- Synthesis methods of various CaP nanostructures. Advantages and disadvantages.  
Synthesis methods 
Nanocrystals 
morphological attributes 
Advantages/Disadvantages 
Sol-gel  
processing 30,40,41 
Aggregated nanocrystals
The crystals with high purity and homogeneous components can be 
synthesized easily using simple experimental apparatus. 
Requires a high sintering temperature and is a time-consuming process. 
Co-precipitation 31,42 
Needle-like, spherical 
and rod-like 
nanocrystals 
Low-cost process allowing the easy synthesis of crystals possesses bone-
like structures. The use of biomacromolecules allows controlling the particle 
aggregation. 
The products have low crystallinity and are easily aggregated. 
Emulsion  
technique 43,44 
Needle-like, spherical 
nanocrystals, nanorods 
and nanoplates  
The size and morphology of the products can be well controlled and the 
products exhibit low aggregation and narrow diameter distribution. 
Requires a high sintering temperature and is a time-consuming process. The 
reaction system is complex. 
Hydrothermal 
process 45,46 
Needle-like, spherical 
and fibrous nanocrystals 
and nanorods 
Particles have high cristalinity and purity and are well dispersed particle size 
and morphology can be well controlled. 
Time-consuming process. 
Mechanic-chemical 
method 47 
Fibrous and spherical 
nanostructures 
Simple and low cost method without high sintering temperature needs. 
Nanocrystals tend to aggregate. Special equipments are required 
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Ultrasonic 
technique 36 
Needle-like and 
spherical nanocrystals 
The products have low aggregation and narrow diameter distribution; fast 
crystallization is obtained at  low temperature. 
Needs special equipment and the yield is very low. 
Template  
method 48,49 
Nanorods, nanoplates, 
mesoporous and fibrous 
nanostructures, flowers 
and layer structures 
The structure, morphology, size and array of the products can be well 
controlled. 
Needs to employ template agents and high sintering temperature and is a 
time-consuming process; low yield. 
Microwave 
processing 36,50 
Rod, needle-like and 
flower structures 
Needs special equipment and is difficult to apply to large-scale synthesis. 
Emulsion-
hydrothermal 
combination 51,52 
Spherical, rod, fibrous 
and strap-like structures 
The method avoids particle aggregation and growth and the final products 
have narrow diameter distribution; the size and shape of products can be 
well controlled under low temperature.  
Needs special apparatus and is a time-consuming process; the reaction 
system is complex and the yield is very low. 
Microwave-
hydrothermal 
combination 53 
Needle-like and 
spherical crystals 
This method is fast and no high temperature is needed; The synthesized 
products have high crystallinity. 
Requires special apparatus and the yield is very low. 
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1.2.4. Hydroxyapatite particles: nucleation, growth and morphology  
In the last two decades, the study and development of nanomaterials including the 
chemical synthesis of inorganic nanocrystals has made remarkable progress. 
Chemical synthesis approach allows hydroxyapatite nanocrystals with different 
sizes and morphologies to be obtained, as shown in figure 1.5. Nanocrystals may 
not be merely objects of nanoscale dimensions. Rather, nanocrystals can be 
complex objects as illustrated in figure 1.6 54. As observed one of the inorganic 
nanocrystal constituents is a nanoparticle (with dimensions of 1 to 100 nm), with a 
single crystallographic domain. Moreover, due to their large proportion of surface 
to bulk atoms, nanocrystals present different types of organic and/or inorganic 
compounds or ions chemically or physically adsorbed. The presence of these 
adsorbed compounds may play an important role in their size and shape control, 
as well as in stabilizing and functionalizing the synthesized material 54-56.  
Figure 1.5- SEM image of hydroxyapatite crystals, with different sizes and morphologies, 
(adapted from 57). 
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Figure 1.6- Schematic representation of a nanoparticle formed from an inorganic 
nanocrystal with an organic/inorganic compound bonded to its surface (adapted from 54). 
 
Another important point to be considered is the fact that during the genesis of 
nanocrystals, a phase-separation process takes place, which is generally 
described by a nucleation step followed by a growth process. According to the 
classical theory, nucleation can be described as the formation of “clusters” of 
chemical units (ions or molecules), i.e, the so-called critical nuclei, having such a 
critical size that a further unit addition causes its free energy to decrease. The 
Gibbs free energy curve depicted in figure 1.7 illustrates this process. The critical 
cluster formation may imply primary clusters formation (step 1) and cluster 
dimension increase (step 2) which are reversible events. When the critical size (r*) 
is reached then a critical nucleus is formed and its natural growth will proceed 
(step 3) as it is a process accompanied by energy decrease being thus irreversible 
(thermodynamics condition). In many precipitation processes the use of stabilizers 
may help to control crystal size (step IV the figure 1.7) 54. 
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Figure 1.7- Schematic diagram of the nucleation and growth process showing the 
dependence of the Gibbs free energy (G) on the crystal radius. Bellow a critical radius 
(r*), reversible events leading to clusters formation take place; for r > r* the process 
becomes irreversible (source 54). 
To a first approximation, the shape of the crystal is controlled by energetic 
arguments (this is a thermodynamic condition). Geometric arrangements that 
minimize the surface energy will frame the cluster growth as proposed by Wulff, 
being this an important argument for predicting the final shape of a nanocrystal 
54,58,59. However molecules, ions or clusters can interfere in the process by 
undergoing preferential on the growing particle surface or by promoting 
adsorption/desorption of a stabilizer, thus originating an anisotropic crystal. In fact, 
the size and shape of nanocrystals have been controlled using a suitable 
combination of stabilizers and/or solvents. As illustrated in the last step (step V) 
interaction of the growing nanocrystals (step IV) may take place hence producing 
larger structures. This nanocrystal based self-assembly process is governed by 
particle–particle and particle–solvent interactions. Thus agglomerated (disordered 
assembly) nanocrystals or mesocrystals (mesoscopically structured crystals) may 
be formed. Needless to say, the above described process is an ideal one. One of 
the major obstacles to achieve a good control of the colloidal synthesis of 
nanocrystals is to separate the nucleation events from the growth process, and 
thus the synthetic routes that succeed to produce nanocrystals with controlled 
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size, size distribution and shape are directly correlated with the ability of controlling 
the nucleation and growth processes 5,25,34,59,60. Therefore particulate systems that 
present non uniform particle size and shape are often considered to reflect the 
overlap of both processes which may further affect particle morphology if 
significant particle size disparities are observed. This will be a fertile field for 
Ostwald ripening (OR). Ostwald ripening (OR) theory has been generally used to 
explain some crystal growth processes where larger particles grow at the expense 
of smaller ones 54,61. This mechanism contributes to the decrease of the system 
Gibbs free energy since as the smaller particles undergo solubilisation, their large 
surface energy contribution vanishes hence decreasing the overall system energy. 
However in recent years, several studies have pointed out the inability of OR 
theory to describe adequately particle growth kinetics in several systems 54,61,62. 
The main reasons for this lack of agreement between theory and experimental 
data have been referred as; (a) the non-equilibrium condition between the 
solubilisation and precipitation processes contrarily to OR assumptions (b) the 
very low solubility of some inorganic compounds, even at the nanoscale and (c) 
the formation of nanostructures with complex shapes and the presence of defects, 
e.g., dislocations and planar defects. In the late 20th century, Penn and Banfield 
identified an important crystal growth mechanism of nanoparticles referred as 
‘‘oriented attachment (OA)’’ or ‘‘oriented aggregation’’ 62-64. This mechanism is 
based on the spontaneous self-organization of adjacent nanocrystals, resulting in 
particle growth by surface addition of a solid particle so that a common 
crystallographic orientation is shared following particles joining at a planar 
interface. Nanocrystal growth via the OA mechanism generally leads to the 
formation of anisotropic nanocrystals and particles with irregular shapes by 
consuming primary nanocrystals as “building blocks”, and the growth rate is size-
dependent 54,61,62. OA has been identified as the predominant growth mechanism 
during the synthesis or hydrothermal/solvothermal treatment of several materials 
54,61-64. One of the characteristics of the OA mechanism not found in the OR 
mechanism is the presence of a solid–solid interface between the nanocrystals, 
indicating that the growth process begins only after contact is established between 
particles, as schematically illustrated in Figure 1.8. The oriented attachment 
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mechanism has not been currently referred for describing the formation of 
hydroxyapatite nanoparticles 65.  
Figure 1.8- Scheme of nanocrystal growth controlled by: (a) Ostwald ripening mechanism; 
(b-1 and b-2) oriented attachment mechanism 54.  
The synthesis of a nanocrystal is not a simple task, because it requires control 
over the chemical composition, size, size distribution and shape of the 
crystallographic phase, as well as the chemical state of the nanocrystal surface 
54,55,57. Detailed investigations of nanocrystals growth process for understanding 
the experimental parameters determining crystal size and shape development are 
fundamental to build a tailoring ability of new nanostructured functional materials 
or to develop chemical protocols of high yield for producing nanocrystals with high 
reproducibility 54,66,67. 
1.2.5. Citric acid and biological Hydroxyapatite particles 
The control of particle size and shape in chemical synthesis methods at the 
nanometer level is commonly achieved by using organic molecules, usually 
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surfactants. Depending on the nature of the surfactant this could be a drawback as 
the surfactant can bind to other active agents especially biological molecules that 
can be used as drug.  
Alternative approaches may rely on simpler organic molecules with physiological 
functions acting as solvent or reactant and/or as ligand for the control of the crystal 
size and shape may be suggested. By properly choosing organic additives that 
might have specific molecular complementarity with their inorganic counterparts, 
the growth of inorganic crystals can be rationally directed to yield products with 
desirable morphologies and/or hierarchical structures. Small chelating ligands 
such as citric acid known for their metabolic functions have already been used as 
“shape modifiers” to adjust and control the size and morphology of precipitated 
products. These organic molecules have been referred to modify the 
hydroxyapatite crystal growth by either promoting or inhibiting the crystal growth 
along specific crystallographic facets 68,69.  
According to literature, Hap crystal dimensions, particularly the crystal thickness, 
are critical to the mechanical properties of bone, since a thickness of ~3 nm can 
prevent the propagation of cracks 70. Also, recent research showed that desirable 
osteoconductivity could be achieved with synthetic Hap resembling bone minerals 
in composition, size, and morphology 70. Many studies on bone biomineralization 
have been focused on the identification of proteins promoting or inhibiting the 
apatite crystal formation, such as a series of Glx-proteins 70. It has been 
hypothesized that proteins, such as osteocalcin provide recognition mechanisms 
of Hap surface and thus control the growth of biological crystals Hap 70. However, 
a recent and closer examination of the interface between collagen and bone 
apatite crystals by advanced solid-state NMR techniques (figure 1.9) 70 has 
revealed that citrate is the dominant organic ion at that interface, tightly bound to 
apatite and covering the surface with a density of one citrate molecule per 4 nm2 
(ca. 1/6 of the available area). About 80 wt % of the total body citrate is 
accumulated in bone. Carboxylate groups are key entities for regulating the 
formation of apatite, since they enable the molecular control of the size and 
stability of hydroxyapatite (Hap) nanocrystals in bone and in vitro 70. According to 
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Y.Y. Hu et al. citrate must remain in bone as an interfacial component that affects 
properties of the bone nanocomposite more profoundly than do simple 
substitutions of carbonate for phosphate or of sodium for calcium in apatite crystal 
lattice 71. They propose that citrate bound to the nanocrystal surface stabilizes the 
apatite nanocrystals by preventing their further growth 70,71. Additionally, is 
described in literature that citrate in bone provides more carboxylate groups than 
all the proteins other than collagen taken together. In vitro studies have shown that 
citrate in bone at higher concentrations results in smaller Hap nanocrystals 70. 
Figure 1.9- Schematic representation of the influence of citrate in bone formation ( 
adapted from 70). 
Moreover, citrate stabilizes Hap 70 and synthetic materials pre-treated with citrate 
give better biocompatibility in tissue repair 70. Despite these studies, the effect of 
citrate on Hap is still not well understood. Citrate molecules have three carboxyl 
groups with pKa values of 3.1, 4.8, and 6.4. At pH =7.5-8 they are completely 
ionized and can bind strongly to Ca 2+ on Hap surface. Studies on citrate in natural 
bone 70 or on citrate in vitro interaction with Hap 70 have revealed that citrate is 
found on the surface of apatite crystals without being incorporated within the 
crystal lattice, due to the relatively larger size of citrate ion (figure 1.10) as 
compared with Hap lattice ions such as phosphate or OH-. This indicates that once 
a citrate molecule occupies a certain surface area of a growing Hap particle, a 
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further crystal growth on the top of that area will be inhibited unless the citrate 
species departs or undergoes surface diffusion. In addition, surface-bound citrate 
molecules generate a negatively charged surface area, 70 which repels negatively 
charged phosphate ions, thus hindering further crystal growth. Via electrostatic 
repulsion, the negatively charged apatite surface also makes difficult the 
aggregation of the primary crystallites into bigger particles 70. 
Figure 1.10- Schematic representation of citric acid molecule (adapt from 72). 
Citrate binding to biological apatite can help to understand the mechanism of 
apatite morphology control in vivo and to explain why the crystal morphology of 
apatite in bone is plate-like, whereas it is rod-like in human tooth enamel. The 
main reason is because the amount of citrate in both biological environments is 
quite different. In bone, it is relatively large at 5 wt% of the organic components 73. 
According to X. Baoquan and H.Nancollas 73 both terminal carboxylate groups of 
citrate can interact with calcium ions of Hap at a distance of 0.3 nm, and all citrate 
carbons are found at approximately 0.4 nm from the top phosphate layer; the long 
axes of the citrate molecules are nearly parallel to the apatite surface, and the 
citrate methylene groups face outward. This unique high binding structure reduces 
the hydrophilic character of the surface, making it more compatible with the 
nonpolar proline and alanine residues of the collagen matrix. In this way, it 
decreases the interfacial energy between the thickness of nanocrystal and 
collagen layer and provides good interfacial compatibility. It also can help direct 
apatite nanocrystal growth, with the c-axis oriented along the long axis of a 
collagen fibril 73. This may be a reason for the formation of layer-by-layer 
composite structures frequently found in biological systems such as bones and 
teeth 73. However other alternative models have been proposed for citrate 
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interaction with Hap surface as is the case of W. Jiang et al 74 who suggested that 
citrate ion coordinates only one surface calcium ion through a terminal carboxylic 
group. This coordination mode would facilitate the self-assemblage of citrate 
molecules by intermolecular hydrogen bonding 74. Thus citrate interaction with Hap 
surface is still an issue under discussion.  
1.2.6. Influence of citric acid on Hap synthesis  
Focusing specifically on the role of citrate ion (Cit) as additive during the formation 
of hydroxyapatite nanoparticles, some phenomena related to the presence of Cit in 
the precipitating medium are interesting 34,75.  When starting from an aqueous 
solution of Hap precursors added with citric acid, the strong chelation ability of 
citrate ion towards Ca2+ reduces the effective concentration of free Ca2+ in 
solution, thereby lowering Hap nucleation rate. It is possible that citrate-chelated 
calcium ions, such as (CaCit)− and Ca(HCit), directly take part in the nucleation 
process 34,75. Once Hap particles are precipitated and regardless particle growth 
mechanism, the as-produced Hap particles are coated with citrate ions 34,75. These 
citrate ions have been considered important players at the Hap surface: their 
adsorption on early precipitated Hap particles (primary Hap particles) contributes 
to their surface energy reduction hence hindering the contact between Hap 
particles and the surrounding aqueous solution that otherwise would undergo an 
aggregation process. Furthermore particle coverage with Cit might help preventing 
crystal growth, particularly of citrate-covered facets, favoring the formation of 
needle-like Hap particles. 
Citrate role is also affected by temperature 34,35,75,76. A temperature dependent 
adsorption mechanism of Cit on Hap surface was considered to account for the 
variation of Cit stabilization ability towards Hap particles. At a low-temperature the 
strong interaction between carboxylate (–COO−) and Ca2+ may explain the linking 
ability of Ca sites belonging to two different Hap primary particles which may easily 
aggregate forming larger precipitates 34,75. As temperature increases according to 
C. Li et al. 75 the interactions between citrate and calcium ions are weakened, thus 
favouring the interruption of some inter-particle citrate–calcium links and hence the 
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increase of Hap particles negative surface charge. Consequently repulsive 
interparticle interactions arise, which in turn enable primary particles of large 
aggregates to get separated from one another 75.  
1.2.7. In vitro and in vivo performance of Hydroxyapatite nanostructures 
In comparison with the conventional CaP porous ceramics, the nanomaterials that 
are composed of nanoscale grains and have high specific surface area surely 
possess micro/nanoscale porosities and more favourable surface topography 36. 
These structural advantages are anticipated to display higher bioactivity and 
unexpected biological properties 36. Unfortunately, little attention has been paid to 
the study of the biological effects to the CaP nanoparticles 36 and only recently 
start to emerge some biological work with hydroxyapatite nanoparticles.  
It is well known that the formation of a normal tissue goes through a series of cell 
biological actions, including proliferation, differentiation, and ultimately, spatial 
organization. Cell differentiation will be regulated by a cascade activated gene 
expression guided by the biological environment and tissue inducible factors to 
initiate and regulate substantially cell actions thereof 36. When implanted into the 
body, biomaterials such as Hap, affect the biological environment and actions of 
cells, thus being able to participate in cell gene expression regulation and 
ultimately to induce cell differentiation into specific lineages. Hydroxyapatite 
nanostructures, normally presenting more sophisticated morphologies and 
structures than Hap microstructures, are expected to have higher bioactivity, 
hence with higher ability to affect the biological actions of cells 36. Previous studies 
have indicated that a layer of bone-like nano apatite crystals formed on the surface 
of CaP particles with specific composition and structure can adsorb many 
osteogenic proteins, especially small molecular proteins which are selectively 
adsorbed (e.g. growth factors) 36. However, when the surface topography of the 
biomaterials is nanostructured, the characteristics of surface protein adsorption 
are largely changed 36.  
Natural bone tissue can auto repair and heal, but synthetic biomaterials cannot. 
The key issue is that synthetic biomaterials for bone replacement do not display 
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osteoinductivity 36. This properties gap has driven humans to mimic the structures 
and properties of natural bone aiming to develop a new generation of biomaterials 
that might regulate the specific gene expression to differentiate along specific 
lineages, and ultimately regenerate the living tissues with the help of the body 
itself 36. To achieve this goal, the main strategies have incorporated growth factors 
or cultured living cells into materials scaffolds 36. However, due to the high cost of 
growth factors and a time-consuming process of cell culture, the clinical use of 
these biomaterials has been limited 36. Another important factor, affecting the 
osteoinductivity of the CaP particles is the phase composition. It is known that new 
bone tissue formation is preferentially induced by biphasic calcium phosphate 
(BCP) ceramics rather than by Hap ceramics. In the BCP, the high solubility of β-
TCP phase (~40%) allows Ca2+ and PO43- ions to be released. It is generally 
accepted that these ions can participate in the growth of a bone-like apatite layer 
at the ceramic surface under the regulation of endogenous biological molecules, 
which play crucial roles on affecting the biological behaviours of cells and provide 
the Ca2+ ions for new bone formation. It is also accepted that the released Ca2+ 
transmits a signal to a receptor on cell membranes thus affecting cell 
differentiation 36. Based on biological tests, a biological response of cell-
nanoceramics interface can be proposed with respect to the osteoinductivity of the 
nanoceramics (fig 1.11) 36. 
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Figure 1.11- A proposed biological evolution of cell-nanoceramics interface according to in 
vivo and in vitro experimental results 36. 
Because of their nanoscale dimensions and hence large specific surface area, 
nanomaterials exhibit remarkable properties that favour biomedical applications 36. 
Therefore it is necessary to investigate the potential threats of the CaP 
nanoparticles before clinic use. Ten years ago, Aoki et al. reported that the 
medium lethal dose of hydroxyapatite-sol (mean length: 50 nm, diameter: 10 nm) 
by injection into rats and dogs vein was determined as 160 mg/kg of animal. The 
main reason for hydroxyapatite-sol injection induced death was due to blockage of 
the capillaries. Injecting one-sixth of the medium lethal dose (i.e., 26 mg/kg) into 
veins, the blood components and pH, O2 and CO2 partial gas pressure, serum ions 
and enzymes undergo a change, but return to a normal state after one day. 
Repeated experiments by similar methods during 2 years showed that Hap 
nanoparticles would not cause chronic damage or permanent side effects to the 
living body by injecting less than one-sixth of medium lethal dose into blood 77. It 
can be thus concluded that bellow a specific concentration Hap nanoparticles are 
safe.  
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According to literature, Xi's group has used neutron-activated Hap nanoparticles 
(length: 60–150 nm, diameter: 20–50 nm) to examine the in vivo distribution of the 
Hap nanoparticles via intravenous administration in mouse models 36. They 
observed that after 1 h, lung, liver, and spleen present the highest concentration of 
the Hap nanoparticles, which is six-times higher than in other organs. After 72 h, 
however, the amount of these nanoparticles has decreased significantly in those 
three organs, suggesting that the Hap nanoparticles can be metabolized or 
excreted 36. The study also showed that the concentration of the Hap 
nanoparticles in bone decreases gradually with time in other organs except in 
bone. The decrease can be well understood because a significant amount of 
nanoparticles has been metabolized or excreted. Contrarilyin bone, the amount of 
the Hap nanoparticles increases slightly at first and then decreases. This 
nanoparticle increase in bone is due to the fact that bone is a store of calcium 36. 
The Hap nanoparticles interacts in mouse body will be collected into bone 36. The 
metabolism of the Hap nanoparticles is further demonstrated by mouse's faeces 
whose calcium concentration always increases with time. This can be obviously 
attributed to the macrophages in spleen, lung and liver, which can capture the Hap 
nanoparticles. The nanoparticles in macrophages can be metabolized by common 
bile duct and finally excluded from body via faeces. Furthermore, experiments 
show that only a very low concentration of calcium is detected in the urine, 
suggesting the nanoparticles are not excluded via kidney 36. Xi's group 
experiments have shown that the health of rats was not generally affected under 
the 9 mg/kg body weight dose of Hap nanoparticles, demonstrating that such dose 
is safe because it will be ultimately metabolized by liver. 
Hap nanoparticles have been also cultured with cells, being found that Hap 
nanoparticles 20 nm sized have a great potential for stimulating mesenchymal 
stem cells bone regeneration (MSCs) and for inhibiting the growth of 
osteosarcoma cells in vivo. The behaviour induced by Hap nanoparticles with 40 
and 80 nm in size is intermediate between that of commercial Hap and 20 nm Hap 
particles. This suggests the potential therapeutic utility of the 20 nm Hap for bone 
replacement and reconstruction, especially after partial ablation of bone tumors 78. 
However, there is conflicting evidence that the 20 nm Hap are internalised, 
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appearing to influence cell proliferation which is significantly higher than for the 
control cells 78. Shi et al. reported that both cell proliferation and cell apoptosis are 
related to the size of the Hap particles. Nanoparticles with 20 nm were the most 
effective at promoting osteosarcoma cell growth and inhibiting cell apoptosis 79. 
These reports suggest that the proper dose of the Hap nanoparticles has low 
cytotoxicity to normal cells. 
Interestingly, Hap nanoparticles are simultaneously reported as expressing low 
cytotoxicity to normal cells and as having considerable antitumor activity 36,80. In 
1993, Aoki accidentally found that the Hap nanoparticles can inhibit the 
proliferation of Ca-9 cells 36. Later, Zhi-Su Liu found that Hap nanoparticles not 
only inhibit proliferation but also induce apoptosis of human hepatoma cell line 
BEL-7402 in vitro 81. Quiang Fu has demonstrated that synthesized spherical 
nanocrystalline Hap particles can function as an effective biomaterial for bone 
tumor rectomy repair, while having little adverse effect 80. Chen's studies 
demonstrated that Hap nanoparticles inhibit the proliferation of SGC-7901 cells by 
inducing apoptosis and can regulate the expression of Bcl 2 gene and the 
expression of Bax, and furthermore activate caspase-3 and caspase-9 (cysteine 
proteases) to induce the apoptosis of tumor cells 82. This study allowed to 
conclude that Hap nanoparticles have the capability to induce the apoptosis of 
tumor cells. 
B. Li have demonstrated that a proper concentration of Hap nanoparticles can 
significantly induce the apoptosis of malignant melanoma A375 cells, but do not 
affect to a significant extent the viability of fibroblasts 83. In summary, the biological 
risks, cytotoxicity, and anticancer activity of Hap nanoparticles are size and dose-
dependent. Hap nanoparticles are suggested to present low cytotoxicity and to be 
safe in animals for doses below 26 mg/kg, and are probably safe for clinic use. 
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1.2.8. Biomedical applications of hydroxyapatite nanoparticles 
1.2.8.1. Bone repair 
The rapid development of nanotechnology has prompted commercial solutions 
based on Hap nanoparticles for medical applications. 
NanOss™ bone void filler from Angstrom Medica, Inc. is considered to be the first 
nanotechnological medical material which received the US Food and Drug 
Administration (FDA) approval in 2005. It is obtained by calcium orthophosphate 
nanoparticles precipitation from aqueous solutions, being the resulting powder 
then compressed and heated to form a dense, transparent and nanocrystalline 
material 5. NanOss™ mimics the microstructure, composition and performance of 
human bone, and is mechanically strong and osteoconductive, being thus used in 
sports medicine, trauma, spine and general orthopaedics markets. 
Ostim® (Osartis GmbH & Co. KG, Obernburg, Germany) is a ready-to-use 
injectable bone matrix in paste form that received CE (Conformite Europeenne) 
approval in 2002. It is an aqueous suspension of synthetic nanocrystalline Hap 
(average crystal dimensions: 100 × 20 × 3 nm3 and specific surface area of 106 m2 
g−1), prepared by a wet chemical reaction 84. Ostim® does not harden off when 
mixed with blood and thus is highly suitable for increasing the volume of 
autologous or homologous material. Simultaneously, its viscosity enables its 
application to form-fit in close contact with bone. Ostim® can be used in 
metaphyseal fractures and cysts, acetabulum reconstruction and periprosthetic 
fractures during hip prosthesis exchange operations, osteotomies, filling cages in 
spinal column surgery, etc. 15,84,85. It can be incorporated into bones, and new 
bone formation is visible after only 3 months 9,85.  
1.2.8.2. Dental applications 
Dental caries is a worldwide oral disease. At the initial stage of caries lesions, 
bacteria cause damage to the enamel, which is the exterior coating of teeth 
possessing remarkable hardness and resistance. Filling with synthetic materials is 
a conventional treatment for repairing damaged enamel. However, secondary 
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caries frequently arise at the interfaces between the tooth and foreign materials 
9,86. 
Hap is often considered as a model compound for dental enamel due to their 
chemical similarity 9,86. Therefore, the remineralisation of enamel minerals by using 
synthetic apatite or other calcium orthophosphates has frequently been suggested 
in dental research 9,86,87. Unfortunately these chemical analogues of enamel are 
not widely applied in clinical practice. The native structure of enamel is too 
complex to be remodelled, and the synthesized apatite crystallites often have 
different dimensions, morphologies and orientations as compared to the natural 
ones, which result in poor adhesion and mechanical strength during dental 
restoration 9. Recent advances in biomineralization also indicate that the features 
of smaller Hap nanoparticles may more closely approximate the features of 
biological apatite than do those of the larger Hap particles that are usually used 
9,87. It has been demonstrated that Hap nanoparticles can be self-assembled to 
form enamel-like structures in the laboratory. Therefore, it is suggested that the 
localized repair of the enamel surface can be improved by Hap nanoparticles, 
analogous to the basic building blocks of enamel rods. Furthermore, it is found that 
nanosized Hap can adsorb onto the enamel surface strongly and can even be 
integrated into the natural enamel structure 88,89. This strategy may have potential 
applications in dentistry as it offers an easy but effective method to reconstruct 
tooth enamel that is suffering from mineral loss 89. Generally it can be also 
suggested that analogues of nanobuilding blocks of biominerals should be 
highlighted in biomineralization, despite the absence of the complicated 
morphology and structures of the natural materials. 
1.2.8.3. Other applications 
Several other applications of nanostructured hydroxyapatite can be also outlined. 
To prevent inflammation, to prevent dissolution in the case of low pH and 
potentiate the enhancement of bioactivity as well as to improve the conjugation 
ability with special functional groups, surface modification of hydroxyapatite 
nanoparticles with polymeric matrices has been performed 90-94. Additionally, Hap 
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nanoparticles can be stably loaded with radioisotopes to be used in patients with 
rheumatoid arthritis and chronic knee synovitis 95. Hydroxyapatite nanoparticles 
have also served as non-viral carriers for drug delivery, gene therapy and protein 
carrier because of their established biocompatibility, ease of handling and 
adsorption affinity 96,97. Nanosized apatite particles after loading with genes or 
drugs by adsorption, acquire protective environment against degradation while 
providing a convenient pathway for cell membrane penetration and the controlled 
release of the gene/drugs 98-102. The literature results have shown that 
nanodimensional Hap possesses a higher penetration rate into cell membranes 
and their transfection efficiency can be 25-fold higher than that of micrometric 
particles. Furthermore, nanosized Hap hold larger load amounts of drugs because 
of its larger specific surface areas as compared to coarser particles 99,103. The 
transfer of nucleic acids (DNA or RNA) into living cells (transfection) is a major 
technique in current biochemistry and molecular biology 104. As nucleic acids alone 
are unable to penetrate the cell wall, efficient carriers are required. Calcium 
orthophosphate nanoparticles as hydroxyapatite represent a unique class of the 
non-viral vector that can serve as efficient and alternative DNA carriers for 
targeted delivery of genes 100,101,104 and cells 105. As mentioned before Hap 
nanoparticles generally possess versatile properties suitable for cellular delivery, 
including wide availability, high functionality, good biocompatibility, potential 
capability for targeted delivery (e.g. selectively destroying cancer cells) and 
controlled release of carried drugs 105. Vaccination to protect against human 
infectious diseases may be enhanced by using adjuvants that can selectively 
stimulate immunoregulatory responses, and nanoparticles of calcium 
orthophosphates were found to be suitable for such purposes 106. 
Figure 1.12 shows a schematical overview of possible modifications on Hap 
nanoparticles allowing to design a smart biomedical nanodevice. As considered 
above the surface of the hydroxyapatite nanoparticles is biocompatible (top right) 
and to increase the attachment to specific cells (top left), specific molecules or 
antibodies can be adsorbed on the surface to develop an active-specific targeted 
system. Additionally, in order to be used as biomedical diagnostic using imaging 
systems, metallic particles as gold or silver can be conjugated on nanoparticle 
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surface (lower left). Finally it is also possible to associate therapeutic agents to the 
hydroxyapatite nanoparticle surface via electrostatic interactions or via covalent 
bonds. The stimuli-responsive release can be operated by a change in the pH or 
by enzymatic action. 
Figure 1.12- Schematic representation of a smart biomedical nanodevice. 
 
Nanotechnology has been an extremely hot topic over the last decade. Two major 
areas of nanoparticle applications are material science and biomedicine. However, 
applications of nanoparticles in the biomedical field have not yet fulfilled the 
expectations. There is still a long way to go before nanotechnology can truly 
revolutionize patient care.  
1.3. Noble metal nanoparticles and surface Plasmon resonance  
Among the different classes of organic and inorganic nanoparticles, noble metal 
nanoparticles have fascinated scientists since historic times because of their 
unique size and shape-dependent optical properties 107-109. Nowadays, the 
potential of noble metal nanoparticles is recognized to derive from the 
addressability of their interesting optical properties via spectroscopic and photonic 
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techniques. While Faraday recognized that the red colour is due to metallic gold in 
colloidal form, Mie was the first to explain this phenomenon theoretically in 1908 
by solving Maxwell’s equation for the absorption and scattering of electromagnetic 
radiation by spherical particles 109,110.  
Mie theory predicts the optical properties of homogeneous spherical particles. For 
very small particles of radius R (where 2R (diameter d) << , being  the 
wavelength of light), the extinction cross-section can be expressed as:  
 
 
 
 
                                                  (1.1) 
 
Where r and i represent the real and imaginary parts of the material dielectric 
function and m is the dielectric constant of the surrounding/embedding medium. 
Equation 1.1 predicts an extinction maximum at wavelength  where r = -2m. For 
a spherical nanoparticle much smaller than the wavelength of light (d<<), an 
electromagnetic field at a certain frequency () induces a resonant, coherent 
oscillation of the metal free electrons across the nanoparticle (figure 1.13).  
Figure 1.13.- Scheme of the interaction of a metal nanosphere with light showing the 
displacement of the conduction electron charge cloud relative to the nuclei (adapted from 
111).  
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This electron oscillation around the particle surface causes a charge separation 
with respect to the ionic lattice, forming a dipole oscillation along the direction of 
the electric field of the light. The amplitude of the oscillation reaches a maximum at 
a specific frequency that is known as the surface Plasmon resonance (SPR) 112. 
The surface Plasmon oscillation of the metal electrons results in a strong 
enhancement of absorption and scattering of electromagnetic radiation in 
resonance with the SPR frequency of the noble metal Au nanoparticles, giving 
them intense colours and interesting optical properties, that can be measured 
using a UV-Vis absorption spectrometer.  
When this condition is fulfilled, the light field induces a resonant coherent dipolar 
oscillation of free electrons across the nanoparticles. For nanoparticles of Au the 
resonance condition is satisfied at visible wavelengths. This is the origin of their 
intense colours 109,110,112,113. The SPR band is much stronger for Plasmon 
nanoparticles (noble metal, especially Au) than for other metals 112. As the particle 
size, shape, structure, composition and dielectric constant of the surrounding 
medium of the Au nanoparticle changes, the optical properties also change only 
slightly as observed for the different samples of gold nanospheres in fig. 1.14. 
However, when an anisotropy is added to the nanoparticle, such as growth of 
nanorods, the optical properties of the nanoparticles change dramatically 114,115.  
Figure 1.14- Tunable optical properties of gold nanoparticles by changing the particle 
aspect ratio. Gold nanoparticles of different aspect ratio (AR) exhibit different dimensions 
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as seen by TEM (a, b), different SPR wavelength (c) and in different colour (d, e) adapted 
from 114,115.  
According to equation developed by Mie, the real part of the dielectric constant of 
the metal determines the SPR position and the imaginary part determines the 
bandwidth. For spherical AuNPs of 5 nm diameter, the SPR is located at 520 nm 
in the visible region and the particles are orange-red, but they turn blue-purple 
upon aggregation to larger AuNPs 109,116. As referred before the SPR band is 
affected by the particle size, if the size of the Au particles increases the SPR 
wavelength shifts for high wavelength and also increases the intensity. Also from 
the Mie theory, it follows that the frequency of the Plasmon band varies from 
spherical to non-spherical nanoparticles of various shapes. For instance with Au 
nanorods (AuNRs), two Plasmon bands are observed (fig. 1.15), one 
corresponding to oscillations along the length of the AuNRs (longitudinal Plasmon 
band) and the other along the width of the AuNRs (transversal Plasmon band). 
The position of these two bands varies with the AuNR aspect ratio (fig. 1.14) being 
the longitudinal plasmon absorption shifted for higher wavelength as the aspect 
ratio of the particles increases.  
Figure 1.15- Shows the UV-vis absorption spectrum of colloidal gold nanorods solution. 
The absorption band at 520 nm is the transverse mode of the surface Plasmon 
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absorption, while the longitudinal mode absorbs around 800 nm for the nanorods, adapted 
from 110. 
Since the aspect ratio influences the position of the Plasmon band absorption, the 
synthesis of AuNRs can be adjusted with a suitable ratio making them to 
correspond to commercial lasers (e.g. 360 nm, 787 nm and 1064 nm). Moreover, 
the shift of the Plasmon band to the near-IR region for AuNRs allows obtaining a 
penetration into living tissues that is much deeper than that of visible light. In 
addition the multi-component Plasmon absorption provides richer information than 
the single visible band of spherical AuNPs 116. Another way to shift Plasmon 
resonance is produce nanoparticles with a core-shell or hollow core. The decrease 
in shell/wall thickness of a core-shell or hollow core nanoparticle shifts the SPR 
117. This fact allows the choice of gold nanoparticles (different size and/or 
morphology) depending on biomedical applications. Another interesting property of 
Au nanoparticles SPR referred previously is its sensitivity to the local refractive 
index/dielectric constant of the environment surrounding the nanoparticles surface 
109. The nanosphere Plasmon resonance shifts to higher wavelengths with 
increasing refractive index of the medium 109. This phenomenon has been 
explored in the sensing of biomolecular analyses by monitoring a change in the 
SPR wavelength with the occurrence of an adsorption/binding event at the surface 
of Au nanoparticles by the biomolecules 109. The possible biological applications of 
the AuNPs will be discussed later.  
1.3.1. Synthesis of gold nanoparticles methods 
AuNPs are available in the range of 1 to more than 120 nm, and their Plasmon 
band visible absorption can be observed above 3 nm 116. Many different 
techniques have been developed to generate gold nanoparticles (AuNPs). 
Nanoparticles can be prepared by physical and chemical methods. The physical 
methods, which frequently involve vapour deposition, depend on the principle of 
subdividing bulk precursors into nanoparticles (top down approach, figure 1.16). 
The chemical approaches involve reducing metal ions to metal atoms in the 
presence of stabilizers, followed by the controlled aggregation of atoms (bottom up 
approach, figure 1.16). The latter method of preparation (chemical method) is 
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more effective for small and uniform particles than the previous (physical method) 
118.  
Figure 1.16- Schematic illustration of metal nanoparticles preparation methods 118. 
Among the conventional chemical synthesis methods of spherical AuNPs by 
reduction of gold(III) derivatives, the most popular one which was introduced by 
Turkevich in 1951 uses the citrate reduction of commercial HAuIIICl4 to Au0 in 
water 119. In this method the citrate is both the reducing agent and the stabilizer 
120. In this process, an aqueous solution of tetrachloroauric acid is brought up to 
boiling and a small volume of trisodium citrate is then added to it 114,115,119,120. In 
~10s, bluish colour appears, indicating formation of gold nuclei 119,120. The 
formation of Au nanoparticles is revealed by a deep wine red colour observed after 
few minutes 114,115,119. The completion of reaction may take several minutes 
depending upon the amount of citrate taken 120. The Turkevich method is a 
procedure still used nowadays but replacing the citrate ligand by appropriate 
ligands of biological interest 116. Following Turkevich method, Frens et al. 
synthesized gold nanospheres using citrate as a particle size controlling agent. 
The resulting nanoparticle sizes are strongly governed by the stoichiometric ratio 
between gold and the reducing agent, and higher ratios lead to the formation of 
particles with larger diameters (~ 10-100 nm). Furthermore, citrate performs as a 
particle size stabilizer via electrostatic repulsion 115,117. However, for particles 
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larger than 30 nm, deviation from a spherical shape is observed as well as a larger 
polydispersity. The major limitations of this method are the low yield and the 
restriction of using water as solvent 108. The dual role of citrate as reducing 
reagent and as protection group has been well identified in the growth of gold and 
other noble metal nanocrystals 121. However, sodium citrate is known as weak 
base, which may change the solution pH to a certain extent if its concentration 
varies. It is known that the reactivity of gold complexes, reflected by their reduction 
potential, changes markedly by varying pH (figure 1.17) 121,122. In addition, the 
molecular forces between citrate protection groups and gold surfaces and -
potential of gold nanocrystals were reported to be also strongly dependent on pH 
121. 
Figure 1.17- Schematic representation of equilibrium between gold species according to 
pH (adapted from 122). 
Although most of the reactions occurring in this method and the intermediates 
formed in the process are known, some of the steps are still not fully understood. 
In the following paragraph, the reactions that usually occur will be discussed. 
According to S. Kumar et al. 120 gold precipitation by Turkevich method can be 
systematized in three steps: the initial step comprises the oxidation of citrate to 
acetone dicarboxylic acid after which a second step consisting of auric salt (AuCl3) 
reduction to aurous salt (AuCl) takes place. The third step involves the 
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disproportionation of aurous ions (Au+) to gold atoms (Au0). The equations 
corresponding to these three steps are respectively: 
                              (1.2) 
AuCl3 + 2e-           AuCl + 2Cl-                                                                          (1.3) 
3AuCl    Au0 + AuCl3                                                                                      (1.4) 
The last step (eq. 1.4) is facilitated by the acetone dicarboxylic specie that helps 
the formation of aurous species and dicarboxy acetone complexes which provide 
the combination of several aurous chloride molecules as required by equation 
(1.4). This is thus a multi-step process where serial and parallel 
oxidation/reduction reactions take place. 
An schematic representation of the complex as well as of the dicarboxy acetone 
specie are presented in figure 1.18 which shows that three Au+ can be tethered by 
a minimum of two dicarboxy acetone molecules 120.  
Figure 1.18- Schematic representation of dicarboxy acetone aurous complex species 
(adapted from 120).  
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The complex disproportionates, and gold atoms are formed. These atoms adsorb 
Au+ and, by complexation with dicarboxy acetone, form large aggregates 120. 
Further disproportionation leads to formation of still larger aggregates of gold 
atoms. When the size of the aggregate reaches a critical value, a nucleus of gold 
atoms is formed. The gold atoms produced by disproportionation are adsorbed by 
the particles, resulting in its growth 119,120. However, the stoichiometric ratio of 
citrate to gold required for complete conversion of auric chloride should be even 
larger than 1.5 119,120. 
Another method that has become extremely popular for Au nanoparticle synthesis 
(ranging in diameter between 1.5 and 5.2 nm) is the two-phase reduction method 
reported in 1993 by Giersig and Mulvaney 108 and improved in 1994 by Brust-
Schiffrin and co-workers 114,123. Basically, HAuCl4 is dissolved in water and 
subsequently transported into toluene by means of tetraoctylammonium bromide 
(TOAB), which acts as a phase transfer agent. The toluene solution is then mixed 
and thoroughly stirred together with an aqueous solution of sodium borohydride 
(NaBH4 a strong reductant), in the presence of thioalkanes or aminoalkanes, which 
readily bind to the Au nanoparticles formed. The colour of gold nanoparticles can 
change from orange to deep brown within few seconds changing the ratio of the 
Au salt and capping agent (thiol/amine) 108,123. Several enhancements of the 
preparative procedure have been reported 114,123. Murray and co-workers improved 
the method by offering a remarkable and well-designed alternative to the two-
phase reduction method. They explored the place exchange of a controlled 
proportion of thiol ligands by various functional thiols and the subsequent reactions 
of theses functional AuNPs 123. Other gold morphologies like polyhedral 
nanocrystals were obtained by a conventional polyol process. The polyol process 
was originally developed by Fievet and co-workers 114,124. In this process, liquid 
polyol or diol acts as both a solvent for precursors and as a mild reducing reagent 
and it has proven to be a convenient, versatile, and low-cost route for the 
synthesis of gold. Several other examples exist of the reduction of gold salts by 
organic solvents, like sulphur-containing ligands such as: xanthates and disulfides, 
di- and trithiols and resorcinarene tetrathiols 123. As mentioned above, deviations 
from spherical geometry strongly affect the optical properties of AuNPs. For this 
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reason, methods for the synthesis of nanoparticles with different shapes like: rods, 
wires, disks, prisms, cubes, tubes, triangles, shell, cage, polyhedral nanocrystals 
and hollow spheres, in solution are continuously being studied and reported 
107,112,115,118,123,124. One of the most reported by a wide variety of strategies is gold 
nanorod. It is typically synthesized using a template method, based on the 
electrochemical deposition of gold within the pores of nanoporous polycarbonate 
or alumina template membranes 108,125. The diameter of the gold nanorods is 
determined by the pore diameter of the template membrane, while the length of 
the nanorod can be controlled through the amount of gold deposited within the 
pores of the membrane 108. The disadvantage of this synthesis method is the 
production of gold particles only on a small scale. However it represents a 
landmark in terms of shape control. Subsequently, Murphy and coworkers 
identified reduction conditions that enable the entire synthesis of Au nanorods to 
be carried out directly in solution 125, with excellent aspect ratio control. The 
method uses preformed Au seeds on which additional metal is grown in solution 
by means of a mild reducing agent (ascorbic acid), in the presence of CTAB to 
promote nanorod formation. The control of Au nanorods with different aspect ratios 
is done by addition of different volumes of the seed solution 116. Besides the 
methods mentioned above, several other approaches have also been investigated 
for the synthesis of gold nanorods, including bio-reduction growth on mica surface 
and photochemical synthesis 108.   
Malikova et al. synthesized Au nanoprisms in aqueous solution by reduction of 
neutralized HAuCl4 with salicylic acid 126. Although the yield of nanoprisms was not 
outstanding, the formation of a thin film shows that strong optical coupling occurs 
when the nanoprisms are close enough to each other. The mechanisms involved 
in the synthesis of spherical metal nanoparticles are well understood in general, 
but those leading to preferential growth in one particular direction are still a subject 
of debate. Evidence for an aggregative mechanism in some cases has been 
demonstrated, but it is clear that such a mechanism does not always apply.  
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Figure 1.19 illustrates the precipitation of AuNPs by the chemical reduction 
method in solution. 
Figure 1.19 - Formation mechanism of AuNPs with various particle sizes and shapes by 
chemical reduction method 124. 
In summary, the affinity of the surface of AuNPs having various sizes and shapes 
for thiols, disulfites, dithiocarbamates and amines allows facile bioconjugation with 
a variety of biomolecules 116. Due to the fact that CTAB has been proven as a 
cytotoxic surfactant, other substances have been searched. For instance non-toxic 
liquid crystals have been used especially if the NaBH4 reducer that leaves boride 
contamination is to be avoided. Thus, liquid-chlorin photosensitizers based on 
purpurin-18 from green algae Spirulina maxima and choline hydroxide were 
recently used to synthesize AuNPs in the absence of surfactant and other 
reducing agent 116.  
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1.3.2. Applications of gold nanoparticles 
1.3.2.1. Labelling and imaging 
Exogenous agents have been used to visualize the subcellular compartments. 
These cell images are achieved through the generation of colorimetric contrasts 
between different cells/subcellular organelles. Usual extraneous imaging agents 
include lanthanide chelates and organic fluorophores 127. However the 
fluorophores are prone to photobleaching, low quantum yields and broad emission 
window 108. Lanthanide chelates, on the other hand, are prone to nonselective 
localization in extravascular space. The shortcomings of the conventional imaging 
agent have limited their applications as biomedical diagnostic tools and have 
stimulated interest in typical nanomaterials, such as paramagnetic nanoparticles 
108, Q-dots, and AuNPs as alternative contrasting agent 108,109,127. These new 
materials with nanometric size are optimal diagnostic tools since they eliminate 
most of the vulnerabilities of the conventional imaging agents. However, the 
intrinsic cytotoxicity and the potential human toxicity of most nanomaterials have 
limited their benefit in many in vitro and in vivo applications 109. AuNPs are unique 
exceptions because they are not susceptible to photobleaching or photoblinking 
and they are more tolerable, photostabile 112,128, and biocompatible with cellular 
environment 109. However the cytoxicity of AuNPs is dose dependent and believed 
to be in the range of 1-100 AuNPs per cell 116. The facile bioconjugation and 
biomodification of AuNPs has been another factor motivating its use 109. However, 
the role of ligands in AuNPs cytotoxicity can be eventually more or less dependent 
on the cell type. According to some studies, AuNPs conjugated with biotin, 
cysteine, citrate and glucose do not appear to be toxic in human leukemia (K562) 
cells at concentrations up to 250 M in contrast to HAuCl4 solutions which were 
found to be 90% toxic 116. Further, AuNPs have been used as a radioactive label in 
vivo since the 1950s 109. Nevertheless the cytotoxic effects of AuNPs in vivo are 
not completely identified and many cytotoxicity studies report negative results. 
Additionally, it is confirmed that AuNPs are redox active and therefore reduce the 
production of reactive oxygen and nitrite species 116.  
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As previously mentioned, the colour of the gold particles is controlled by the size 
119, shape 107,112,115,118,123,124, or surface modification of these particles, due to the 
SPR effect. When excited, the SPR of gold nanoparticles can scatter or absorb 
light in the visible (spherical particles) or near to the infrared (NIR) (particles with 
different size or shape of spherical). This property is extremely important for in vivo 
testing since it allows the use of various imaging techniques such as: i) 
photoacoustic using heat-induced liquid expansion, ii) reflectance confocal 
microscopy, iii) multiphoton Plasmon resonance microscopy (when illuminated by 
laser light in resonance with their Plasmon frequency, these AuNPs generate an 
enhanced multiphoton signal measured in a laser scanning microscope), iv) 
fluorescence microscopy that allows detection at the single particle level, v) 
photothermal coherence tomography that is an optical analogue to ultrasound with 
relative good penetration depth and resolution 116,128. Other noninvasive diagnostic 
tools such as MRI and X-ray computer tomography (X-ray CT) have utilized 
AuNPs as contrasting agent due to the ease of surface modification and higher X-
ray absorption coefficient, respectively 116.  
Furthermore AuNPs exhibit special optical and electronic properties such as 
enhanced Raman scattering (SERS). These properties have been used in sensing 
and/or monitoring numerous molecular events including protein-protein interaction, 
protein aggregation and protein folding 127. For example, the SPR signals of 
AuNPs have been used not only to selectively detect DNAs but also to differentiate 
between perfect and mismatched DNA.   
It is known that the SPR absorption and scattering cross-sections of Au 
nanoparticles are significantly superior to the absorbing and fluorescing dyes 
conventionally used in biological and biomedical imaging 109. Mie theory estimates 
that the optical cross-section of the Au nanospheres is typically four or five orders 
of magnitude more intense compared to the emission from the most efficient 
fluorophores 109,128.  
 
 
 
Chapter 1       Background on hydroxyapatite nanoparticles synthesis and functionalization 
51 
1.3.2.2. Clinical diagnostics and therapy 
Several varieties of engineering nanoparticles such as: metal nanoparticles, 
nanotubes nanowires, dendrime, liposomes, polymeric micelles, ceramic 
nanoparticles, protein-based nanosystems, have been widely used for drug 
delivery, imaging, biomedical diagnostics and therapeutic applications 127. Due to 
their small size (1 nm to 100 nm), some of these nanoparticles can have some 
degree of intracellular penetration. Furthermore the charge and its lipophilicity also 
play critical roles in their uptake by the cells 117,127. Many are also known to be 
biocompatible, undetected by the immune system and biodegradable 127. 
Additionally, many could possess unique optical and electrical properties; key 
examples include quantum dots and gold nanoparticles making it possible to track 
their intracellular trafficking and localization 127. The current use of AuNPs in 
medicine will be next summarized. Crysotherapy, the use of gold in medicine, has 
been practiced since antiquity. Ancient cultures such as those in Egypt, India, and 
China used gold to treat diseases such as smallpox, skin ulcers, syphilis and 
measles 127. Presently the gold is used in medical devices including pacemakers 
and gold plated stents, for the management of heart disease; middle ear gold 
implant and gold alloys in dental restoration 127. Recently, several organogold 
complexes have shown a considerable potential as antitumor, antimicrobial, 
antimalarial, anti-HIV activities. They are also used in treatment of Cancer, 
Alzheimer, bronchial asthma, AIDS, Hepatitis B, Tuberculosis, and Diabetes 
116,127,129. 
According to the World Health Organization, cancer accounted for 7,9 million 
deaths in 2007 making it one of the leading causes of death in the world. Deaths 
from cancer around the globe are expected to climb upwards with an estimated 12 
million deaths by cancer in 2030 130. The frontiers of cancer research are therefore 
consistently challenged in order to advance the most effective means of cancer 
diagnosis, monitoring and treatment. Finding alternatives to cancer treatment 
would inevitably benefit mankind and will save countless lives 130. Conventional 
strategies for cancer intervention include surgery, chemotherapy that suffers from 
dramatic side effects and radiation therapy that is also invasive to healthy tissues 
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along the radiation path. On the other hand, laser hyperthermia (photothermal 
therapy) that uses optical heating for tumour ablation is a mild solution that avoids 
all these drawbacks. Malignant cells require larger amounts of nutrients in order to 
sustain their accelerated growth and division. To reach this demand, solid tumours 
stimulate the production of new vasculatures through which increasing amounts of 
blood can be supplied (tumor angiogenesis). In contrast to normal vessels, the 
tumor neovasculature is characterized by a highly disordered endothelium with 
large gaps that permit the preferential penetration of nanosized conjugates 117 (fig 
1.20). Several organic and inorganic photoabsorbers such as indocyanine green 
and iron oxide have been used for photothermal therapy 116. However to be 
effective it requires a lot of energy and large amounts of particles 116. The 
advantages of AuNPs come from their high absorption cross sections requiring 
only minimal irradiation energy besides being considered as non-toxic 116. 
Irradiation exploiting SPR of AuNPs is followed by fast conversion of light into heat 
116. 
Figure 1.20- Schematic illustration of how large and small gold particles penetrate through 
blood vessels at tumor sites due to their disordered endothelial cells (adapted from 117).  
Relatively small AuNPs (between 10-30 nm) are delivered more easily to cancer 
cells using various methods, like physiological transportation, conjugation with 
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antibodies among others, than larger AuNPs 116. After delivery, these AuNPs are 
self-assembled into larger clusters of closely located AuNPs directly among tumor 
cells, resulting in laser-induced bubble formation that are more effective for cell 
killing and SPR shifts from the visible region to the 700-1000 nm NIR region 116. 
The AuNPs can be advantageous in treating tumours in areas poorly accessible 
by surgery or with ill-defined margins 117. For clinical therapy applications involving 
tumors located deep within bodily tissue, there is a need to use laser light in the 
near-infrared (NIR) region of the biological water window (650-900 nm) 128. Human 
tissues and physiological fluids (e.g. oxy/deoxyhemoglobin and water) have the 
highest transmissivity in this spectral region and the absorption is minimal in the 
near-infrared region (fig 1.21). The spherical AuNPs offer very limited tunability of 
their SPR frequency. As referred above with increasing nanosphere size, the SPR 
red-shifts to a very limited extent as a result of electromagnetic retardation effects 
in larger nanoparticles 116,128. Au nanospheres over a broad-size range have 
resonances in the 520 to 580 nm region 128. For that reason they are not ideal for 
NIR applications 128. However, changing the shape of AuNPs the SPR band may 
be tuned for longer wavelengths.  
Figure 1.21 – Wavelength range of the near-infrared (NIR) tissue transmission window 
(adapted from 117).  
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It is known that the localization of the tumour is extremely important and 
determines the laser potency applicability. According to literature Microwatt NIR 
lasers (FDA class 1) have an efficient penetration as much as 4 cm through 
skull/brain and deep muscle tissue and 10 cm through breast tissue. Higher power 
lasers (FDA class 3) have exhibited 7 cm penetration depths through muscle and 
neonatal skull/brain tissue 117. However, there are tumours that are not so deep 
like skin cancer and for these types of tumours spherical particles can be a good 
choice.  
Another widely use of organogold compounds is in the treatment of rheumatoid 
arthritis 127,129. Organogold compounds relieve arthritis symptoms such as joint 
pain, stiffness, swelling, bone damage, and also reduce the chance of joint 
deformity and disability 127.  
Drug attachment to and release from AuNPs is another challenging area. While 
the ease of surface modification makes AuNP attractive for drug delivery, the 
strength of drug attachment and timing of the release needs to be suitably 
controlled to produce the highest therapeutic efficacy 130. Foremost, the method of 
release at the tumor site is dependent on how the drug is attached to the AuNPs, 
whether covalently or through non-covalent binding 130. Generally, drugs in the 
active form are loaded non-covalently while the covalent-conjugation of the drug to 
AuNPs is in the pro-drug form, thereby requiring a second reaction to release the 
drug from the attachment as well as to activate it 130. Although there have been 
quite a number of strategies proposed for the triggering of drug release at the 
tumour site, they can generally be narrowed down to three methods: light or 
photothermal release, glutathione-mediated and non-covalent encapsulation of the 
active drug with subsequent off-loading by diffusion through the membrane 130. 
The other methods correspond to modification or combinations of these ones. 
However, given the vast array of AuNPs of different shapes and sizes, it is still 
unclear which type(s) of AuNPs would be the most suitable for drug delivery 
applications. 
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Drug delivery with nanotechnological products takes advantage of 
pathophysiological conditions and anatomical changes within unhealthy tissues, 
compared with normal tissues, to achieve site-specific and targeted delivery 127. 
Nanosystems are often accumulated at higher concentrations than normal drugs, 
thereby enhancing bioavailability at the targeted site. The enhanced drug targeting 
to the unhealthy tissues usually leads to reduced systemic toxicity. Moreover, 
incorporation of drug molecules in nanosized systems could improve drug 
solubility.  
Drug delivery (both drug and DNA) appears as one of the most promising future 
applications of AuNPs because they are biocompatible, easily bio-conjugable and 
very promising for imaging, diagnostics and cancer therapy applications as well as 
in a number of other human diseases. Literature describes a large variety of 
methods to functionalize AuNPs with a large panoply of substances, though few 
data on the functionalization of inorganic nanoparticles, like hydroxyapatite, with 
AuNPs are found in the literature. This reflects the easiness of conjugating 
different molecules to the surface of AuNPs.  
Nanoparticles have been explored for non-invasive imaging, drug delivery, 
bacterial diagnostics, nerve repair and other therapeutic and diagnostic 
applications 99,131. However, advances in nanoparticle engineering accompanied 
by a better fundamental understanding of their properties are needed.  
1.4. Folic acid conjugation 
Folic acid (FA), also known as pteroyl-L-glutamic acid or vitamin B9, one of many 
“B” vitamins 132, is a water soluble vitamin required for normal tissue growth and 
development that plays an important role in the metabolism of amino acids and 
biosynthesis of DNA and RNA which is essential for humans 133. All “B” vitamins 
help the body to convert food (carbohydrates) into fuel (glucose), being thus used 
to produce energy. Folic acid is the most oxidized, stable and synthetic analogue 
of the large family of folates. The generic term “folate” refers to the class of 
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compounds having a chemical structure and nutritional activity similar to that of 
folic acid 134.  
Folic acid is present, as folate, in several vegetables and citrus fruits, being very 
sensitive to light and oxygen. This is one of the reasons why there is a risk of 
deficiency in the population. Even if it is proven that when a supplementation of 
mixed fruits and vegetables is administered, the serum concentration of folate is 
increased, the majority of the population does not attain the recommended daily 
intake (RDI) of 400 μg through their diet 133,135. This is the reason why folic acid is 
present in the majority of the nutritional vitamin supplements sold across the world. 
European Union allows the enrichment of bread and cereals with folic acid and in 
the United States, such an enrichment is even compulsory for cereals 136. Since 
folate deficiency has been associated with the incidence of neural tube defects 
during the embryo development, higher intake (600 μg/day) is recommended for 
women before and during pregnancy. A low folate intake has also been associated 
with a number of health disorders, namely, Alzheimer's and coronary heart 
diseases. Osteoporosis, increased risk of breast and colorectal cancer, poor 
cognitive performance, hearing loss, and many others have been attributed to the 
folate deficiency. Therefore, an exogenous supply of folic acid appears inevitable 
to prevent nutritional deficiency especially in view of the inability of mammalian 
cells to synthesize this vital biomolecule 133,136. Folic acid may also have potential 
applications in cancer prevention due to its retention capability of free-radical and 
antioxidant activity 137. 
Among the possible low molecular weight (MW) targeting agents, folic acid (MW 4 
441 Dalton) could be exploited to actively target cancer cells. In addition, the folate 
receptor is efficiently cell internalized after binding with its ligand (folic acid) 138. 
Thus, folic acid presents advantages as a targeting agent. First, it is stable, 
inexpensive, and not immunogenic compared with proteins. Second, folic acid has 
a very high affinity for its cell surface receptor (dissociation constant (Kd ~1 nM)) 
and it moves into the cell cytoplasm, which is an advantage for more efficient 
intracellular delivery of anticancer agents than using a cell membrane marker that 
is not cell internalized 138-140.  
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The use of FA as an adequate targeting is already well accepted owing to its 
smaller size, lack of immunogenicity, ready availability and low cost. Folic acid 
consists of a pterin ring (PT) system, a p-aminobenzoic acid (PABA) portion, and 
the amino acid glutamic acid (Glu) 141 as illustrated in figure 1.22. Folic acid has 
three dissociable groups on the molecule, the  and -carboxyl groups of the 
glutamyl moiety with dissociation constants (pKa values) of 3.46 and 4.98 
respectively, and the N-1 nitrogen in the pteridine moiety with pKa 2.38 as reported 
by Zoltán Szakács et al 142.  
Figure 1.22- Chemical structure of folic acid (adapted from 141). 
Folates are very sensitive to light, oxidants and pH. All these influences can 
drastically affect the stability of the compound. As mentioned the stability of 
reduced folates is pH-dependent, Veerle de Brouwer et al. have shown that at 
37°C most folates are stable at pH values between 4 and 8 143. The chemical 
reactivity of some important folate compounds makes the vitamin one of the most 
vulnerable to losses during food processing. Considerable losses have been 
reported; oxidative degradation enhanced by oxygen, light and heat is responsible 
for a major part of these losses 134.  
Targeting the therapeutic load at the tumour site is essential to augment the 
efficacy per dose. It is currently recognized that only parts of intravenously 
administered drugs reach the in vivo site. This finding emphasizes the need of 
developing a tumour-specific targeting of therapeutic loads 144. Nanoscience can 
play a significant role here by delivering multiple drugs on single nanoparticles in 
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an organ-specific manner. Moreover, the nanoscale size of these bioconjugates 
helps to prevent uptake by mononuclear phagocytic cells and allows for their 
penetration through the smallest capillary pores within the human vasculature. 
Therefore, if the particles bearing anticancer drugs can be delivered in a targeted 
fashion, it is expected that a better efficacy to inhibit tumour growth with reduced 
systemic toxicity will result 144. 
Folic acid receptors (FRs) exhibit limited expression on healthy cells but are often 
present in large numbers on cancer cells 144. FRs are overexpressed on epithelial 
cancers of the ovary, uterus, mammary gland, colon, lung, prostate, nose, throat, 
and brain 138-140,144-146. FRs are also overexpressed on hematopoietic malignancies 
of myeloid origin, including chronic and acute myelogeneous leukemias. A strong 
correlation has been observed between FR expression and the grade and 
histological stage of a tumour 144. Two tumour markers most commonly used as 
targets for directed therapy are the folic acid (FA) receptor and the EGFR-2 
(erbB2/HER2) 26. In general, highly undifferentiated metastatic cancers express 
considerably more FRs than their localized, low-grade counterparts. FR has also 
been found at significant levels in some normal epithelia involved in the retention 
and uptake of folate, primarily the choroid plexus, placenta, lung, intestine, and 
kidney 144. However, these FRs are mostly inaccessible to blood folate conjugates, 
because they are localized to the apical surfaces of polarized epithelia. Therefore, 
toxicity to healthy tissues expressing FRs has not been observed 144. Thus, FRs 
represents an important target for tumour-specific delivery of anticancer drugs. 
Therefore, controlling the attachment of the ligand, folic acid (FA), to nanoparticles 
constitutes an important step for FR mediated targeted delivery of nanoparticles or 
anticancer drugs 144. 
Today different strategies have been exploited for attaching FA on nanoparticles 
surfaces for the active targeting of cancer cells overexpressing folate receptors. 
Despite the large variety of formulations available, this bibliographic review will 
focus on the more recent published works, which includes natural and synthetic 
polymers, metal and ceramic nanoparticles.  
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In a very recent study, Dipsikha Bhattacharya et al. reported a study on the 
development and in vitro examination of bio-functionalized, magneto-fluorescent 
multifunctional nanoparticles (iron-oxide folate nanoconjugates) suitable for 
cancer-specific targeting, detection and imaging. They observed that nanoparticles 
show excellent aqueous dispersion stability over a range of physiological 
conditions. The cell-uptake behaviour of nanoparticles shows that cancer cells 
(HeLa) over-expressing the human folate receptor internalized a higher level of 
these nanoparticle-folate conjugates than normal cells (L929 cells) 147. Sun et al. 
also used iron oxide nanoparticles conjugated with folic acid and poly(ethylene 
glycol) in cellular tests. They confirm that iron oxide nanoparticles conjugated with 
FA can be used to specifically target tumor cells that overexpress the FA receptor 
140. Gold nanoparticles are another class of metal nanoparticles that were found to 
target tumours when functionalized with FA. Retnakumari et al. have shown the 
success on the synthesis of a folic-acid-conjugated fluorescent gold nanocluster 
capable of specifically targeting molecular receptors on cancer cell membranes 
148. Additionally they have shown that gold nanoparticles conjugated with 
glutathione and folic acid, which are easily assembled onto gold surface, through 
the reaction between amino groups of FA and carboxyl group of glutathione, allow 
the selective detection of human HeLa cells 149. Their work underscores the 
relevance of these nanoparticles for optical-imaging-based cancer detection. 
Zhang et al. discuss the chemical synthesis of a magnetic drug carrier system 
functionalized with PEG and subsequently coupled to the ligand folic acid. They 
observed that the magnetic drug carrier present a characteristic drug release 150. 
Platinum nanoparticles were also used for developing new drug candidates. The 
work reported by Teow et al. using different capping agents (folic acid capped 
platinum nanoparticles and poly(N-vinyl-2-pyrrolidine-capped nanoparticles) show 
that the inherent toxicity of the platinum nanoparticles conferred an additional 
advantage to this nanocarrier by eliminating the need for attaching anticancer 
drugs to kill cancer cells 151. Polymer chemistry allows for many variations, 
whereby polymeric nanoparticles can be easily manipulated without the loss of 
their desired physical, chemical and biological properties. In one way, this principle 
can be used to greatly improve the function of the nanoparticles in cancer therapy 
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through the attachment of tumor-specific targeting moieties (e.g. folic acid), 
directed at cell surface markers unique to the cancer cell. Shen et al. prepared 
albumin nanospheres conjugated with folic acid. For that purpose they used 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide as a catalyst. They confirmed that 
the presence of folic acid on albumin nanospheres provides an actively targetable 
drug delivery system to improve drug targeting to cancerous cells 139. Another 
study reported by Yang et al. showed that chitosan nanoparticles were 
successfully conjugated with folic acid and loaded with 5-aminolaevulinic acid. 
Additionally, they verified that particles were taken up by HT29 and Caco-2 cell 
lines via receptor-mediated endocytosis. Their work emphasized the relevance of 
those particles for fluorescent endoscopic detection of colorectal cancer 152.  
As mentioned, engineered nanoparticles have the potential to revolutionize the 
diagnosis (using e.g. gold nanoparticles) and treatment of many diseases for 
example, by allowing the targeted delivery of a drug (Folic Acid) to particular 
subsets of cells. However, so far, such nanoparticles have not proved to be 
capable of surmounting all of the biological barriers required to achieve this goal. 
Nevertheless, the developments on nanoparticle engineering supported, by the 
understanding of the effects of nanoparticle characteristics such as size, shape 
and surface properties on their biological performance are creating new 
opportunities for theragnostic nanoparticles. The recent progresses are thus 
expected to foster the rational design of such nanoparticles.  
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2.1. Introduction  
As mentioned in chapter 1, for tailoring Hap particles with predefined shapes and 
sizes an appropriate method of synthesis is required. In this research, as already 
referred a hydrothermal synthesis (HS) and a wet chemical method (WCS) 
assisted by citrate ion (Cit) were selected to produce Hap-NPs.  
Experimental details of the synthesis conditions and the variations of the 
parameters such as the molar ratio Cit:Ca of the starting solution and synthesis 
time will be described aiming to understand their influence on Hap particle size 
and shape evolutions and on the control of particles physicochemical 
characteristics. Additionally a complete description of the experimental 
characterization techniques of the synthesized Hap particles is also addressed. 
As in vitro studies require sterilized materials, the sterilization impact on the 
particles properties was evaluated as well. The experimental procedure used in 
the autoclaving sterilization is detailed.  
In an attempt to characterize the toxicity and to assess the biological performance 
of the synthesized materials their cellular response was also analyzed. The 
experimental methods used for biodistribution and toxicological studies of Hap-
NPs with different particles concentrations and culture times are described. 
The possibility of functionalizing Hap-NPs surface with gold nanoparticles (AuNPs) 
and then with folic acid (FA) for multifunction purposes (diagnosis and therapy, for 
instance) was also exploited in the present work. The techniques employed to 
characterize the produced particles as well as the experimental procedure used on 
the assessment of the biological response of Hap-NPs functionalized with AuNPs 
and FA are also detailed in this chapter. 
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2.2. Hydroxyapatite particles synthesis 
2.2.1. Hydrothermal Method (HS) 
Chemicals: All reagents were of analytical grade and used as received. Citric acid 
monohydrate (C6H8O7.H2O, 99.5%), calcium nitrate-4-hydrate (Ca(NO3)2.4H2O, 
99%), ammonia solution (NH4OH, 25%) were purchased from Riedel-deHaën. 
Ammonium hydrogenophosphate ((NH4)2HPO4, 99%) was purchased from Merck. 
Water used in the experiment was obtained with a water-purification appliance. 
Preparation of Hap particles: in a typical procedure, an aqueous citric acid solution 
(0.6 M) was prepared. Under constant stirring, ammonia solution was added for 
adjusting the pH to a value close to 8.1. After that the appropriate amounts of 
Ca(NO3)2.4H2O 0.2 M and (NH4)2HPO4 0.2 M solutions were added. The prepared 
solution was transferred into a 50 ml Teflon-lined stainless steel autoclave (see 
figure 2.1a), and was 50% capacity of the total volume of the autoclave (figure 
2.1b) were filled (50 ml). The autoclave was sealed and heated at 180 °C for 24 h 
and then cooled to room temperature with water (figure 2.1c). The precipitate Hap 
particles were obtained by filtration, through a 0,22 m Millipore and then washed 
with distilled water several times. After that, the products were dried in a 
desiccator. To study the growth of the as-prepared products, the concentration of 
citric acid (cit) was systematically varied (0.7; 0.8; 1.4 M) while the calcium nitrate 
(Ca) concentration was maintained constant. The used Cit:Ca ratio (R) were 3:1; 
3.5:1; 4:1; 7:1 respectively. 
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Figure 2.1- a) Schematic diagram of the oven setup used to precipitate hydroxyapatite 
particles. b) Detail of the calcium/citrate solution inside of the Teflon vessel and was 50% 
capacity of the total volume of the autoclave were filled; c) thermal cycle used for 
precipitating Hap particles.  
2.2.2. Wet Chemical Method (WCS) 
The technique followed to prepare hydroxyapatite nanoparticles was the method 
reported by M.A. Martins et al. 1. The necessary supersaturated solutions were 
prepared by mixing citric acid (Riedel-deHaën, 99.5% purity), calcium nitrate 
(Riedel-deHaën, 99% purity) (0.2 M) and ammonium hydrogen phosphate (Merck, 
99% purity) (0.2 M) as follows: an aqueous citric acid solution (0.6 M) was added 
with small amounts of ammonia (Riedel-deHaën) (25 vol. %) for pH adjustment to 
8.1 and then mixed with appropriate amounts of calcium nitrate and of ammonium 
hydrogen phosphate solutions. The mixture of all the reagents was performed 
under continuous stirring, at room temperature. The resulting homogeneous 
(calcium/citrate/phosphate) solution was put in a glass vessel and maintained at 
37ºC in a thermostatic water bath for 24 hours (figure 2.2). After that time the 
precipitated particles were collected by filtering the suspensions through a glass 
filter Millipore 0.22 m and washed repeatedly with deionised water. The obtained 
powders were dried in a desiccator. 
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Figure 2.2- Image of the thermostatic water bath used in WCS precipitation.  
 
2.2.3. Sterilization procedure 
The so prepared Hap particles (HS and WCS) were sterilized in a steel autoclave 
at 121ºC during 20 minutes, according to the standard procedure used in dentistry 
2. After being submitted to sterilization, the particles obtained by HS and WCS 
methods were here labelled as HSster and WCSster, respectively.  
2.3. Surface nano-functionalization of Hap nanoparticles 
2.3.1. Gold nanoparticles  
For precipitating gold particles, 86.5 μL of an acidic solution of hydrogen 
tetrachloroaurate III (HAuCl4 30 wt % solution in dilute hydrochloric acid (Aldrich, 
99.99%)) were added to 500 mL of deionized water being obtained a gold solution 
0.25x10-3 M and with pH ~3. 25 mL of the so prepared gold diluted solution were 
subsequently heated at ~100ºC 3 for 3 minutes. Then 50 mg of the previously 
synthesized Hap-NPs particles (HS) were added to the boiling gold diluted 
solution. The resulting suspension was kept without stirring for different reaction 
times: 5, 10 or 20 minutes. After that the particles were collected and filtered using 
a glass Millipore filter vessel with a 0.22 m pore size. The particles were then 
identified as HS-AuNPs 5, HS-AuNPs 10 and HS-AuNPs 20.  
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2.3.2. Folic acid molecule  
The Hap-NPs prepared by HS method and Hap-NPs functionalized with gold 
nanoparticles HS-AuNPs were selected for the attachment of folic acid (FA) onto 
the nanoparticles surface. Folic acid (FA) (0.050 g) was added to 100 ml 
phosphate buffer solution (PBS) with a pH of 7.6. After that 0.1 g of the HS and 
HS-AuNPs were suspended, in separated vessels, in PBS buffer with FA for 48H, 
in the dark, at room temperature. Finishing this process, the nanoparticles were 
then repeatedly washed in a glass filter Millipore water followed by filtration (0.22 
m millipore). 
2.3.3. Interaction of MG63 osteoblast-like cells with Hap-NPs  
MG63 osteoblast-like cells are malignant bone tumor cells with abnormal cellular 
functions 4. However, the osteosarcoma-derived cells are commonly used for 
osteoblastic models 4. 
MG63 osteoblast-like cells, originally isolated from a human osteosarcoma, were 
used in this thesis to assay the cellular effects of the different Hap-NPs. The 
selection of this cells line is due to the fact that MG63 cells have been well 
characterized, and widely used in biomaterials testing 5,6. In this work the MG63 
osteoblast-like cells (ATCC number CRL-1427) were cultured in α-Minimal 
Essential Medium containing 10% fetal bovine serum, 50 g/ml ascorbic acid, 50 
g/ml gentamicin and 2.5 g/ml fungizone, at 37ºC in a humidified atmosphere of 
5% CO2 in air. For subculture, adherent cells were enzymatically released (0.05% 
trypsin, 0.25% EDTA) and the cell suspension was cultured (104 cell/cm2) in 
standard polystyrene tissue culture plates. After 24 hours, the medium was 
removed and fresh medium containing WCSster and HSster Hap-NPs, 50 g/ml – 5 
mg/ml, was added to the adherent cells. Cultures were maintained for further 3 
and 6 days, without any medium change. Cultures performed in the absence of 
Hap-NPs were used as control. For functionalized Hap nanoparticles the same 
procedure as used for WCS and HS was followed. After 24 hours, the medium 
was removed and fresh complete culture medium, containing sterilized HS, HS-
AuNPs, HS-FA or HS-AuNPs-FA nanoparticles - 1, 10, 100 and 500 μg/ml - was 
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added to the adherent cells. These cultures were maintained for further 1, 3 and 7 
days without any medium change. 
2.4. Hap-NPs characterization techniques 
2.4.1. Physical characterization  
2.4.1.1. X-Ray diffraction analysis 
The crystalline phases of the hydroxyapatite precipitated particles before and after 
the sterilization step (HS, HSster, WCS and WCSster), as well as the Hap-NPs 
functionalized with Au nanoparticles (HS-AuNPs), were first identified by powder 
X-ray diffraction (XRD) analysis. The measurements were performed using an X-
ray diffractometer, model Rigaku PMG-VH with a Cu-K incident radiation (1.5405 
Å). The diffraction patterns were recorded at room temperature over the 2θ range 
of 10–70 at 3º/min in continuous mode. A characteristic pattern for each 
compound in a powdery form is produced by plotting the angular positions and 
intensities of the resultant diffracted peaks. The unit-cell parameters of Hap and 
other probable calcium phosphates were refined using Celref software (JCPDS, 
cards No. 9-432 for Hydroxyapatite and Nº 071-4614 for gold). 
Furthermore, in order to establish a semi-quantitative relationship between the 
peak width and the crystallite size D (diameter of the coherently scattering 
domains) of the prepared WCS (WCSster) and HS (HSster) particles the Scherrer 
equation 7 was applied. Considering this the crystallite sizes of HS, HSster, WCS 
and WCSster particles were estimated from the X-ray diffractograms using the 
Scherrer formula 1 
D = kλ/β1/2 cos θ      (2.1) 
where D is the crystallite size (Å) estimated using the reflection (002), k is a shape 
factor equal to 0.9, λ is the X-ray wavelength (1.5405 Å), θ is the diffraction Bragg 
angle related to the reflection (002), and β1/2, expressed in radians, is defined as 
β1/2 = (B − b2)1/2,     (2.2) 
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B being the diffraction peak width at half height and b the experimental width of the 
instrument 8,9. 
2.4.1.2. Differential thermal analysis and thermogravimetry 
The thermal behaviour of the prepared samples was studied by thermogravimetric 
and differential thermal analysis (TG-DTA) from room temperature up to 900ºC 
using a 10ºC/min heating rate under nitrogen flow (Setaram Labsys 1600).  
2.4.1.3. Specific Surface Area Analysis, Brunauer-Emmett-Teller (BET)  
Specific surface area (SSA) analysis materials is often assessed via a gas 
adsorption method, where a nonreactive gas (nitrogen) is adsorbed on the 
particles surface at or near the boiling point (77 K) of the adsorptive liquid at a 
single or at multiple pressures. The amount of gas molecules required to form a 
monolayer of adsorbed gas on the particles surface is determined. This is done via 
mathematic modelling the adsorption isotherms (amount adsorbed vs adsorptive 
pressure), with the most established theory developed by Brunauer, Emmett and 
Teller (BET) in 1938 10. Indeed, the BET method is now accepted as a standard 
procedure for the determination of the surface area of a wide range of fine 
powders and porous materials. Porous materials are classified according to the 
size of pores and the geometries: pores less than 2 nm are called micropores, 
pores between 2 and 50 nm are called mesopores, and pores greater than 50 nm 
are macropores 11. The evaluation of the pore geometries (figure 2.3) is generally 
associated with the isotherm (adsorption and desorption) shape type, well known 
as hysteresis loops (HL). The current IUPAC classification of adsorption isotherms 
establishes four types of hysteresis loops designated as H1, H2, H3, and H4. 
These types are illustrated in figure 2.4. 
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Figure 2.3- Schematic representation of the pore geometry, present in a porous material 
(adapted from 11). 
Figure 2.4- Schematic representation of IUPAC classification of sorption hysteresis loops 
(adapted from 11,12). 
Two extreme types are shown as H1 (formerly Type A) and H4 in figure 2.3 and 
figure 2.4. In the former the two branches are almost vertical and nearly parallel 
over an appreciable range of gas uptake, whereas in the latter they remain nearly 
horizontal and parallel over a wide range of p/p0. In certain respects Types H2 and 
H3 (formerly termed Types E and B, respectively) may be regarded as 
intermediate between these two extremes. A feature common to many hysteresis 
loops is that the steep region of the desorption branch leading to the lower closure 
point occurs (for a given adsorptive at a given temperature) at a relative pressure 
which is almost independent of the nature of the porous adsorbent but depends 
mainly on the nature of the adsorptive (e.g. for nitrogen at its boiling point at p/p0 
0.42). Type H1 is often associated with porous materials known, from other 
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evidence, to consist of agglomerates or compacts of approximately uniform 
spheres in fairly regular array, and hence to have narrow distributions of pore size. 
Many porous adsorbents tend to give Type H2 loops, but in such systems the 
distribution of pore size and shape is not well-defined. Indeed, the H2 loop is 
especially difficult to interprete: in the past it was attributed to a difference in 
mechanism between condensation and evaporation processes occurring in pores 
with narrow necks and wide bodies (often referred to as 'ink bottle' pores). The 
Type H3 loop, which does not exhibit any limiting adsorption at high p/p0, is 
observed with aggregates of plate-like particles giving rise to slit-shaped pores. 
Similarly, the Type H4 loop is often associated with narrow slit-like pores, but in 
this case the Type I isotherm character is indicative of microporosity 13. 
The specific surface area (SSA) and the hysteresis loops of the prepared Hap 
samples were determined by N2 gas adsorption, using the multipoint Braunauer-
Emmett-Teller isotherm (BET) Micromeritics-Gemini 2370 V5 equipment. The 
samples were outgassing for 24 hours. 
2.4.2. Morphological characterization  
2.4.2.1. Scanning electron microscopy  
Classical microscopes are limited in resolution to the dimension of wavelength of 
visible light (400-750 nm). The scanning electron microscope (SEM) is one type of 
electron microscope capable of producing high-resolution images of a sample 
surface 14,15. With scanning electron microscopes, much smaller objects can be 
observed because high energy electrons are used for imaging 14,15. When an 
electron beam interacts with a solid, various types of elastic and inelastic 
processes occur, including electron scattering and excitation. Secondary electrons 
are emitted from the samples with an energy less than 50 eV. The secondary 
electron current reaching the detector is recorded and the microscope image 
consists of a plot of this current against probe position on the surface. The 
contrasts in a micrograph arise from variations in the surface topography, 
additionally contain information about the sample surface, composition 14,15. 
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The microstructure and size of the obtained Hap particles with micrometric size 
were observed by scanning electron microscopy (SEM) using a Hitachi SU-70 
(Schottky emission) and a JEOL JSM-7001F (field emission). Samples were 
holded onto aluminium stubs using adhesive carbon tabs and imaged in high 
vacuum mode with an applied 25 kV (Hitachi SU-70) and 15 kV (JEOL JSM-701F) 
accelerating voltage respectively and a working distance of 15 mm for energy 
dispersive X-ray analysis (EDX). EDX analysis was performed using an Oxford 
INCA instruments EDX spectrometer in order to determine elemental compositions 
(which can be obtained with accuracy for elements of atomic number from carbon 
upwards). 
2.4.2.2. Transmission electron microscopy 
Today the ability to understand and control particles at dimensions of few 
nanometers is just possible due to a powerful tool, the transmission electron 
microscope (TEM), that allows the observation and the characterization to 
nanoscale of virtually all types of materials 16,17. Instead of using optical light for 
imaging, transmission electron microscope employs electrons with energies in the 
range of 50 to 1000 KeV 17. This technique is aimed at investigation of the 
properties of crystal with a spatial resolution that provides the observation into the 
unit cell of the crystal 18. In the transmission electron microscope, in addition to the 
high spatial resolution, the strong interaction of the electrons with matter allows the 
interaction volume to be extremely small 18. The interaction of the electron beam 
with the specimen provides different types of information such as, microstructural, 
crystallographic and chemical, that can be used to characterize the material.   
The microstructure and morphological features of  all prepared Hap particles were 
characterised via transmission electron microscopy (TEM) using bright-field 
imaging and selected area electron diffraction (SAED) using a Hitachi H-9000-NA 
operated at an accelerating voltage of 200 kV. For measurements, samples were 
dispersed in ethanol, and applied dropwise onto a holey carbon film supported on 
a 300 Mesh copper grid.  
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In separate experiments the particles co-culture with cells were selected. For 
these sample preparations, adherent cells were enzymatically released (0.05% 
trypsin, 0.25% EDTA) and the cell suspensions were centrifuged at 2000 
rotations/min for 10 min. The resulting pellet was fixed with 2.5% glutaraldehyde, 
post fixed with 2% osmium tetroxide, dehydrated in ethanol (p.a.) and later 
embedded in Epon, using routine methods. Ultra-thin (100 nm) sections mounted 
in copper grids (300 Mesh) were contrasted with uranyl acetate and lead citrate for 
TEM analysis. The TEM observation was performed using a Zeiss EM 10A 
operated at an accelerating voltage 60kV.  
2.4.2.3. Confocal Laser Scanning Microscope  
The conventional optical microscope was a milestone for biological medical 
sciences which allowed many important innovations. However, the desire of 
scientists to look in more and more details into biological materials stumbled 
against several limitations of the instrument. The optical microscope, for instance, 
does not allow observing details of living tissues. The development of the confocal 
laser scanning microscope (CLSM) enabled to overcome this limitation. Many 
fields in life sciences have taken advantage of the exceptional quality of images 
provided by confocal microscopy. For instance, in biology and pharmacology, the 
high resolution and improved contrast have been exploited for histological 
observation of the tissues at cellular level. Contrary to conventional light 
microscopy, CLSM enables direct examination of tissues at high resolution (0.2 
m) without requiring fixation and sectioning 19-21. 
The confocal principle is now reasonably well known. A light source (typically a 
laser) is focused to a diffraction-limited spot (Airy disk) at the specimen by the 
objective lens. Reflected light or emitted fluorescence is focused by the same lens 
to a spot at the detector. At this point a pinhole is placed, so that only the in-focus 
spot will pass to the detector — light from out-of-focus planes does not form a spot 
and so will be blocked by the pinhole. By scanning successive planes, a three-
dimensional image of the sample can be created 20. 
Chapter 2       Materials processing and experimental techniques 
86 
The morphological features of the MG63 cells cultured with WCSster, HSster, HS 
and HS-AuNPs nanoparticles were examined by a confocal laser scanning 
microscope (CLSM). For microscope observation the cultures exposed to WCSster 
and HSster nanoparticles, 50 and 500 g/ml, and to HS and HS-AuNPs, 1, 10, 100 
and 500 g/ml, were fixed in 4% formaldehyde (methanol free), permeabilized with 
0.1% Triton (5 min, RT) and incubated in 10 mg/ml bovine serum albumin (BSA, 1 
h, RT) with 100 µg/ml RNAse. Following, F-actin filaments were stained with 
Alexa-Fluor-conjugated phalloidin® (1:100, 1 h, RT) and nuclei were 
counterstained with 10 µg/ml propidium iodide (10 min, RT). Labelled cultures 
were mounted in Vectashield® and examined with a confocal laser scanning 
microscope (CLSM) Leica SP2 AOBS (Leica Microsystems). 
2.4.3. Chemical characterization 
2.4.3.1. Fourier transforms infrared spectroscopy  
Infrared spectroscopy is a technique based on the vibration of the atoms of a 
molecule. An infrared spectrum is commonly obtained when radiation with 
appropriated wavelength is focused on a sample and the fraction of the incident 
radiation absorbed at a particular energy is determined. The resulting spectrum 
represents the molecular absorption and transmission, creating a molecular 
fingerprint of the sample. Because each different material is a unique combination 
of atoms, no two compounds produce the exact same infrared spectrum 22. 
However, for a molecule to show infrared absorption it must possess a specific 
feature, i.e. an electric dipole moment of the molecule must change during the 
vibration 22. Infrared spectroscopy (FTIR Spectroscopy) is a type of absorption 
spectroscopy that uses the infrared part of the electromagnetic spectrum 
(wavelength ( 760 nm up to 500 μm). It may be observed that the wavelength  
is inversely proportional to the frequency  (number of cycles per second) and is 
governed by the relationship  = c/, where c is the speed of light (figure 2.5). Also 
the energy is directly proportional to the frequency:  
E = h      (2.3) 
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where h is the Planck’s constant 22,23.  
Figure 2.5- A portion of the electromagnetic spectrum showing the relationship of the 
vibrational infrared to other types of radiation 23. 
Molecules vibrate when they absorb infrared radiation. The simplest types, or 
modes, of vibrational motion in a molecule are the stretching and bending modes 
(figure 2.6). However, other, more complex types of stretching and bending are 
also active. In general, asymmetric stretching vibrations occur at higher 
frequencies than symmetric stretching vibrations; also, stretching vibrations occur 
at higher frequencies than bending vibrations. The terms scissoring, rocking, 
wagging, and twisting are commonly used in the literature to describe the origins 
of infrared bands (figure 2.6). Additionally, a ligand (ion or molecule) could be 
coordinated to another ion or molecules. This coordination usually causes: (i) the 
appearance of new bands and splitting of the degenerate modes due to lowering 
of the symmetry, (ii) frequency shifts of the bands, and (iii) intensification of the 
spectra 24. The main types of coordinating modes are described in literature 24.  
In this work special attention is given to the interaction between a carboxylate 
ligand and a cation, since this form of coordination will be important in several 
results discussion. The carboxylate group can act as an uncoordinated anion 
(“ionic” structure) or form a monodentate ligand, a bidentate chelate, a bidentate 
bridging structure, or pseudo bridging (Figure 2.7) 24. The type of coordination can 
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be determined from differences in absorption frequencies in infrared spectra as 
can be seen in table 2.1. 
Figure 2.6.- Typical molecular vibrations of the molecules (adapted from 23). 
Figure 2.7- Main types of interaction between a carboxylate ligand and a cation (adapted 
from 24). 
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Table2.1- Literature-reported carboxylate stretching bands for the main coordination types 
between a carboxylate ligand and a cation (adapted from 24). 
Fourier transform infrared spectroscopy (FTIR) was used to identify the infrared 
absorption peaks of the prepared particles. The spectral scan was carried out in 
the frequency range spanning from 4000 to 400 cm-1 using a Mattson galaxy 3020 
spectrophotometer. The test samples were prepared by mixing ~2 mg of Hap 
powder with ~300 mg of spectroscopic-grade KBr (Merck) and pressing the 
mixture as a disk.  
2.4.3.2. Zeta potential 
Zeta potential is a physical property which is exhibited by any particle in 
suspension. It depends on properties of the surface particles and on the 
suspending medium. Zeta potential is not measurable directly but it can be 
calculated using theoretical models and an experimentally determined 
electrophoretic mobility or dynamic electrophoretic mobility. In practice, zeta 
potential of the particles is measured by applying an electric field across the 
dispersion. Charged particles within the dispersion will migrate towards the 
electrode of opposite charge with a velocity proportional to the magnitude of their 
zeta potential. 
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From a theoretical point of view, zeta potential is the electric potential in the 
interfacial double layer (DL) at the location of the slipping plane versus a point in 
the bulk fluid away from the interface (figure 2.8). In other words, zeta potential is 
the potential difference between the dispersion medium and the stationary layer of 
fluid attached to the dispersed particle.  
Figure 2.8 - Schematic representation of the structure of the electric double layer 25. 
Evaluation of zeta potential is one of the most critical tests to validate the stability 
of the particles via a study of their electrophoretic behaviour. The relationship 
between suspension stability and zeta-potential arises from the mutual repulsion 
that occurs between equally charged particles. For this reason, particles with a 
high surface charge tend not to agglomerate, since surface charges are the same 
in all particles and the tendency is for the repulsion. Typically accepted zeta-
potential values are summarized below in Table 2.2 26.  
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Table 2.2- Zeta potential and associate stability 
Zeta Potential (absolute 
values) 
Stability 
0 Little or not stability 
15 Some stability but settling lightly 
30 Moderate stability 
45 Good stability, settling possible 
60 Very good stability, little settling likely 
 
The measurement of the electrophoretic mobility of the synthesized particles in 
aqueous suspensions was performed at 25º C, using a Malvern equipment 
Zetasizer Nano ZS (with a zetasizer nano series 6.00 software). This equipment 
makes use of non-invasive back scatter (NIBS) technology to perform particle size 
analysis in the range of 0.6 nm to 6 mm. In addition, it performs zeta potential 
analysis by the combination of laser Doppler velocimetry and phase analysis light 
scattering (PALS) in a Malvern’s patented M3-PALS technique. A small amount of 
the particles was suspended in a 2x10-3 M KCl solution in order to ensure a 
constant electrical double-layer thickness and then allowed to equilibrate for two 
hours before measurement. The measurements were done in triplicate for each 
pH value. HCl and NaOH solutions were used to decrease or to increase the 
suspension pH, respectively. 
2.4.3.3. Ultra Violet-Visible spectrophotometer (UV-Vis) 
As observed in figure 2.5 the ultraviolet (UV) and visible radiation comprise only a 
small part of the electromagnetic spectrum. As referred before, when radiation 
interacts with matter, a number of processes can occur but in general, when 
measuring UV-Visible spectra only absorbance is concerned 27. In some 
molecules and atoms, photons of UV and visible light have enough energy to 
cause transition between the different electronic energy levels. The wavelength of 
light absorbed has energy required to move an electron from a lower to a higher 
energy level. These transitions should result in a very narrow absorbance band at 
wavelength characteristic of the difference in energy levels of the absorption 
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species. In molecules, many transitions with different energies can occur, for that 
reason the bands are broadened (figure 2.9) 27.  
 
 
 
 
 
 
 
Figure 2.9- Electronic transition and UV-visible spectra in molecules (adapted from 27). 
An optical spectrometer records the wavelengths at which absorption occurs, 
together with the degree of absorption at each wavelength. The resulting spectrum 
is presented as a graph of absorbance (A) versus wavelength. Beer-Lambert’s 
Law is given as:  
     A= ε.b.c     (2.4) 
where ε is the absorption coefficient (dm3 mol-1 cm-1) of the absorbing medium, c is 
the concentration (mol dm-3) of the sample and b is the path length (cm) through 
the sample. According to Beer-Lambert’s law, absorption is directly proportional to 
concentration and the path length. The unknown concentrations of the sample can 
be measured by plotting the absorption (A) versus known concentration (c) of the 
standard samples. This results in a linear plot, following the Beer-Lambert’s law.  
In this work was important to test the Hap particles coupled with gold by UV-Vis 
technique, however it is not possible to use Beer-Lambert´s law to test solid 
materials by this technique. For a solid material the absorption spectrum in the 
Electronic energy level
Vibrational energy level
Rotational energy level
Chapter 2       Materials processing and experimental techniques 
93 
ultraviolet and visible is determined by a transmission experiments, by replacing 
the cell of liquids for a thin wafer of the solid 28. Due to the fact that measuring the 
absorption of the power was determined indirectly, not by measuring the 
absorption as such, the measurement of the reflection from the absorbing solid is 
used 28. For large particles one can treat the components of reflection, refraction, 
and diffraction separately using the classical work of Mie 28, but this is not possible 
for small particles where the three effects are indivisibly mixed together 28. For 
these cases there are several theories, but the most general and also most widely 
accepted is the Kubelka-Munk theory 28.  
The Kubelka-Munk theory is based upon the premise that the reflection is diffuse. 
It also assumes that the incident radiation is diffuse, i.e. that the intensity is the 
same in all directions 28,29. The rearrangement of several equations gives an 
expression that is known as the Kubelka-Munk equation 28,29:  
       ஺௖ௌ ൌ
௄
ௌ ൌ
ሺଵିோሻమ
ଶோ    (2.5) 
Where, R is the reflectance, k and S are the absorption and scattering coefficients 
respectively. c is the concentration of the absorbing species and A the 
absorbance.  
The advantages of measuring powder directly in the UV-Vis equipment is to obtain 
simultaneously information about the adsorbent (in this study HS) and adsorbate 
(gold nanoparticles) 28. The samples used for UV-Vis analysis were the particles 
HS, HS-AuNPs 5; HS-AuNPs 10 and HS-AuNPs 20 min. The reflectance values of 
the particles were measured from 200 to 700 nm in a double beam, Shimadzu 
MPC-3100 PC series spectrophotometer. The white standard was BaSO4 whose 
reflectance was taken to be 100%. Both samples and standards (as dry powder) 
were bulk-filled into aluminium frames and then gently pressed to minimize 
preferential orientations. These powders were covered with a glass. The 
reflectance measurements were converted to absorption according to Kubelka-
Munk equation, using the software installed in the equipment. 
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2.4.3.4. Liquid Chromatography 
Modern liquid column chromatography, now called high-performance liquid 
chromatography (HPLC) is one of fastest growing techniques in analytical 
chemistry. It enables to perform rapid, efficient separations of complex mixtures of 
organic, inorganic, pharmaceutical and biochemical compounds 30.  
The theoretical, chemical and physical aspects of HPLC are quite complex. 
However, the technique is easy to understand from a practical standpoint (figure 
2.10). HPLC utilizes a liquid mobile phase to separate the components of a 
mixture. The stationary phase can be a liquid or a solid phase. These components 
are first dissolved in a solvent, and then forced to flow through a chromatographic 
column under a high pressure. In the column, the mixture separates into its 
components. The amount of resolution is important, and is dependent upon the 
extent of interaction between the solute components and the stationary phase. 
The stationary phase is defined as the immobile packing material in the column. 
The interaction of the solute with mobile and stationary phases can be 
manipulated through different choices of both solvents and stationary phases. As a 
result, HPLC acquires a high degree of versatility not found in other 
chromatographic systems and it has the ability to easily separate a wide variety of 
chemical mixtures. There are many detection principles used to detect the 
compound eluting from a HPLC column. The most common are: spectroscopic 
detection, refractive index detection and fluorescence detection. Additionally there 
are various types of HPLC, their main characteristics are summarized in the table 
2.3.  
Figure 2.10- Schematic diagram of an HPLC unit (re-printed from 31). 
 
Chapter 2       Materials processing and experimental techniques 
95 
Table 2.3- Various types and applications of HPLC.  
Type 
Sample 
polarity 
Molecular 
weight 
range 
Stationary phase Mobile phase 
Adsorption 
non-polar to 
somewhat 
polar 
100 - 104 
 
silica or alumina 
non-polar to 
polar 
Partition 
(reversed-
phase) 
non-polar to 
somewhat 
polar 
100 - 104 
 
non-polar liquid adsorbed or 
chemically bonded to the 
packing material 
relatively polar 
Partition 
(normal-
phase) 
somewhat 
polar to 
highly polar 
100 - 104 
 
highly polar liquid adsorbed 
or chemically bonded to the 
packing material 
relatively non-
polar 
Ion Exchange 
highly polar 
to ionic 
100 - 104 
 
ion-exchange resins made of 
insoluble, high-molecular 
weight solids functionalized 
typically with sulfonic acid 
(cationic exchange) or amine 
(anionic exchange) groups 
aqueous buffers 
with added 
organic solvents 
to moderate 
solvent strength 
Size 
Exclusion 
non-polar to 
ionic 
103 – 106 
small, porous, silica or 
polymeric particles 
polar to non-
polar 
 
In this thesis the high-performance liquid chromatography (HPLC) measurements 
were obtained with the collaboration of Instituto Superior Tecnico de Lisboa. This 
technique was used for accessing the presence of citrate groups on the surface of 
the precipitated Hap particles. For that purpose a column YMC-Pack ODS-AQ, gel 
lot 9110 250x4.6mm ID, 5 mm, 12 nm AQ12S05-2546WT, PART# 0425026662 
(W) was used. The eluents used were: C: 20 mM KH2PO4 at pH 5.29 and D: 20 
mM H3PO4, pH 2.60. The calibration of the column was made in the following way:  
0,5 min     0%C e 100%D at 2200 psi, in the oven at temperature of 30ºC 
0,5 min      100%D for 75%D linear 
0,5 min      25%C and 75%D step 
0,5 min      75%D for 100%D linear 
4,5 min    0%C and 100%D step 
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The flow used was 1.0 mL/min, during 15 min, and the detection by UV 
spectrophotometer was at 254 nm. All the tested samples were dissolved in 
phosphoric acid 1M and injected 50L in the equipment. 
2.4.4. Biological characterization 
The biological characterization was obtained with the collaboration of Faculdade 
de Medicina Dentaria da Universidade do Porto. For that reason the description of 
the used techniques is as detailed as the previous ones, since the assays were 
monitored but not prepared in full by the author. 
2.4.4.1. Cell Viability/proliferation  
Many methods have been developed to measure cell proliferation including those 
based on direct counting of viable cells, measurement of metabolic activity and 
cellular DNA content. The traditional cell counting methods such as trypan blue 
dye exclusion assay using a hemacytometer are simple and inexpensive but very 
time consuming and sometimes inaccurate 32. Measurement of mitochondrial 
metabolic rate using MTS a tetrazolium compound (3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H- tetra-zolium) to indirectly reflect 
viable cell numbers has been widely applied 32,33. MTS in vitro cytotoxicity assay is 
a method for assessing cell viability 34. The concept of this assay is based on the 
conversion of a tetrazolium salt into a yellow-colored, aqueous soluble formazan 
product by mitochondrial activity of viable cells at 37°C. The amount of formazan 
produced by dehydrogenase enzymes is proportional to the number of living cells 
in culture34. Usually the color modification of formazan in experiments is analyzed 
using a spectrophotometer in absorbance mode. In this study the absorbance was 
measured at 492 nm (visible region fig. 2.5) using an ELISA reader (Synergy HT, 
Biotek®). The referred spectrophotometer works with the same principles as UV-
visible spectrophotometer (described previously) obeying the Beer-Lambert’s law.  
Cell cultures were exposed to Hap-NPs, 50 – 5000 g/ml and Hap-AuNps, 1-500 
g/ml. Control cultures and those exposed to nanoHap were incubated with MTS, 
a tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium] (20 l /well, in 96-well plates), during the last 4 h 
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of the culture periods tested (3 and 6 days) at 37 ºC. Six replicates were set up at 
each condition. 
2.4.4.2. Immunofluorescent staining of F-actin cytoskeleton filaments and nuclei 
To evaluate the physical cellular processes that include: cell adhesion, migration 
and division, a confocal laser scanning microscope (CLSM) was used. The main 
functionalities of the CLMS were described previously in microscope section in this 
chapter. Each of these mentioned processes (adhesion, migration and division) 
requires precise regulation of cell shape and mechanical force generation which is 
regulated by the dynamic mechanical behaviors of actin cytoskeleton 35. The 
morphology of the actin cytoskeleton changes rapidly in response to a wide variety 
of internal and external stimuli. The actin cytoskeleton is a dynamic network that is 
regulated by a variety of extracellular signals. Growth factors or extracellular 
matrix (ECM) proteins transmit signals with actin modulating intracellular 
trafficking, cell morphology and cell migration 36. Dynamic structural modifications 
of the actin cytoskeleton require polymerization, depolymerization, stabilization, 
branching, and severing of actin filaments. Rapid extension and retraction of 
filopodia and lamellipodia through F-actin assembly and disassembly is the driving 
force that permits cells to explore and navigate in response to extracellular signals. 
This is evident in cell spreading and migration 36. As mentioned the morphological 
evaluation of F-action cytoskeleton filaments and nuclei was done using CLMS 
and the samples preparation was previously described in detail.  
2.4.4.3. Apoptosis 
The process of programmed cell death, or apoptosis, is generally characterized by 
distinct morphological characteristics and energy-dependent biochemical 
mechanisms 37. Apoptosis is considered a vital component of various processes 
including normal cell turnover, proper development and functioning of the immune 
system, hormone-dependent atrophy, embryonic development and chemical-
induced cell death. Inappropriate apoptosis is a factor in many human conditions 
including neurodegenerative diseases, ischemic damage, autoimmune disorders 
and many types of cancer 37. 
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The apoptosis of the tested cells in presence of WCSster and HSster was evaluated 
by flow cytometry. Flow cytometry is a powerful technique for the analysis of 
multiple parameters of individual cells within heterogeneous populations. Flow 
cytometers are used in a range of applications from immunophenotyping, to ploidy 
analysis, to cell counting and GFP expression analysis. The flow cytometer 
performs this analysis by passing thousands of cells per second through a laser 
beam and capturing the light that emerges from each cell as it passes through. 
The data gathered can be analyzed statistically by flow cytometry software to 
report cellular characteristics such as size, complexity, phenotype, and health. 
In this thesis, it is presented in a summary way how a flow cytometer works, how 
scattered light and fluorescence are detected by a flow cytometer, and how the 
resulting data can be analyzed. The figure 2.11 shows the primary systems of the 
flow cytometer schematically, which are: the fluidic system, which presents 
samples to the measuring point and takes away the waste; the lasers, which are 
the light source for scatter and fluorescence; the optics, which gather and direct 
the light; the detectors, which receive the light; and, the electronics and the 
peripheral computer system, which convert the signals from the detectors into 
digital data and perform the necessary analyses 38. 
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Figure 2.11- Schematic overview of a typical flow cytometer setup (adapted from 38). 
 
As a cell passes through the laser, it will refract or scatter light at all angles. 
Forward scatter, or low-angle light scatter, is the amount of light that’s scattered in 
the forward direction as laser light strikes the cell. The magnitude of forward 
scatter is roughly proportional to the size of the cell. Light is quantified by a 
detector that converts intensity into voltage. In most cytometers, a blocking bar 
(called an obscuration bar) is placed in front of the forward scatter detector. The 
obscuration bar prevents any of the intense laser light from reaching the detector. 
As a cell crosses the laser, light is scattered around the obscuration bar and is 
collected by the detector 38.   
Cells have traditionally been gated according to physical characteristics. For 
instance, subcellular debris and clumps can be distinguished from single cells by 
size, estimated by forward scatter. Also, dead cells have lower forward scatter and 
higher side scatter than living cells. The different physical properties of cells allow 
them to be distinguished from each other and from cellular contaminant 38.  
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Adherent 24 hour MG63 cells were exposed to WCSster or HSster Hap 
nanoparticles, 50 g/ml, for three days, and evaluated by flow cytometry for the 
presence of apoptosis. Cells were enzymatically released (0.05% trypsin, 0.25% 
EDTA) and approximately 106 cells were processed with the TACS Annexin V-
FITC Apoptosis Detection kit, following the manufacturer’ instructions. Annexin V, 
an anticoagulant protein, binds negatively charged phospholipids 
(phosphatidylserine) on the outer leaflet of the cytoplasmic membrane, following 
phospholipid asymmetry disruption in early apoptotic event. The combination of 
annexin V-FITC and propidium iodide allows the differentiation between early 
apoptotic cells (annexin V-FITC positive), late apoptotic and/or necrotic cells 
(annexin V-FITC and propidium iodide positive) and viable cells (unstained). 
2.4.4.4. Gene expression by Reverse-Transcription Polymerase Chain Reaction 
(RT-PCR) 
In the present thesis different aspects of cell-cell and cell-Hap NPs interaction 
were evaluated at the gene level. Several steps in the gene expression process 
may be modulated, including the transcription, RNA splicing, translation, and post-
translational modification of a protein. Gene regulation gives the cell control over 
structure and function, and is the basis for cellular differentiation, morphogenesis 
and the versatility and adaptability of any organism. Generation of RNA from DNA 
is known as transcription. In other word transcription is the process of creating a 
complementary RNA copy of a sequence of DNA.  
 
Adherent 24-hour MG63 cells were exposed to WCSster, HSster, HS-AuNPs, HS-
AuNPs-FA, 50 g/ml, for three days, and evaluated by Reverse-Transcription 
Polymerase Chain Reaction (RT-PCR) for the expression of the housekeeping 
gene GAPDH (glyceraldehyde 3 phosphate dehydrogenase) and the osteoblastic 
genes collagen 1 (Col 1), alkaline phosphatase (ALP), Runx-2 and Bone 
Morphogenetic Protein-2 (BMP-2). Total RNA was extracted using RNeasy® Mini 
Kit (QIAGEN) according to manufacturer’s instructions. The concentration and 
purity of total RNA in each sample were determined by UV spectrophotometry at 
260 nm and by calculating the A260nm/A280nm ratio, respectively. The mechanism 
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and the principle functionality of UV spectrophotometry were already described in 
this chapter (section of Ultra Violet-Visible spectrophotometer). Half microgram of 
total cellular RNA from each sample was reverse transcribed and amplified (25 
cycles) with the Titan One Tube RT-PCR System (Roche), with an annealing 
temperature of 55ºC. The primers used are listed on Table 2.4. The RT-PCR 
products were separated on a 1% (w/V) agarose gel and visualized by Ethidium 
Bromide staining. Ethidium Bromide is a DNA intercalator, inserting itself into the 
spaces between the base pairs of the double helix 39,40. Ethidium Bromide 
possesses UV absorbance maxima at 300 and 360 nm. Additionally, it can absorb 
energy from nucleotides excited by absorbance of 260 nm radiation. Ethidium re-
emits this energy as yellow/orange light centered at 590 nm 39,40. 
The images of the gel were captured with a camera and analyzed with Image J 
1.41 software. To obtain a semi-quantitative assessment of gene expression, data 
were expressed as normalized ratios by comparing the integrated density values 
for all genes tested with those for GAPDH. 
 
Table 2.4 – Primers used on RT-PCR analysis of MG63 cell cultures. 
Gene 5’ Primer 3’ Primer 
GAPDH 5’-CAGGACCAGGTTCACCAACAAGT-3’ 5’-GTGGCAGTGATGGCATGGACTGT-3’ 
COL1 5’-TCCGGCTCCTGCTCCTCTTA-3’ 5’ACCAGCAGGACCAGCATCTC-3’ 
ALP 5’-ACGTGGCTAAGAATGTCATC-3’ 5’-CTGGTAGGCGATGTCCTTA-3’ 
BMP-2 5’-GCAATGGCCTTATCTGTGAC-3’ 5’-GCAATGGCCTTATCTGTGAC-3’ 
RUNX-2 5’-CCCCACGACAACCGCACCAT-3’ 5’-CACTCCGGCCCACAAATC-3’ 
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3.1. Introduction 
As referred in Chapter 1 hydroxyapatite has been extensively involved in bone 
related therapies due to its excellent biocompatibility and bone bonding ability and 
also due to its structural (nanometric sized crystallites) and compositional similarity 
to the mineral phase of human bones. It can also be used in other biomedical 
applications such as: non-viral carriers for drug delivery, gene therapy and protein 
carrier due to its ease of handling and notorious adsorption ability 1,2. 
Nanotechnology offers opportunities to interface with biology in new ways and with 
unprecedented precision. In some of the above mentioned applications like drug 
delivery systems, nanoparticles with specific size, shape and other physico-
chemical properties are required, since they may modulate cellular pathways 3,4. 
Recent studies have shown that depending on many factors, including particle 
morphology issues, sedimentation effects of large and dense particles, and the 
composition of the protein corona on the particle, a favorable or adverse cell 
response will be induced 5,6. Although being extensively studied this subject is not 
yet fully understood. The development of successful nano engineered particles 
and the clarification of its impact on cellular response remains a challenge. 
For controlling the particle morphology, an appropriate method of synthesis is 
required. Therefore, new synthesis methods enabling to produce particles with 
predetermined morphology are thus currently needed. During the past few 
decades, considerable research efforts have converged to the development of 
synthesis processes able to produce hydroxyapatite nanoparticles with different 
sizes and shapes. Several methods have been proposed including wet chemical 
precipitation, sol-gel, hydrothermal synthesis, multiple emulsion, biomimetic 
deposition and electrodeposition technique 5-7, among others. Many experimental 
variables can be manipulated to control the characteristics of the Hap 
nanoparticles. The effect of some of these variables such as: additives (organic or 
inorganic chemical species), temperature, pressure, etc, can change dramatically 
the shape and size of the obtained particles.  
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A conventional hydrothermal synthesis method was the technique chosen in this 
research for obtaining at low cost hydroxyapatite nanoparticles with high degree of 
crystallinity and thus easily characterizable. Additionally this method is also 
particularly suitable for the growth of large crystals while maintaining good control 
over their composition. To maintain a good control of precipitated particles 
morphology an additive is used frequently as a tailoring agent, which main function 
is to draw the shape and size of the particle. The additive used in this study is citric 
acid. The selection of citric acid is justified by citrate ion chelant properties which 
account for its current use in food and drinks industry 8. An important physiological 
function of citric acid is also found in Krebs cycle, in which it plays a key role 
contributing to energy production in mitochondria 9. Another biological role of 
citrate is found at the interface of bone apatite and collagen where it stabilizes the 
apatite platelet morphology 10. It is known that about 80% wt.% of the total citrate 
present in the body is accumulated in bone 10. Bio inspired by nature, citrate 
assisted growth of Hap particles is envisaged as a promising synthesis technique 
in terms of the ability of particle morphology control.  
 
In the present work, the production of Hap particles by hydrothermal synthesis 
(HS) at high temperature (180ºC) with different morphologies is studied. The 
effects of citrate concentration on the Hap nucleation and growth at high 
temperature will be here analysed. 
The chapter is organized as follows: The effects of different amounts of citrate ion 
(Cit) on the final morphology of Hap particles obtained after a synthesis time of 
24H are firstly discussed and then the morphology evolution with the synthesis 
time is analysed for two of the citrate concentrations corresponding to the lower 
and upper limits of the covered Cit concentrations, attempting to correlate the 
particle morphology development with the interplay among citrate (or citrate 
derived species) and other relevant precipitating variables.  
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3.2. Synthesis of Hap particles  
3.2.1. Effects of (Citrate:Calcium) ratio on Hap particle morphology 
Hap particles were precipitated under different citrate calcium (Cit:Ca) ratios as 
described in table 3.1. Table 3.1 summarizes the characteristics of the Hap 
particles selected for the present work. For convenience the Hap particles samples 
are labelled according to the used Cit:Ca ratios. The XRD (X-ray diffraction) 
patterns of the obtained particles under different Cit:Ca ratio, at 180ºC for 24 hours 
are shown in figure 3.1. It is observed that hydroxyapatite is the precipitated 
crystalline phase in all the precipitating media regardless (Cit:Ca) since all of the 
diffraction peaks can be assigned to hexagonal hydroxyapatite (space group 
P63/m) according to JCPDS Nº 09-0432. No secondary crystalline phases could 
be identified in any of the various precipitating conditions.  
Table 3.1- Characteristics of Hap particles precipitated from solutions with different 
(Cit:Ca) ratios. 
Cit:Ca ratio Sample code 
Crystallite 
size (nm) 
(002) 
Specific 
Surface Area 
(m2/g) 
Pore 
size 
(nm) 
SHape 
3:1 HS 3:1 38 55 12,5 Rod like 
3,5:1 HS 3,5:1 35 48 20,2 Hedgehogs like 
4:1 HS 4:1 33 43 16,1 Hedgehogs like 
7:1 HS 7:1 34 17 16,7 Bundle like 
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Figure 3.1- XRD patterns of Hap particles synthesized by HS method under different 
(Cit:Ca) ratios, after 24 hours. 
 
The crystallite size estimated according to Scherrer equation was seen to be of the 
same order of magnitude for the different Hap particles (table 3.1). Wu et al. have 
precipitated fluoroapatite particles in presence of citric acid and EDTA 11 and did 
observe a variation on (h00)/(00l) peak ratio which was indicative of a preferential 
growth along c axis. The present XRD results do not evidence significant variation 
of (h00)/(00l) peak ratio as (Cit:Ca) increases. This reflects possibly the fact that a 
combination of citric acid and EDTA as that used by Wu et al. might be more 
effective for complexing Ca ions than citrate ion and thus affect more severely the 
coherence length of the crystallite along the [100] axis 11. 
Figure 3.2 shows the microstructures of Hap particles synthesized at 180ºC after 
24 hours from solutions containing different (Cit:Ca) ratios. First, it can be seen 
that Hap particles synthesized under different (Cit:Ca) ratios have different 
morphologies. Additionally it is also shown that when an increase in the initial 
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molar ratio of citric acid to calcium (Cit:Ca) takes place, a strong modification of 
Hap morphology also occurs, i.e. the rod like shaped particles obtained with a HS 
3:1 (fig 3.2a) change to hedgehogs (3,5:1- 4:1) (fig 3.2 b and c) and to bundle like 
shaped particles (HS 7:1) (fig 3.2 d). Moreover the size of the resulting particles 
increases from the nanometric size of HS 3:1 up to a micrometric size observed 
for the others ratios. It is worth mentioning that a Cit:Ca ratio of 2:1 was also 
attempted giving place to an instantaneous precipitation. This fact indicated that a 
certain amount of Ca2+ ions remained uncomplexed after citric acid addition and 
thus were free to react promptly with PO43- ions hence giving place to the ready 
precipitation of hydroxyapatite particles with non-uniform morphology. However 
when an additional small amount of citrate ions was added to the system, i.e. 
(Cit:Ca) was increased to (3:1), nucleation was inhibited at room temperature as 
the solution remained clear and transparent for several hours. As the temperature 
was increased then nucleation took place and precipitation occurred. 
Figure 3.2- TEM and SEM micrographs of Hap particles synthesized from solutions with 
different (Cit:Ca) ratios: (a) 3:1; (b) 3.5:1; (c) 4:1 and (d) 7:1. 
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To obtain a more detailed information about particle morphology and preferential 
growth, transmission electron micrographs were acquired (figure 3.3). Figure 3.3 
(a) shows the TEM micrographs of the Hap nanoparticles obtained with a Cit:Ca 
ratio of 3:1, being visible that the size of the nanorods is approximately 20 nm in 
width while the length varies between 20 and 100 nm. The thickness is about 15 
nm. The clearly visible lattice fringes are indicative of the high crystalinity of the 
Hap nanoparticles (fig 3.3 (b)) 12. It is evidenced that particles have hexagonal 
crystal structure and grow preferentially along c-axis. The prismatic facets seem 
differently developed as larger facets alternate with less developed ones. The 
obtained results indicate that the citrate or citrate-related species assist the 
precipitation of Hap particle as additives binding to specific crystallographic facets 
of hydroxyapatite crystal hence limiting the growth perpendicular to such facets. 
These results are in line with the conclusions of M. A. Martins et al. who pointed 
out that citrate binds preferentially to lateral prismatic facets and thus favours the 
rod like morphology of Hap particles precipitated under specific conditions of 
citrate concentration and pH 7. Others authors reported similar results but using 
others synthesis methods 13-16.  
As already referred, further addition of citrate ions causes significant modifications 
to the particle morphology. This effect is sharply felt when Cit:Ca ratio changes 
from 3:1 to 3.5:1 leading to hedgehogs formation. As observed in fig 3.3 ((c) and 
(d)) TEM micrographs show two well defined populations of particles: one that is 
nanometric sized and a second one composed of longer sized particles. 
Hedgehogs particles are composed by multiple fiber-like particles irradiating from 
a central junction (fig 3.2 (b)). The length of such fibers is around 800 nm and their 
width is about 20 nm (figure 3.3 (c)). The central region reveals a large number of 
small Hap nanoparticles, hence suggesting that the central junction may result 
from Hap nanoparticle assemblage in a early stage of particle growth. 
Additional increase of the Cit:Ca ratio beyond 3.5:1 has now a less pronounced 
impact on the final shape of the Hap particles as observed in figure 3.2 (c) and (d). 
Nevertheless it is visible by SEM and TEM (fig 3.2 and 3.3) that nano fibers in 
hedgehogs particles become longer. The length varies between 1,2 and 1,5 m 
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and the width is now around 35 nm (figure 3.3). A closer look on these particles 
(figure 3.3 (f)) reveals that small Hap particles are now less abundant. When the 
maximum concentration of citric acid is added to the synthesis medium, i.e. the 
Cit:Ca ratio increases to 7.1, the morphology of the Hap structures changes from a 
fiber-structured particle to a sheet-like structured particle. Apparently fiber-like Hap 
particles underwent an oriented aggregation process which enabled fibre lateral 
attachment hence resulting in bundled sheet-like units (figure 3.3 (g) and (h)). 
Under Cit:Ca = 7:1 the fiber-like particles seem to have grown preferentially in 
length as compared to other Cit:Ca ratios: a length of 2-3 m and a width of 42 nm 
could be observed in the images of figure 3.3 ((g) and (h)).  
It is known that citric acid possesses three carboxylic and one hydroxyl group, 
which can provide chelating ability and bind selectively to specific crystallographic 
facets 17. In the beginning of the precipitation process, citrate ion reacts with Ca2+ 
ions to form calcium complexes hence decreasing the concentration of free Ca2+ 
ions in the bulk solution. When the solution temperature increases complexes 
stability is changed allowing Ca2+ ions to get free and combined with PO43- leading 
to the precipitation of hydroxyapatite. Under hydrothermal conditions and 
depending on the used Cit:Ca ratio, citrate ion helps tailoring different particle 
morphologies which seem mainly related either to selective growth of primary 
particle along certain crystallographic directions or to particular assemblage mode 
of primary particles thereby resulting in differently nanostructured Hap particles.  
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Figure 3.3- TEM images of Hap particles precipitated at 180ºC after 24 H from solutions 
with different (Cit:Ca) molar ratios: 3:1 (a, b); 3,5:1 (c, d); 4:1 (e, f) and 7:1 (g, h). Images 
f) and h) are amplified views of particular sample regions identified by dotted circles on the 
images e) and g), respectively. As Cit:Ca ratio increases from 3:1 to 7:1, particle 
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morphology changes from prism (with approximate thickness and width of 15 nm and 20 
nm, respectively, and 20 to 100 nm in length) ((a) and (b) to bundled fiber-like particles 
exhibiting fiber later attachment indicative of oriented aggregation process ((g) and (h)). 
The strong influence of (Cit:Ca) ratio on the morphology of the particles is also 
expressed through the specific surface area (SSA) of the different particles as can 
be seen in table 3.1. The specific surface area is 55 m2/g for nanometric Hap 
particles (HS 3:1) and 17 m2/g for nanostructured Hap particles (HS 7:1). The 
significant reduction in SSA reflects the size increase of the particles. N2 
adsorption/desorption isotherms for different types of particles are presented in 
figures 3.4. According to IUPAC classification the synthesized Hap particles 
present a type IV isotherm which exhibits the characteristic hysteresis loop (HL) of 
a mesoporous material. For all the obtained Hap particles (figure 3.4) the obtained 
HLs reflect a H1 isotherm indicative of tubular pores 18. Although the morphologies 
of the obtained particles are rather different, the type of pores evidenced by HLs is 
similar. The porosity of the precipitated Hap particles is also evidenced by TEM 
results. As observed in figure 3.3 (a) the HRTEM image of a HS 3:1 particle allows 
some pores to be detected (indicated by dotted circles and/or arrows). The 
average pore size (BJH analysis of adsorption curve) evolves from 12.5 nm for HS 
3:1 to 16,7 nm for HS 7:1, respectively, whereas the total N2 adsorbed amount 
suffers a drastic reduction with the increase of the (Cit:Ca) molar ratio (figure 3.4). 
Such pore size increase during precipitation may result from the merging of 
smaller pores accompanying the particle structure evolution as reported for other 
inorganic materials, like silica 19. Although particles synthesized with Cit:Ca 7:1 
present a bigger pore size when compared with Cit:Ca 3:1 the volume adsorbed 
by Cit:Ca 7:1 is significantly lower. This result shows that HS 3:1 particles are not 
only smaller than HS 7:1 particles but also have a larger amount of pores. These 
are thus two cooperative attributes explaining the larger surface area of HS 3:1 
particles which are thus expected to have enhanced adsorptive capability. 
Literature reports on Hap pore morphology are relatively scarce. J. Chen et al. 
synthesized rod Hap particles with slit-shaped pores, but the experimental 
conditions used by the authors were different from those used in this study 20. 
Dodecylamine, CaCl2 and H3PO4 were mentioned as reagents as well as a high 
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pH value (10), a shorter precipitation time (12 hours) and a lower synthesis 
temperature of 100ºC 20 as precipitating conditions which are rather different as 
compared to the ones adopted in this work.  
Figure 3.4- Nitrogen adsorption and desorption isotherms of Hap particles synthesized 
from solutions with different Cit:Ca ratios. 
It is known that citrate ion binds strongly to the surface of calcium phosphate 
particles 21 but the particular features respecting the binding mode of citrate 
species on Hap particle surface is still poorly defined and thus remains a 
challenging issue. The binding mode of citrate cannot be dissociated from the 
configuration of citrate as adsorbate which in turn may help to understand the 
different morphologies of the synthesized particles while giving us clues about the 
possible growth mechanisms. Recent literature has proposed different models for 
interfacial structures of adsorbed citrate on Hap surface. Y.-Y. Hu et al suggested 
that citrate adsorbs on (100) face, coordinating strongly to three surface calcium 
ions via its three carboxylic groups 21. This adsorption model is based on the 
correct matching of carboxylate groups inter-spacings in citrate molecule with 
those of calcium ions along the apatite c-axis. A different coordination mode was 
suggested by W. Jiang et al 22 according to which citrate ion coordinates only one 
surface calcium ion through a terminal carboxylic group. This coordination mode 
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would benefit the self-assemblage of citrate molecules by intermolecular hydrogen 
bonding 22. 
The presence of adsorbed citrate species on the prepared Hap particles with 
different Cit:Ca ratio can be examined through FTIR analysis. Figure 3.5 shows 
the FTIR spectra of Hap particles synthesized from solutions with 3:1; 3.5:1; 4:1 
and 7:1 Cit:Ca ratios. All the graphs show the characteristic bands of PO43- groups 
at 1096, 1047, 962, 601, 563 and 472 cm-1 23. The broadening bands attributed to 
absorbed water are observed at about 3440 and 1637 cm-1. For all samples the 
hydroxyl bonds (OH) absorption bands at 3572 cm-1 and 633 cm-1 corresponding 
to stretching and vibration modes respectively are also observed 23. Moreover the 
broad band detected at 3200 cm-1 in the spectra of the samples corresponding to 
Cit:Ca ratios of 3:1 and 3,5:1 can be ascribed to ammonium ion. Despite the 
common features, some marked differences are clearly detected in the 1200-1900 
cm-1 region.  
Figure 3.5- FTIR spectra of Hap particles synthesized from solutions with different Cit:Ca 
ratios at 180ºC during 24 hours. 
For an easier analysis, a magnification of the FTIR spectra in the range of 1300-
1800 cm-1 is presented in Figure 3.6. As observed the intensity of the 1384 cm-1 
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band attributed to –CH2- scissoring mode of citrate or citrate-derived compounds 
24 decreases as Cit:Ca molar ratio increases 24. Another visible difference regards 
the 1670 cm-1 band, recognized as C=O band in monodentate configuration, 
whose intensity decreases as the Cit:Ca ratio increases besides shifting to low 
wavenumbers. Other bands were also identified in the same spectral region which 
were attributed to the antisymmetric (1650 and 1567 cm-1) and to the symmetric 
(1458 and 1402 cm-1) stretching modes of carboxylate groups coordinated to Hap 
surface Ca2+ cations 25-28 either in a monodentate or in a bidentate manner 29-31, 
respectively (see the illustration of the different coordination modes in figure 3.7). It 
is visible that the antisymmetric vibrations in both (monodentate and bidentate) 
configurations are less expressed as Cit:Ca ratio increases. Therefore the present 
results indicate that the position and intensity of carboxylate related bands get 
changed as citrate concentration increases in the starting solution, i.e. suggesting 
that less carboxylate groups remain adsorbed but in a different coordination mode 
to Hap surface. 
Figure 3.6- FTIR results corresponding to Hap particles synthesized from solutions with 
different Cit:Ca ratios at 180ºC during 24 hours: magnification of the 1900-1200 cm-1 
spectral region.  
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The presence of the original citrate ions (Cit) as adsorbed species on Hap particle 
surface is highly questionable: instead smaller carboxylated ions resulting from 
citric acid decomposition under the high temperature and pressure used for Hap 
thermal synthesis will probably exist. It was already reported that citric acid may 
degrade at T>145ºC 9,32,33 leading to reaction products that include different 
dehydroxylated or decarboxylated acids and anhydrides depending on the used 
heating ramp temperature and pressure 9. It is thus hypothesized that citrate ion 
derived species containing carboxylate groups exist as adsorbed entities on Hap 
particle surface. This hypothesis is furthermore supported by the absence of the 
1270 and 1305 cm-1 bands on Hap particles spectra normally assigned to citrate 
skeletal vibrations and free OH group, respectively 34.  
Figure 3.7- Different coordination modes of carboxylate ligands to a surface metal cation 
(adapted from 31). 
High-performance liquid chromatography (HPLC) measurements were used for 
accessing the existence of citrate groups on the surface of the precipitated Hap 
particles. Figure 3.8 shows the chromatogram of a citric acid solution having 
different citric acid concentrations and using acetic acid as internal standard. The 
first peak observed at 5,6 min corresponds to the internal standard, whereas the 
peak at 7,0 min corresponds to citric acid. Figure 3.9 shows the HPLC 
chromatogram corresponding to Hap particles obtained from solutions with 
different Cit:Ca ratio. The Hap particles were firstly solubilized in phosphoric acid. 
As observed a new peak is detected at 4,7 min which cannot be attributed to the 
acetic acid neither to citric acid. Instead this new peak should presumably 
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correspond to a chemical species having a smaller number of atoms as compared 
to acetic acid, since the peak retention time is shorter than that of acetic acid. 
Formic acid molecular weight is lower than of acetic acid and may be thus a 
hypothesis to be considered.  
Figure 3.8- HPLC chromatogram corresponding to citric acid solution having different citric 
acid concentrations when using acetic acid as internal standard. 
Figure 3.9- HPLC chromatogram of the Hap particles prepared under different Cit:Ca 
molar ratios after being dissolved in a phosphoric acid solution. The peak at 4,7 min which 
cannot be attributed to the acetic acid neither to citric acid. 
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Furthermore it is observed that the new peak intensity decreases as the Cit:Ca 
ratio increases in the precipitating medium of Hap particles, thus indicating that the 
amount of the chemical species under analysis decreases as Cit:Ca increases. It 
is worthy to remind that this trend correlates well with the evolution of FTIR results 
at the region 1300-1800 cm-1 where carboxylate related bands intensity decreases 
as the Cit:Ca ratio increases (figure 3.6). It is thus thought that the chemical 
species detected by HPLC might be related to the carboxylic group detected in 
FTIR spectra.  
Thermogravimetric analyses of the synthesized particles give further evidence of 
adsorbed organics. Figure 3.10 compares the thermal behaviour of Hap samples 
prepared under different molar ratios of Cit:Ca. It is observed that the total weight 
loss decreases substantially as the Cit:Ca ratio increases namely for Cit:Ca ratios 
above 3.5:1. Additionally, three distinct weight losses could be identified in the 
thermogravimetric curves corresponding to the two lower Cit:Ca ratios, i.e. Cit:Ca= 
3:1 and 3.5:1. The first loss (w1) takes place beneath ~120ºC and is followed by 
a well-defined endothermic peak which can be assigned to the loss of weakly 
adsorbed water. A second steep weight loss (w2) is detected in the temperature 
range between ~140ºC and ~250ºC, also accompanied by an endothermic effect. 
This second loss accounts for 2.5% of the total weight loss, approximately. 
Following literature data 35 this loss may be ascribed to the release of NH3 
resulting from ammonium ion whose presence was clearly denounced by the FTIR 
results of the samples HS 3:1 and HS 3.5:1 as previously pointed out. The third 
loss (w3) is the strongest one as it accounts for at least 3.5% of the total weight 
loss in both cases. The temperature range corresponding to (w3) is comprised by 
a broad exothermic band. The interpretation of both features is the oxidative 
burning out of the existing organic residues (citrate derived ones). It is also worth 
to mention a last and smaller weight loss observed at 800ºC that can be attributed 
to the phase transition from Hap to -TCP 35. Comparing now the thermal 
behaviours of these two samples with those of (4:1) and (7:1) samples one main 
evidence comes up: (i) the organic content of these two last samples is  2%, i.e. 
almost half of the content of the former samples (HS 3:1 and HS 3.5:1). Thermal 
analyses data thus corroborate FTIR and HPLC results as far as particle organics 
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content is concerned. As just demonstrated this amount decreases as Cit:Ca ratio 
increases. 
As a conclusion the variation of Hap particle morphology induced by different 
Cit:Ca ratios is accompanied by variations on the absorption bands of adsorbed 
carboxylate groups, i.e., band type and intensity. These adsorbed species 
apparently help to tailor the particle morphology. As observed Hap particles grow 
further along c direction as (Cit:Ca) increases but undergo lateral attachment 
under the highest Cit:Ca ratio (7:1). Accordingly the formed carboxylic species 
and/or their attachment mode to Hap surface seems conditioned by the solution 
citrate initial content. 
More detailed studies aimed at elucidating the mechanism underlying the 
formation of these peculiar structures will be presented in the next section. 
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Figure 3.10.- (a)Thermogravimetric and (b) Differential thermal analyses plots of Hap 
nanoparticles precipitated from solutions containing different (Cit:Ca) ratios: 3:1, 3.5:1 and 
4:1.The dotted circles 1, 2 and 3 identify the endo and exothermic effects that accompany 
the weight losses w1, w2 and w3, respectively. 
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3.3. Morphology evolution with growth time 
The results respecting Hap particles obtained after different precipitation times, i.e. 
15, 30, 45 and 60 min, are here presented and discussed for the particular (Cit:Ca) 
ratios of (3:1) and (7:1). The samples under analysis are identified in the table 3.2. 
Table 3.2- Identification of the samples precipitated under different (Cit:Ca) ratios and 
during different times. 
Precipitation time (min) 
(Cit:Ca) molar ratio 
3:1 7:1 
15 HS 3:1/15 ---------- 
30 HS 3:1/30 ----------- 
45 HS 3:1/45 HS 7:1/45 
60 HS 3:1/60 HS 7:1/60 
The morphologies of the particles precipitated after the different times are 
illustrated in figure 3.11. The samples HS 3:1 obtained after 15 min and 30 min 
(figure 3.11(a), and (b)) show the formation of needle like nanoparticles. When the 
precipitation time was increased to 45 and 60 min, the TEM images reveal 
particles (HS 3:1/45 and HS 3:1/60) tending to a rod like morphology (figure 3.11 
(c) and (d)). The width and the length of the particles are in the ranges of 5-10 nm 
and 50-75 nm, respectively. No bundle like Hap nanostructure was observed 
under this Cit:Ca ratio of (3:1). Furthermore it is worthy emphasizing that 
nucleation and growth processes already took place after 15 min. 
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Figure 3.11- TEM images of Hap nanoparticles precipitated from solutions containing 
(Cit:Ca)= (3:1) after different times: (a) 5 min, (b) 30 min, (c) 45 min and (d) 60 min. 
The specific surface areas of the particles obtained for HS 3:1 after 15, 45 and 60 
minutes of precipitation are 11, 80 and 96 m2/g, respectively. As observed the 
specific surface area increases with the synthesis time, and this effect could be 
related with the presence and/or type of pores present in Hap particles. Figure 
3.12 shows the N2 adsorption–desorption isotherms of Hap nanoparticles 
precipitated from solutions containing (Cit:Ca)= (3:1) after different times: (a) HS 
3:1/15, (b) HS 3:1/45 and (c) HS 3:1/60. It is visible that the different samples 
present different hysteresis loops (HLs). The sample with low time of precipitation 
(15 minutes) presents a H1 type type according to IUPAC classification, which 
indicates that pores network effects are not dominating the N2 sorption behaviour 
of Hap particles 36. With the increase of the precipitation time a strong HL 
modification is observed: after 45 minutes a H2 type hysteresis loop is observed 
whilst after 60 minutes a H3 type is obtained. The main difference between these 
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two hysteresis loops is related with the pore shape: ink-bottle shaped pores are 
present when H2 is observed and slit-shaped pores when the hysteresis loop is of 
H3 type 36.These HL differences may be a consequence of the adsorbed species 
on the Hap surface and/or reflect the synthesis conditions (time/ temperature) 
since the temperature of the precipitating keeps increasing during approximately 
45 min which is the time required to reach the final set-point temperature (180ºC). 
Figure 3.12- N2 adsorption–desorption isotherms of Hap nanoparticles precipitated from 
solutions containing (Cit:Ca)= (3:1) after different times: (a) 15 min, (b) 45 min and (c) 60 
min. It is visible that the different samples present different hysteresis loops (HLs). 
The XRD patterns of the samples HS 3:1 obtained after different precipitation 
times are shown in figure 3.13. The sample precipitated after 15 min shows broad 
peaks characteristics of a poorly crystalline hydroxyapatite. However several other 
peaks well defined are also visible. It is believed that those peaks can be assigned 
to precursor compounds of hydroxyapatite. The XRD spectra of HS 3:1 after 45 
and 60 min show that all the peaks matched well to those of Hap phase (JCPDS 
9-432), and no other secondary phase peaks could be detected. These results 
indicate that the precursor compounds detected after 15 min gave place to Hap. 
Moreover it is possible to observe that Hap peaks become sharper with the 
increase of synthesis time (fig 3. 13).  
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Figure 3.13- X-ray spectra of Hap nanoparticles precipitated from solutions containing 
(Cit:Ca)= (3:1) after different times: (a) 15 min, (b) 45 min and (c) 60 min. The sample (a) 
shows broad peaks characteristics of a poor crystalline hydroxyapatite. 
FTIR spectra of the samples precipitated with different times are presented in 
figure 3.14 (a) and (b). The main vibrational bands assigned to the hydroxyapatite 
PO43- groups (figure 3.14 (a)) are observed in all spectra, although the bands 
intensity and definition are less evident for HS 3:1/15. The intensity of these bands 
increases with the time of precipitation due to the increasing degree of crystallinity 
of the precipitated particles. Moreover in the range of 1200-1700 cm-1 bands 
assigned to citrate carboxylate (COO-) groups are present in all studied samples 
as is the case of 1270, 1305, 1384, 1402, 1436, 1458, 1540, 1567 and 1610 cm-1 
bands. The band at 1270 cm-1 can be assigned to coupled stretches and bends of 
carboxylate groups 37 or skeletal vibrations of citrate species 34. The band 
observed at 1305 cm-1 can be attributed to citrate OH group able to rotate freely 
around its C-OH axis 38 and the band at 1436 cm-1 is given as -CH2- bending 
mode 37. Two bands are also visible at 1540 cm-1 and 1610 cm-1 which can be 
associated with antisymmetrical stretching vibration of carboxylate groups (COO-) 
31,39. The band at 1540 cm-1 could also represent a type A substitution where the 
CO32- anions are partially occupying OH- position 5,40. The bands detected at 1458, 
1402 and 1567 cm-1, were already identified as symmetric or antisymmetric 
15 min 
45 min 
60 min 
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stretching vibrations of carboxylate groups. Initially (after 15 min) a pseudobridging 
configuration (1610 and 1402 cm-1) of carboxylate groups is observed; with the 
increase of the precipitation time a broad band is observed at 1590 cm-1 which 
may result from an overlap of two bands, i.e. a band at 1610 cm-1 and the band at 
1567 cm-1. This suggests that there are changes in the coordination geometry of 
the carboxylic ions to Hap surface. The comparison of the spectra of Cit:Ca 
synthesized after different times thus indicates that the intensity of the 
characteristic bands of citrate (detected at 1270, 1305, 1436 cm-1) decreases with 
the increase of the synthesis time. These results suggest that original citrate 
groups may exist as adsorbed species at the surface of the precipitated particles if 
short synthesis times are meant. Moreover the carboxylate groups seem weakly 
bonded to the surface of the particles since they are able to undergo coordination 
rearrangements. Apparently the stability of the citrate species adsorbed on Hap 
surface is largely dictated by the precipitation time and has influence in the final 
morphology of the Hap particles. 
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Figure 3.14- (a) FTIR spectra of Hap nanoparticles precipitated from solutions containing 
(Cit:Ca)= (3:1) after different times: 15 min, 45 min and 60 min ;(b) FTIR details of the 
1200-1800 cm-1 spectral region. 
Figure 3.15 compares the thermal behaviour of the obtained Hap particles after 
different precipitation times (samples HS 3:1/15; 3:1/45 and 3:1/60). The first 
weight loss occurs at temperatures up to ~100ºC and is followed by an 
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endothermic effect. This weight loss can be assigned to the release of weakly 
adsorbed water on the precipitated particles. The second weight loss is detected 
between 180 and 280ºC, being also followed by endothermic effects including a 
peak at 150ºC and a shoulder at 230ºC. A very steep weight loss is then identified 
being accompanied by an endothermic peak centred at 300ºC. When temperature 
increases beyond 300ºC a lower slope is recovered until 500ºC. The 300ºC-500ºC 
region is covered by an exothermic band. As compared to this curve, the 
thermograms of HS 3:1/45 and 3:1/60 samples have only one endothermic feature 
adjacent to 200ºC and an almost constant weight loss rate extending from 180ºC 
until 500ºC. These different thermal behaviours are in line with XRD results that 
showed the existence of precursor compounds in HS 3:1/15 whose decomposition 
is expected to produce additional endothermic features. It is also observed that the 
total weight losses are significantly higher in HS 3:1/15 (42%) as compared to its 
counterparts HS 3:1/45 and 3:1/60 (25 and 22%, respectively). These differences 
are assigned to the precursor compounds contributions. According to FTIR results 
some of these precursors may be citrate based compounds which could not be 
successfully identified yet.  
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Figure 3.15- (a) Thermogravimetric plots and (b) Differential thermal analyses plots of Hap 
nanoparticles precipitated from solutions containing (Cit:Ca)= (3:1) after different times: 15 
min, 45 min and 60 min. 
The Hap particles precipitated from solutions containing (Cit:Ca) = 7:1 after 45 and 
60 min were characterized as poorly crystallized hydroxyapatite as found for HS 
3:1. The analysis of the XRD spectra (figure 3.16) shows a slight increase in 
cristallinity with the increase in time of precipitation.  
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Figure 3.16- XRD patterns of Hap nanoparticles precipitated from solutions containing 
(Cit:Ca)= (7:1) after different times: 45 min (HS 7:1/45) and 60 min (HS 7:1/60). 
The morphologies of the Hap particles precipitated from solutions containing 
(Cit:Ca)= (7:1) after different times (HS 7:1/45 and HS 7:1/60) are illustrated in 
figure 3.17. As observed, further increase of (Cit:Ca) ratio from (3:1) to (7:1) 
resulted in the formation of particles with a cotton like aspect as shown in the SEM 
and TEM images provided in Figure 3.17((a) and (b)). The average size of these 
Hap particles is around 600 nm and 800 nm respectively. However it should be 
pointed out that precipitation could not be observed before a period of time of 45 
min. Moreover, comparing the morphological results obtained for two studied 
Cit:Ca ratios (3:1 and 7:1) it is observed that the nucleation and initial growth of 
Hap particles are different in these two conditions. The increase in the amount of 
citrate ion in the starting calcium solution delayed considerably the nucleation of 
Hap. Thus the calcium citrate complexes formed under the larger amounts of 
citrate remained stable for longer periods as compared to (Cit:Ca) = (3:1) 
conditions. This indicates the chemistry of citrate calcium complexes to be 
particularly sensitive to the ratio of Cit:Ca which in turn determines the stability of 
the resulting complexes.  
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Figure 3.17- SEM and TEM images of Hap particles precipitated from solutions with a 
(Cit:Ca) ratio of (7:1) and after different times: (a, b) 45 min and (c, d) 60 min.  
FTIR spectra of the samples precipitated with different times are present in figure 
3.18 (a) and (b). As in HS 3:1 the main vibrational bands assigned to the 
hydroxyapatite PO43- groups (figure 3.18 (a)) are observed in all spectra which 
confirms the formation of hydroxyapatite. The spectrum of HS 7:1/45 is different in 
the range of 1200-1700 cm-1 as compared to that of HS 7:1/60 and HS 7:1. It is 
clearly shown that the sample HS 7:1/45 present a larger number of vibration 
bands than the others samples. As observed, this FTIR spectrum is similar to that 
of HS 3:1/15 with well-defined absorption bands assigned to citric acid. Moreover 
comparing HS 7:1/45 to HS 7:1/60 it is seen that the bands detected at 1270, 
1305, 1436 cm-1 are no longer present in HS 7:1/60. A similar trend with 
precipitation time was found in HS 3:1 results suggesting that adsorption of citrate 
species on Hap particles is dependent on the synthesis time, i.e., on the solution 
temperature. Despite this trend similarity, citrate bands could not be identified in 
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the samples obtained with HS 7:1 after 60 minutes whereas they are still present 
in samples with HS 3:1/60, although with a reduced intensity. 
Figure 3.18- FTIR spectra of Hap particles obtained from solutions with a (Cit:Ca) ratio of 
(7:1), at 180ºC and after different synthesis times (—) 45 min, (—) 60 min and (—) 24 
hours. Figure 3.18 (A) covers the wavenumbers range of 400 to 1200 cm-1 and figure 3.18 
(B) covers the range from 1200 to 1800 cm-1. 
As previously discussed a further increase of the synthesis time to 24 hours FTIR 
results indicate that citrate bands are no more present in FTIR spectra. 
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The TG curves of the HS 3:1 and HS 7:1 after 60 minutes of synthesis are 
compared in figure 3.19. As seen the total weight losses of HS 3:1/60 and HS 
7:1/60 samples are ~25% and ~70% respectively. In this last case of huge weight 
loss, it can be precised that around 30% of the sample total weight is lost in 
300ºC-500ºC temperature interval which is the region of organics burning out 
against 7.5% for HS 3:1/60. Attempting to correlate these findings with FTIR 
results it is found that, although carboxylate bands are better differentiated in HS 
3:1/60 samples as compared to HS 7:1/60, the amount of citrate derived organics 
existing in HS 7:1/60 particles largely surpasses the equivalent organic content of 
HS 3:1/60. It may be thus concluded that, after a short precipitation time (such as 
45 min) the amount of carboxylate species adsorbed on Hap surface roughly 
correlates with the amount of citrate initially introduced in the system. However as 
the synthesis time increases, carboxylate related species probably undergo 
thermal decomposition being part of the reaction products desorbed and released 
back to the solution thus depleting the organic content of particle surface. The 
reason why after 24 H organics depletion is fairly stronger in HS 7:1 as compared 
to 3:1 may rely on the different possibilities for citrate decomposition reaction path 
as reviewed by Cody, G.D et al. 9. Accordingly, if gaseous reaction products are 
formed (like acetone) a larger pressure increase will take place in the case of HS 
7:1 which may dramattically condition the reaction prosecution. This may explain 
why different products would be originated and consequently affect the type and 
final amount of adsorbed organics: citrate derived species specifically produced in 
HS 7:1 system would easily desorb from Hap surface and restore appropriate 
conditions for lateral particle attachment. Particle nucleation and growth 
mechanisms are thus strongly dependent on the amount of citrate ion introduced 
in the starting solution.  
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Figure 3.19- (a) Thermogravimetric analysis (TGA) plots of Hap nanoparticles precipitated 
from solutions containing (Cit:Ca) ratios of (3:1) and (7.1), after 60 min. 
The main conclusions to be withdrawn from the present chapter are: 
Hap particles were precipitated from calcium/citrate/phosphate solution at 180ºC 
by a hydrothermal method. The morphology of the precipitated particles has 
evidenced a great dependence on the experimental conditions, principally on the 
citrate/calcium molar ratio. Nanometric or micrometric Hap particles with different 
morphologies could be obtained by varying the solution Cit:Ca ratio. This 
morphology dependence on citrate initial amount can be explained as a result of 
the amount and configuration of carboxylate groups adsorbed on particles surface. 
For the experimental conditions selected in this study, the amount of adsorbed 
citrate derived species on Hap surface after 24 hours of synthesis decreases as 
the Cit:Ca ratio increases, which conditions particle growth and agglomeration 
leading to the formation of microparticles. The present studies also demonstrate 
that during the early growth stages (<60 min) the particles carry a large organics 
content which becomes strongly reduced after a time of 24 h. It is thus concluded 
that initial citrate species undergo thermal decomposition as the synthesis time 
increases being followed by rearrangement and/or desorption processes with a 
strong impact on particle morphology which may vary from a nanometric to a 
micrometric size which is particularly evident for the higher Cit:Ca molar ratio. 
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4.1. Introduction 
Although conventional calcium phosphate materials have been well studied and 
shown to be biocompatible, the utility of smaller Hap particles as biomaterial 
materials is now receiving strong attention. It has been reported that nanosized 
Hap particles can be a better candidate in biomedical applications 1,2 since they 
have less inflammatory response when compared with microsized particles. The 
recent research efforts on this field have been particularly focused on the need 
of controlling Hap particle morphology. Some reports have shown the possibility 
of synthesizing Hap nanoparticles with well-defined size and shape 3-5. It was 
also demonstrated in the previous chapter that crystalline Hap particles with a 
well-defined prismatic shape but maintaining nanometric dimensions may be 
produced by a hydrothermal method under the presence of an organic additive, 
i.e. citric acid, provided the ratio of the organic specie to the calcium ion is 
maintained close to 3:1. However, the particle size and shape impact on the 
various biomedical application possibilities of Hap nanoparticles are still far from 
being completely covered. Furthermore questions concerning the mechanisms 
whereby cells detect and respond to Hap nanometric particles are still 
unresolved 6. It is likely that these mechanisms involve modulation of the 
interfacial forces that guide the organization of cytoskeletal elements and 
membrane receptors cells. This, in turn, may modify intracellular signaling, 
binding sites of proteins and integrin signaling 7,8. This hypothesis suggests that 
it may be possible to optimize the functionality of cells on the basis of the size 
and other features of Hap nanoparticles. 
This reasoning provides the main motivation for the present study in which Hap 
nanoparticles with different morphological attributes tailored under specific 
synthesis conditions will be then exposed to osteoblastic cells (MG63) aiming to 
access the effects of particle morphology and concentration on cell response.  
Two Hap synthesis methods were selected for producing Hap nanoparticles 
with different characteristics: the hydrothermal method assisted by citric acid 
under a specific (Cit:Ca) ratio of 3:1 (one of the conditions discussed in the 
previous chapter, chapter 3) and a second wet chemical synthesis method 
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previously reported in the literature 5. The particles obtained by the first method 
and second method will be referred hereafter as HS and WCS, respectively. 
Reminding that the ultimate application of Hap nanoparticles will demand the 
produced particles to be sterilized before subsequent in vivo application, the 
sterilized particles corresponding to HS and WCS, i.e. HSster and WCSster 
respectively, will here be addressed as the true targets to be studied. Moreover, 
the as prepared particles (HS and WCS) will be contrasted to their sterilized 
counterparts (HSster and WCSster, respectively) for accessing the influence of 
autoclaving sterilization on the chemical and physical properties of the two 
synthesized Hap nanoparticles. 
For the in vitro studies, HSster and WCSster will be examined for their effects on 
human osteoblastic cells aiming to elucidate the impact of the particle 
physicochemical profile and concentration on the in vitro cell culture behaviour.  
The experimental results will be discussed in the present chapter by the 
following order: the different physicochemical characteristics of Hap 
nanoparticles obtained by two synthesis procedures will be firstly analyzed and 
then the modification of Hap nanoparticles characteristics induced by 
autoclaving sterilization will be addressed. Finally osteoblastic cells response to 
the distinct sterilized Hap nanoparticles will be evaluated.  
4.2. Comparing the characteristics of hydroxyapatite 
nanoparticles synthesized by hydrothermal (HS) and Wet 
Chemical Method (WCS)  
Figures 4.1 show the XRD patterns of HS and WCS particles. The peaks of the 
XRD patterns of all the examined specimens can be attributed to hexagonal 
hydroxyapatite (space group P63/m, a =b=9.4320Å, c =6.8810 Å) according to 
the data referenced by JCPDS Nº 09-0432. For both WCS and HS particles it is 
noticed an XRD baseline hump centred on the 2θ region of 20-35º which is 
usually ascribed to amorphous calcium phosphate (ACP) 9. However it is worth 
mentioning the better defined XRD spectrum of HS nanoparticles with sharper 
peaks which indicate HS particles to have higher crystallinity than WCS which is 
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furthermore confirmed by the larger crystallite size estimated for HS as 
compared to WCS (see table 4.1). 
Figure 4.1- X-ray diffraction patterns (XRD) of (a) WCS particles (b) HS particles as 
prepared; (c) WCSster after being sterilized and (d) HSster after being sterilized. 
The size and morphologies of the obtained nano-Hap particles were 
characterized by transmission electron microscope (TEM). Figure 4.2 shows the 
TEM images of the obtained WCS and HS particles. HS and WCS 
nanoparticles are both seen to be well dispersed particles as well (Figures 
4.2(a) and 4.2(b)). It is observed that WCS present a needle like shape with a 
width of few nanometres and a length (l) around 100 nm (figure 4.2(a)). The 
particles obtained by hydrothermal method (HS) as already described in chapter 
3, present a prismatic rod-like shape with hexagonal cross section, whose 
average length (l) and widh (w) are 20 nm<l<100 nm and w≈20 nm, respectively 
(figure 4.2(b)) and, hence a smaller aspect ratio (l/w).  
(a) (b)
(c) (d)
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Figure 4.2- TEM images of nano-Hap synthesized by (a) Wet chemical method (WCS) 
method, (b) Hydrothermal (HS) method, (c) nano-Hap WCS after sterilization in 
autoclave (WCSster) and (d) nano-Hap HS after sterilization in autoclave (HSster). 
The morphology and crystallinity dissimilarities between the synthesized WCS 
and HS nanoparticles reflect the temperature and pressure conditions that 
distinguish the two synthesis methods used for particle precipitation. Such 
differences are in line with frequent reports showing that Hap synthesis at high 
temperature (T>100ºC) leads to crystalline and well defined prismatic particles 
while lower temperature synthesis generally favours thinner particles with less 
perceptible contours and lower crystallinity 10-13. 
Table 4.1 compares some physical and chemical characteristics of the 
hydroxyapatite particles obtained by Wet Chemical precipitation (WCS) and by 
Hydrothermal synthesis (HS). The EDX technique used to measure particle 
Ca/P ratio revealed the values of 1.62 and 1.70 for HS and WCS particles, 
respectively. These results evidence a negligible deviation from the 
stoichiometric value of 1.67 14-16. 
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The specific surface area (SSA) of the prepared nano-Hap particles was 
determined by N2 adsorption using the multipoint Brunauer-Emmett-Teller 
isotherm (BET) as reported in chapter 2.2. SSA values of 170 m2/g and 55 m2/g 
were found for WCS and HS, respectively. These results reflect the different 
particle sizes described above, being the larger SSA exhibited by the thinner 
WCS particles. In line with the observations from Naruporn Monmaturapoj et al. 
who sustained that the wet chemical method produces Hap particles with 
greater specific surface area than the hydrothermal method 17 the present work 
points out that under equivalent conditions of pH and Cit:Ca ratio larger 
nanometric Hap particles are obtained by the Hydrothermal method.  
Table 4.1. Properties of hydroxyapatite particles obtained by wet chemical precipitation 
(WCS and WCSster) and by hydrothermal synthesis (HS and HSster): particles as 
prepared (WCS and HS, respectively) and after being sterilized (WCSster and HSster, 
respectively). 
Sample Code Ca/P ratio 
SSA 
[m2/g] Morphology 
Crystallite size 
(nm) 
[002] 
WCS 1,70 171 needle like shape 17 
HS 1,62 55 rod like shape 38 
WCSster 1,71 22 rod like shape 21 
HSster 1,69 55 rod like shape 37 
Figure 4.3 shows the pH dependence of zeta potential (ξ) for the nanoparticles 
under analysis. The observed ξ values are constantly negative for both (WCS 
and HS) nano-Hap particles in the examined pH range as revealed by the 
curves (a) and (b) respectively. Hap particles of different morphologies obtained 
by hydrothermal synthesis were reported with different zeta potential at 
physiological pH namely: nanorod shape -11,4 mV 18, spherical -5,5mV 18, 
whiskers -17,8 mV 19. In the present study the values of zeta potential for Hap 
nanoparticles (HS) produced by hydrothermal method is -20±1 mV, slightly 
higher than reported, however is within the same range of values. WCS 
nanoparticles present more negative ξ values as compared to HS nanoparticles 
in the examined pH range. At physiological pH (~7.4) the zeta potential of WCS 
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is -40±5 mV, whereas the zeta potential for HS is -20±1 mV. The present results 
thus indicate that the particle synthesis temperature conditions the particle 
surface chemical groups which in turn affect considerably the particles zeta 
potential.  
Figure 4.3- pH dependence of zeta potential () for the (a) WCS nanoparticles (b) HS 
nanoparticles; for the (c) HSster sterilized and (d) WCSster sterilized. The observed () 
values are constantly negative for WCS and HS.   
Fig 4.4 ((a) and (b)) compares the FTIR spectra of WCS and HS particles which 
both reveal the main vibration bands normally attributed to Hap which were 
already discussed in chapter 3. The features distinguishing WCS from HS 
particles include: (i) an intense shoulder at 3200 cm-1 less evident in HS spectra 
attributed to ammonium ions 5,20; (ii) a small band at 877 cm-1, only visible in HS 
spectra, indicating the presence of CO32- in a B type substitution 21,22 and (iii) 
the peaks at 3570 cm-1 and 632 cm-1, absent in WCS, assigned to the stretching 
(νs) and vibrational modes (νL) of the structural hydroxyl anions, respectively 23. 
The 1250-1700 cm-1 spectral region where citrate related bands are expected to 
be found is detailed in the amplified view shown in figures 4.4 (c) and 4.4 (d). 
Common features are identified including the sharp peak at 1384 cm-1 which 
has been assigned to the –CH2- scissoring mode 24 and the bands attributed to 
the antisymmetric (1650 and 1567 cm-1) and to the symmetric (1465 and 1402 
cm-1) stretching modes of carboxylate groups coordinated to Hap surface Ca2+ 
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cations 10,25-27 either in a monodendate or in a bidentate manner 28-30. However 
some dissimilar bands that distinguish the two particles spectra are remarked: 
the 1614 and 1434 cm-1 bands absent in HS which may be attributed to the 
asymmetric (a) and symmetric (s) modes of a carboxylate group acting as 
uncoordinated anion (“ionic” structure) 30 and the band at 1540 cm-1 in WCS but 
not evident in HS. This last band may be ascribed to a 3 vibration of a CO32- 
group substituting OH- being found at 1465 cm-1 and 880 cm-1 the remaining 
characteristic bands of such substitution in WCS 31,32. However other 
contributions likely related to differently coordinated carboxylate groups are not 
ruled out for explaining the origin of this 1540 cm-1 band as it is questionable 
that thermally untreated Hap powders (as is the case of WCS particles) might 
exhibit a so developed CO3 band. Other meaningful differences include the 
1270 cm-1 band in WCS spectrum assigned to the skeletal vibrations of citrate 
species 33 together with a well-defined band at 1305 cm-1 attributed to citrate 
OH group able to rotate freely around its C-OH axis 34.  
Due to the presence of citric acid in the starting precursor solutions of both 
types of particles, the presence of adsorbed carboxylate groups was expected 
on both WCS and HS particle surface. As just discussed, FTIR results revealed 
carboxylate species coordinated under different manners thus denoting the 
influence of their different synthesis temperatures. Citric acid degrades at 
T>145ºC 35,36 leading to reaction products that may include different 
dehydroxylated or decarboxylated acids and anhydrides depending on the used 
heating rate and temperature. This legitimates the assumption that original 
citrate ions might not exist as adsorbed species on HS particle surface but 
instead smaller carboxylated ions resulting from citrate ion decomposition under 
the high temperature (180ºC) and pressure used for HS thermal synthesis. The 
absence in HS spectrum of the 1270 and 1305 cm-1 bands respectively 
assigned to citrate skeletal vibrations and free OH group 33 is in line with this 
reasoning. The presence of unreacted citrate species together with 
uncoordinated carboxylate ions also detected on WCS surfaces could perHaps 
account for the more negative zeta potential measured for these particles. As 
the surface charge of Hap particles may modulate the cellular pathways by 
modifying intracellular signalling and the binding sites of proteins and integrin 
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signalling, it is here concluded that particle synthesis details like temperature 
might condition particle electrical surface charge and hence the mechanisms 
operating at the particle/biological environment interface.  
Figure 4.4 - FTIR spectra of (a) WCS particles (b) HS particles as prepared; amplified 
view of FTIR spectra in the range of 400-2000 cm-1 for (c) WCS and (d) HS. 
4.3. Sterilization process of HS and WCS nanoparticles 
The sterilization method used in the present study was autoclaving. Figures 4.1 
(c) and (d) show the XRD patterns of HS and WCS particles, respectively, after 
being sterilized. It is observed that both sterilized Hap particles exhibit an 
increased intensity of XRD peaks though WCSster nanoparticles crystallinity still 
stays behind that of HSster nanoparticles. A flattening of the amorphous hump 
(2-Theta- 20-35º) with sterilization is also noticed in both types of particles. The 
Table 4.1 compares the crystallite size evolution of WCS and HS particles 
during sterilization. A slight increase in WCSster crystallite size is observed 
which denotes larger coherent crystalline domains 9. Figure 4.2 ((d) and (e)) 
shows the TEM images of the particles after sterilization (HSster and WCSster). It 
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is observed that sterilization induces a significant modification of WCS features: 
besides looking significantly agglomerated (figure 4.2(d)) the particles undergo 
a thickening process as they become less transparent to the electronic beam 
after sterilization. Thus WCS morphologic evolution indicates that sterilization 
conditions promoted both a shape modification and a visible particle 
agglomeration as WCSster particles appeared clearly outlined as rod like units 
but merged into large aggregates. It is difficult to quantifay WCS thickening 
amount since the thickness of the WCS particles prior to sterilization is of very 
difficult estimation. Regarding HS nanoparticles they do not suffer any 
significant morphology change as documented by figure 4.2 (e). The evolution 
of the specific surface area (SSA) of both type of particles is in line with the 
morphology changes previously referred: HS particles SSA is not appreciably 
affected by sterilization (Table 4.1) while a large SSA decrease occurs for WCS 
during sterilization, from 171,0 m2/g to 22,3 m2/g. As referred, the sterilization 
process exposed WCS particles to a temperature higher than that of synthesis, 
furthermore assisted by a saturated steam atmosphere. It is here suggested 
that such conditions allowed the smaller sized amorphous calcium phosphate 
(ACP) particles to undergo a partial dissolution subsequently followed by a re-
precipitation process which contributed to the growth of the existing Hap 
coherent crystalline regions. Moreover, it is also postulated that these 
phenomena might have occurred preferably in the neighbourhood of larger 
particles where enhanced Oswald ripening driving forces would operate 37. The 
large aggregates observed after sterilization are thus envisaged as resulting 
from re-precipitation processes that allowed adjacent particles to get chemically 
bonded. These events would explain the large decrease of WCS specific 
surface area, from 171 to 22 m2/g, and the observed crystallite growth during 
sterilization as documented in table 4.1. In line with the previous reasoning the 
hump flattening in WCSster XRD is thought to reflect the ACP decrease due to 
the referred dissolution. The present results interpretation are consistent with 
previous literature reports showing that a combined high temperature and 
saturated steam regime promotes the local dissolution of the extremely unstable 
and hydrolysable ACP phase and its recrystalization as Hap phase 38,39. 
Regarding the steam sterilization behaviour of HS particles some crystallite size 
variations are also remarked but with a smaller extent as compared to those of 
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WCS (Table 4.1). Since particle size, shape and surface area are maintained 
practically unchanged during autoclaving it is concluded that dissolution and re-
precipitation processes, if any, were negligible. Additionally the crystallite size 
results (Table 4.1) together with the amorphous calcium phosphate depletion 
inferred from the flattened HSster XRD baseline are interpreted as expressing 
the amorphous calcium phosphate (ACP) reorganization into Hap crystalline 
phase under the favourable high temperature and H2O enriched atmosphere 
conditions underlying the sterilization process 26,39,40. 
The pH dependence of zeta potential (ξ) of the sterilized nanoparticles is 
presented in figure 4.3 ((c) and (d)). The observed ξ values are negative in the 
examined pH range except for HSster which display positive ξ values for the 
lowest pH values (pH<5,4). In addition it is shown that WCSster nanoparticles 
present more negative ξ values than HSster nanoparticles. Moreover WCS and 
WCSster particles are seen to display close ξ curves in the range 5<pH<7 
becoming then WCSster more negative as pH increases. As for HS nanoparticles 
it is remarked that their ξ curve is shifted towards more negative potential 
values as compared to HSster thereby indicating HS nanoparticle surface charge 
to become less negative upon sterilization.  
The FTIR spectra of WCSster and HSster sterilized nanoparticles are depicted in 
figures 4.5. As mentioned the WCS or WCSster spectra (fig 4.5 (a) and (c)) are 
distinct from those of HS or HSster (fig 4.5 (b) and (d)) particles but no 
remarkable changes are detected between non-sterilized nanoparticles and 
their sterilized counterpart. When comparing sterilized and unsterilized particle 
spectra, no visible differences are detected between WCS and WCSster and only 
minor ones are observed between HS and HSster. These include the shoulder at 
1402 cm-1 and the broad band centred at 1670 cm-1 which appears less intense 
in HSster. This may indicate a partial loss of adsorbed citrates carboxylate 
groups by HS particle.  
The different morphology variations suffered by HS and WCS particles during 
sterilization were accompanied by different trends in surface charge variation: 
whereas WCS surface charge remained practically unchanged with sterilization 
in the lower pH range (5≤pH≤7), HS particles tended to a less negative surface 
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charge. The FTIR results have evidenced that the configurations of some 
carboxylate groups adsorbed on the surfaces of WCS or WCSster and HS or 
HSster particle are different. As previously referred, the intensity of some 
carboxylate related bands in HS FTIR spectra tended to decrease upon 
sterilization being thus concluded that a partial desorption of adsorbed 
carboxylated species on Ca2+ might explain the small increase of HSster zeta 
potential. WCSster appear to be less prone to surface charge modifications by 
sterilization. Considering that no visible variations were detected in WCS FTIR 
spectra after sterilization the adsorbed citrate ions seem to behave as a buffer 
chemical layer whose thermal stability plays a key role on its surface charge 
maintenance.  
 
Figure 4.5- FTIR spectra of sterilized (a) WCSster particles, (b) HSster particles; amplified 
FTIR area of (c) WCSster particles and (d) HSster particles. 
4.4. Interaction of Hap nanoparticles with osteoblastic cells 
after sterilization  
4.4.1. Cell viability/proliferation 
As mentioned before the particles to be used in cellular culture should be 
sterilized. For that reason only the WCSster and HSster nanoparticles will be 
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analysed in this section. Figure 4.6 shows the proliferation of MG-63 osteoblast-
like cells in contact with various concentrations of WCSster and HSster 
nanoparticles during 3 and 6 days. Osteoblast-like cells without any contacts 
with nano-Hap were used as a control. As observed, both types of nano-Hap 
induced concentration-dependent deleterious effects in the cell 
viability/proliferation of MG63 osteoblast cells at concentration levels higher 
than 500 g/ml. At 1000 and 5000 μg/ml, a large amount of particles were seen 
in the well plate, covering completely the cell layer. For these concentrations, 
WCSster particles caused an inhibition of cell proliferation slightly higher than 
HSster. From these results it is also observed that, as the percentage of the 
inhibition of cell growth was higher at day 6, than on day 3, the deleterious 
effects were time-dependent. With this information, cell response was further 
characterized in the cultures exposed to 50 and 500 μg/ml, to evaluate in more 
detail the effects in the cell behavior.  
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Figure 4.6- Cell viability/proliferation of MG63 cell cultures exposed to (a) WCSster and 
(b) HSster nanoparticles, after 3 and 6 days for a nanoparticles concentration range 
between (50-5000g/ml). *Significantly different from control. Both types of nano-Hap 
induced concentration-dependent deleterious effects in the cell viability/proliferation of 
MG63 osteoblast cells at concentration levels higher than 500 g/ml. 
4.4.2. F-actin cytoskeleton organization 
The cultures studied were also analysed by confocal laser scanning microscopy 
(CLSM). Figure 4.7 shows the CLSM images of MG63 cells cultures exposed to 
a concentration of 500 g/ml of WCSster and HSster nanoparticles during 3 and 6 
days. The selection of that concentration is due to the fact that cell 
viability/proliferation is affected at a nano-Hap level greater than 500 g/ml. 
Observation of the cultures, show that the control cells displayed an elongated 
morphology, cell to cell contact and the formation of a continuous cell layer by 
(a) 
(b) 
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day 6; in addition, the F-actin cytoskeleton of these cells stained mainly within 
the dense peripheral actin ring. At day 6 the presence of 500 g/ml nano-Hap 
appeared to induce some changes on the overall cell morphology, reflected by 
a lower intensity of the F-actin at the cell limits; besides, it is also noticed the 
presence of intercellular gaps and retraction of the cell layer from the culture 
substratum. Such effects are particularly clear in the cultures exposed to the 
WCSster particles. The observation of the cells exposed to 50 g/ml nano-Hap 
was also done but they displayed a similar appearance and therefore the results 
were not documented. 
Figure 4.7- CLSM images of MG63 cell cultures exposed to the WCSster and HSster 
nanoparticles, for a nanoparticles concentration of 500 g/ml, during 3 and 6 days. 
Observation of the cultures, show that the control cells displayed an elongated 
morphology, cell to cell contact and the formation of a continuous cell layer by day 6; in 
addition, the F-actin cytoskeleton of these cells stained mainly within the dense 
peripheral actin ring.  
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4.4.3. Apoptosis  
The apoptosis is the programmed cell death by the fragmentation of DNA, cell 
shrinkage, followed by cell fragmentation and formation of membrane vesicles 
called apoptosis bodies 41,42. To quantify the cell apoptosis, the MG63 cells 
cultures were exposed to WCSster and HSster (50 g/ml and 500 g/ml) during 3 
days and analysed by flow cytometry as illustrated by figure 4.8. Cultures 
exposed to 50 g/ml nanoHap for 3 days presented a low percentage of 
apoptotic cells, similar to control. However, interaction with 500 g/ml particles 
showed an increase in the number of cells in apoptosis, Figure 4.8. 
Figure 4.8- Rate of apoptosis of MG63 cell cultures exposed to WCSster and HSster 
nanoparticles during 3 days for the 50 and 500 g/ml concentrations. 
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4.4.4. Gene expression of osteoblastic proteins 
The RNA was analysed by RT-PCR for the expression of the housekeeping 
gene glyceraldehydl-3-phosphate dehydrogenase (GAPDH), collagen (Col I), 
alkaline phosphatase (ALP) and bone morphogenetic protein 2 (BMP-2), 
respectively using a densitometric analysis (figure 4.9). Under the same 
experimental conditions as the apoptosis tests, RT-PCR analysis showed 
WCSster and HSster particles, 50 and 500 g/ml, did not affect the expression of 
collagen type I but caused significant effects in the expression of ALP and BMP-
2, figure 4.9. HSster particles caused a dose-dependent increase in the 
expression of ALP and BMP-2. WCSster particles induced significantly the 
expression of ALP and BMP-2 at 50 g/ml, but decreased values were 
observed in the presence of 500 g/ml. 
Figure 4.9- Gene expression of Collagen, ALP, BMP-2 of MG63 cell cultures exposed 
to WCSster and HSster nanoparticles, 50 g/ml and 500 g/ml, for 3 days. RT-PCR, the 
PCR products were subjected to a densitometric analysis and normalization to the 
corresponding GAPDH value. *Significantly different from control.  
4.4.5. Nano-Hap cell uptake  
MG63 cells cultured with 50 and 500 g/ml of nanoparticles for 3h, 24h and 3 
days were observed by TEM, Figures 4.10, 4.11 and 4.12. It can be seen that in 
the cell environments, isolated nanoparticles and aggregates of various sizes 
Chapter 4              Viability and proliferation of MG-63 osteoblastic cells exposed to 
hydroxyapatite nanoparticles with different characteristics 
159 
 
were detected, interacting with the cell membrane. Furthermore it can also be 
observed that HSster particles maintained their shape within the aggregates, but 
a different behaviour was revealed by WCSster particles which appeared more 
loosely than that seen in the compact aggregates, before contacting with the 
cell culture medium (figure 4.10 and 4.11).  
Control cells showed a fusiform shape with intact cytoplasmic and nuclear 
membranes. These cells presented a normal distribution of the intracellular 
organelles, i.e. nucleus with uniformly dispersed chromatin and clear nucleolus 
and the cytoplasm containing randomly distributed organelles and 
electrondense granules. As can be seen in figures 4.10 and 4.11, following 
nano-Hap interactions, cells readily internalized the nanoparticles. Uptake of the 
particles was apparently initiated by the emission of pseudopod-like projections 
towards nanoparticles with further fusion of their membranes, which entraps 
particles inside endosomes (figures 4.10 and 4.11). Several vesicles of different 
sizes and loaded with particles were observed scattered within the cytoplasm 
(figures 4.10 and 4.11); besides, isolated particles were not detected either in 
the cytosol, cell nucleus or in other organelles. As cells exposed during 3 days 
to 500 g/ml of HSster and WSCster nano-Hap presented huge loaded vesicles, 
the uptake of the nanoparticles seemed to be time and concentration-
dependent. Furthermore, it was also noticed several cells exhibiting 
characteristic signs of apoptosis, i.e. cell membrane shrinkage with blebs 
formation, cytoplasm budding with vacuolization, and chromatin condensation at 
the nuclear periphery (figures 4.10 and 4.11). Cellular debris were also present 
in HSster and WCSster cultures, mainly after 3 days of exposure, which probably 
result from the progressive degeneration of apoptotic bodies. At high 
magnification, Figure 4.12, it is observed a close interaction between the 
nanoparticles and the cell membrane and the vesicles loaded with clustered 
particles; after 3 days, a high percentage of particles, especially HSster, 
maintained their rod-like morphology. However, particle dissolution seemed to 
have occurred, particularly in WCSster particles. This might reflect the lower 
crystallinity of WCSster particles, compared to HSster, favouring their dissolution. 
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Figure 4.10- Representative TEM micrographs of MG63 cell cultures exposed to 
WCSster nanoparticles, 50 and 500 g/ml, during different periods (3 hours, 24 hours 
and 3 days). The emission of pseudopods surrounding adjacent nanoparticles is 
observed in A (3 hours, 50 g/ml) and B (3 hours, 500 g/ml); D (24 hours, 500 g/ml) 
and E (3 days, 500 g/ml), depict clusters of nanoparticles entrapped in endosomes. 
Apart the entrapped nanoparticles within endosomes, it can be also observed in C (24 
hours, 50 g/ml) cellular debris in intercellular space. A cell with early signals of 
apoptosis, such as the rounded shape, the cytoplasmic vacuolization and signs of 
blebs formation is shown in F (3 hours, 50 g/ml).  
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Figure 4.11- Representative TEM micrographs of MG63 cell cultures exposed to HSster 
nanoparticles, 50 and 500 g/ml, during different periods (3 hours, 24 hours and 3 
days). A (3 hours, 50 g/ml) and B (3 days, 50 g/ml) depict the emission of 
pseudopods surrounding nanoparticles and in D (24 hours, 500 g/ml), E (3 days, 50 
g/ml), and F (3 days, 500 g/ml) it can be observed clusters of nanoparticles 
entrapped in endosomes. An apoptotic cell with a rounded shape, condensed 
chromatin at nuclear periphery, cytoplasmic vacuolization and signs of blebs formation 
is shown in C (24 hours, 500 g/ml).  
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Figure 4.12- High magnification TEM images of MG63 cell cultures exposed to WCSster 
and HSster nanoparticles, 500 g/ml, for 24 hours. A and E show the close interaction of 
the nanoparticles with the cell membrane, and B and F the intracellular vesicles loaded 
with the particles. C and G, a high magnification of B and F, respectively, display the 
nanoparticles within the intracellular vesicles, showing signs of particle dissolution. D 
and H display the electron diffraction patterns of the internalized nanoparticles. 
As observed, sterilization induced significant effects in the physicochemical 
profile of WCS particles, being the most relevant changes observed in the 
morphology (size and shape), in the crystallinity and surface electrical charge. 
Culture medium was supplemented with foetal bovine serum which contains a 
variety of proteins and other bioactive molecules that quickly form an adhesion 
layer on the reactive surface of the nanoparticles, favouring the formation of 
agglomerates of attached particles, as also seen in previous studies involving 
several cell types 43-45. The biological relevance of surface adsorbed proteins 
has been highlighted and the particle with its “protein-corona” is considered the 
effective unit of interest in the cell nanomaterial interaction. Regarding nano-
Hap particles, surface adsorbed serum proteins was reported to alter the 
surface biochemistry and also physicochemical properties such as size, surface 
charge, aggregation behaviour and solubility 45. WCS and HS particles were 
both negatively charged at physiological pH, but WCS particles exhibited a 
much lower zeta potential value (figure 4.3), which is expected to influence the 
composition, and stability of this protein corona. However, as the zeta potential 
of the resulting particle-protein complex is not recognized, the relevance of the 
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different surface charge of WCS and HS particles on cell uptake and response 
is not known. 
TEM images of cultures exposed to WCSster and HSster nano-Hap showed a 
close interaction of the particles with the cell membrane, followed by an 
internalization process by endocytosis pathways, with a time and dose-
dependent uptake. The presence of intracellular Hap loaded vesicles induced 
alterations on the overall cell morphology, particularly in the presence of high 
levels, 500 g/ml. Cells displaying signals of apoptosis were also seen; this 
appeared to result from the presence of big sized filled vesicles that damaged 
the cell structure, causing the cell degeneration. For both WCSster and HSster 
nano-Hap, cultures presented a high variability concerning particles uptake, i.e. 
the percentage of cells showing internalized particles and the number and size 
of the loaded vesicles. This is probably because, in the experimental protocol 
used, a suspension of particles was added to the adherent cells and, thus, the 
particle-cell interaction was associated with a great heterogeneity. Previously, 
nano-Hap internalization was observed in periodontal ligament cells 43, liver 
cancer cells 44, macrophages 46 and mesenchymal stem cells 47 interacting with 
isolated particles, or in rabbit osteoblastic cells and U2OS cells 6 and MG63 
cells 48 growing over nanoparticles films. In these studies, a great variability on 
the uptake of the nanoparticles was observed, which might be related with the 
cell type 6 and, in the same cell type, with the particles properties 46. At high 
nano-Hap levels, 500 g/ml, CLSM images also showed signals of deleterious 
effects in the cell layer, namely a lower definition of the F-actin peripheral ring, 
especially the cultures exposed to the WSC particles. F-actin plays a critical role 
in cell architecture and mobility, and the observed effects might suggest cellular 
responses to mechanical strain, probably arising from the presence of the nano-
Hap loaded vesicles, as suggested before regarding endothelial cells 49,50.  
In spite of the deleterious effects of WCSster and HSster nano-Hap at high levels, 
it is worth to mention that the interaction with low levels, 50 g/ml, results in a 
rapid internalization without affecting cell viability/proliferation, cell morphology 
and the percentage of apoptosis. Besides, a significant increase in the gene 
expression of the osteoblastic markers ALP and BMP-2 was observed in the 
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presence of HSster particles. This is in line with previous studies showing that 
Hap nanoparticles exhibit functional properties, namely modulating the 
expression of several genes in osteoblastic cells, including ALP expression 51. It 
was also reported 47 an increased ALP activity in periodontal ligament cells 
interacting with nanoHap 43. 
Dissolution of nano-Hap has been previously suggested to occur in osteoblasts 
51 and macrophages 46. The dissolution process may induce the saturation of 
the lysosome environment regarding calcium, phosphate and hydroxide ions 
and the elevation of the local pH 52,53, which might contribute to inhibit further 
Hap dissolution 46. Such behaviour might explain the relatively low dissolution of 
WCSster and HSster nano-Hap particles after 3 days. It has been suggested that 
diffusion of calcium and phosphate ions from the lysosome to the cytoplasm 
plays a relevant role in the modulation of cell behavior by nano-Hap. In the 
cytoplasm, calcium concentration is lower than 200 nM but higher 
concentrations (400 to 600 M) can be reached within the lysosome 52, and 
even minor changes in cytoplasmic calcium has significant effects in cell 
behavior, as this ion has a major role as a second messenger modulating a 
variety of cellular functions 54.  
In the present work, WCSster and HSster particles exhibited some differences on 
the induced cell response, namely in the cytotoxic potential and in the gene 
expression of osteoblastic markers. Main differences in the physicochemical 
profile of the sterilized particles are the more negative zeta potential and the 
lower crystallinity of WCSster nano-Hap, conditioning the interaction with proteins 
and cells and the particles dissolution rate. Particles also differed on the amount 
of adsorbed citrate ions, which may be of biological significance, as citrate is an 
important metal ion binder, with a high affinity for calcium, being involved in key 
physiological functions and intracellular metabolic events 55. However, no single 
property was identified to explain the differences seen in the response of MG63 
cells, which is in line with previous studies 6,43,46,48-52, showing a great variability 
in the cell response to nano-Hap. These studies involved a variety of 
experimental conditions, i.e. characteristics of the Hap nanoparticles, the cell 
type, the exposure conditions and the characterization of the cell response. In 
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some of the works, particles were poorly characterized and, in others, the 
physicochemical profile of sterilized nanoparticles prepared at room 
temperature was not assessed. Nevertheless, results suggested that the elicited 
response depends on the combined interaction of various nanoparticles 
characteristics, i.e. crystallinity, size, surface charge and surface area, leading 
to a different profile of protein adsorption, particle aggregation, uptake, 
degradation/dissolution and rate of intracellular release of calcium ions, 
justifying a nanoparticle targeted research, oriented to the intended application.  
In conclusion, the results reported in this study indicate that the WCS and HS 
nanoHap particles display different morphological attributes, i.e. size and shape. 
Besides, their different surface chemical condition is reflected in both zeta 
potential curves and FTIR spectra. Furthermore, the sterilization modified 
markedly the shape, size and aggregation state of WCS nanoparticles whose 
high surface area suffered a drastic reduction during autoclaving. Sterilized 
WCS and HS nanoHap particles were readily internalized by MG63 osteoblastic 
cells, by an endocytic pathway, and exhibited some differences in the elicited 
cell response. Low levels, not associated with deleterious effects in the cell 
viability/proliferation, F-actin cytoskeleton organization and apoptosis rate, were 
able to increase the expression of ALP and BMP-2. Only at high nanoparticles 
concentrations deleterious effects on cell behaviour were observed, probably 
due to the vesicular entrapment of the particles and their low degradability. As a 
consequence of their low toxicity and their potential for the modulation of the 
osteoblastic cell behaviour, WCS and HS nanoHap particles are likely to exhibit 
an interesting profile for bone tissue applications. 
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5.1. Introduction  
Nanotechnology is currently offering various stimulating possibilities in many 
scientific areas being ‘nanomedicine’ a new paradigm in the biomedical field 1. 
Theragnostics is a strategy that integrates therapeutics with diagnostics to 
develop new personalized treatments with enhanced efficacy and safety which 
imply diagnostic imaging with high sensitivity and molecular specificity 2. 
Depending on the molecular imaging modality and contrast agent used, 
theragnostics benefits include treatment planning, drug and dosage selection, 
and therapeutic response monitoring 2. Various nanoparticles (NPs) with high 
target specificity and often combining multifunctions for more than one clinical 
purpose are being actively studied for theragnostics. Iron oxide, gold, and 
quantum dots exhibiting intrinsic imaging abilities 1 are examples of such 
nanoparticles. Photothermal imaging and therapy are novel techniques closely 
related to theragnosis. Photothermal imaging consists of detecting and imaging 
thermal energy converted from light while photothermal therapy consists on 
cancer cells destruction by thermal energy converted from light. Metal 
nanostructures of noble metals like gold or silver are excellent thermal 
conductors and photothermal converters as they strongly absorb light at a 
particular wavelength and can convert light energy into thermal energy very 
quickly, being thus excellent theragnostic candidates 3. 
Theragnosic nanoparticles have been produced from various building blocks 1,4-
8, but drawbacks including synthesis limitations, handing and loading difficulties, 
poor stability and potential toxicity 1 still persist.  
In the present study hydroxyapatite nanoparticles are proposed as templates for 
theragnostic particles due to their excellent biocompatibility 9 and enhanced 
adsorptive ability 10-12. Addressing the combination of these exceptional 
properties with the unique characteristics of gold nanoparticles, new materials 
based on coupled Hap and gold nanoparticles (Hap-Au) are envisaged with 
interesting biomedical potential. 
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The present chapter exploits the possibility of Hap nanoparticles 
functionalization with gold aiming at novel applications in which coupled 
therapeutic and contrasting functionalities are demanded.  
Hap nanoparticles precipitated from a solution containing citric acid by the 
hydrothermal method (HS) as previously described in chapter 2 (section 2) are 
here addressed as templates for gold precipitation. The experimental results 
comprising the characteristics of the nanometric gold precipitates will be here 
discussed.  
While benefits of gold nanoparticles (AuNPs) have been widely publicized 13, 
the discussion of the potential effects of AuNPs coupled to hydroxyapatite 
nanoparticles on the proliferation, differentiation, and mineralization of human 
osteoblast-like cells in vitro has not been addressed so far. Thus, MG63 cells 
response to Hap nanoparticles with coupled AuNPs will be also examined and 
compared to the response to Hap-NPs.  
A second objective of this chapter was to design a folic acid (FA)-conjugated 
nanoparticle for the specific recognition of the soluble form of the folate receptor 
expressed at the surface of cells. The adopted method relies on FA adsorption 
on nanoparticles surface 14,15 whose results will be also discussed. The results 
of in vitro studies covering the interaction of the prepared nano materials with 
MG63 cells will be examined as well. 
5.2. Precipitation of nanosized gold dots on hydroxyapatite 
nanoparticles facets 
The choice of nano hydroxyapatite particles obtained by the hydrothermal 
method (particles HS 3:1 which will be simply referred as HS) as templates for 
gold precipitation and folic acid functionalization relies on the following reasons: 
firstly, HS are obtained by a simple procedure, which allows Hap particles with a 
high level of reproducibility and stability to be produced. Additionally this method 
uses an organic additive, i.e. a citric acid, which the human body is able to 
recognize. Thus HS nanoparticles which were found not to show toxicity effects 
(chapter 4), have a nanometric size and possess on their surface organic 
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species (citric acid related groups) which are envisaged as chemical entities 
potentially able to act as reducing agents towards gold ions or  to be linked with 
folic acid.  
5.2.1. Crystal structure and microstructure 
Figure 5.1 presents the optical pictures of the collected HS particles after being 
exposed during different periods of times to hydrogen tetrachloroaurate solution. 
It is observed that the original yellowish colour of HS (fig 5.1 (a)) becomes a 
purple-like colour after 5 min and deeper purple after a longer reaction time of 
20 min (fig 5.1 (b) and (d)). These colour changes anticipate the presence of 
nanometric sized gold particles in the collected particles 16. Further evidences of 
gold precipitation are provided by the particle X-ray diffraction (XRD) patterns 
shown in figure 5.2 ((b) and (c)): the presence of metallic gold (Au) is revealed 
by the peak detected at 2 ~ 38º which denotes the presence of metallic gold 
17,18. This is the more intense peak in Au XRD pattern according to the JCPDS 
Nº 071-4614. Other smaller peaks may also be present but superimposed on 
hydroxyapatite peaks thus being indistinguishable from Hap XRD pattern.  
 
 
Figure 5.1- Optical pictures of HS particles (a) as synthesized at 180ºC or after reacting 
with hydrogen tetrachloroaurate solution during (b) 5 min, (c) 10 min and (d) 20 min. 
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Figure 5.2- X-ray diffraction patterns of hydroxyapatite particles (HS) as prepared (a), 
and after reacting with HAuCl4 solution during (b) 5 min, (c) 10 min and (d) 20 min. The 
presence of metallic gold (Au) is revealed by the peak detected at 2 ~ 38º. 
 
Figure 5.3 shows the TEM images of the Hap particles collected after different 
precipitation times. It is clearly observed that the prismatic HS particles surfaces 
previously imaged in chapter 3, in figure 3.3 ((a) and (b)), are now uniformly 
spotted with nanosized dark dots, whose dimensions vary approximately from 
1,5 to 2,5 nm as the reaction time increases from 5 min (fig. 5.3 (a), (b)) to 20 
min (fig. 5.3 (c), (d)). These are metallic gold nanosized dots which were 
precipitated on Hap facets accounting for the previously described colour 
variations of HS. Thus the used strategy allowed to couple nanometric sized 
gold particles (AuNPs) to the facets of hydroxyapatite nanoparticles (HS) 
forming a nanostructured assemblage of gold metal and hydroxyapatite (HS-
AuNPs). It was also found that HS-AuNPs after 20 min of reaction apparently 
have a lower density of larger AuNPs dots on their surface which indicates that 
AuNPs have grown during the reaction period. The growth of AuNPs may be 
explained by an Ostwald ripening mechanism which would favour the growth of 
larger Au particles at the expense of smaller ones 19-21. Although the dots 
become larger, they apparently preserve a spherical shape which is known to 
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be the lowest-energy shape and that observed for most of the metal 
nanoparticles usually obtained from metal salts reaction with reducing agents 22. 
The colour evolution of HS-AuNPs described before is thus in line with the 
AuNPs size variations revealed by TEM analysis. The present precipitation 
technique proved to be highly reproducible, consistently yielding uniform 
spherical nanoparticles without the need of any additional surfactant for 
stabilization.  
Figure 5.3- TEM images of HS particles coupled with Au nanoparticles after different 
reaction times with HAuCl4 solution: 5 min ((a) and (c)) and 20 min ((b) and (d)). 
 
Recent literature conveys a large amount of interest on Hap-Au synthesis and 
properties optimization. Yanjun Ding and co-workers produced a hybrid material 
by assembling gold nanoparticles previously synthesized onto nano-
hydroxyapatite using a sonicated method 10. T.P Sastry and co-workers 
developed physiologicaly clotted fibrin capped gold nanoparticles to be used as 
support for growing hydroxyapatite in order to improve osteoinductive properties 
23. Santosh Aryal et al. firstly immobilized collagen on gold nanoparticles and 
then precipitated hydroxyapatite by a wet chemical method to be applied in 
bone tissue repair and regeneration 24. With a similar purpose Yogita Gupta et 
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al. synthesized primarily the polymer (Poly-(9-(4-vinylbenzyl)-purin-6-yl)-amino 
caproic acid (AP-1)), subsequently hydrolyzed octacalcium phosphate and 
finally synthesized gold nanoparticles on the prepared composite particles 25. 
Sujatha K. Arumugam et al. synthesized gold nanoparticles on hydroxyapatite 
surface, i.e using commercial hydroxyapatite they adsorbed a gold salt (HAuCl4) 
on the Hap surface, and then reduced the gold with hydrazine hydrate. These 
particles are intended to control platelet adhesion and to enhance blood 
compatibility 17. The authors found that Hap-Au nanoparticles can be combined 
in a single construct, allowing simultaneous targeting, diagnosis, and 
therapeutic functionality which can be chemically tailored for a particular patient 
or disease. As compared with these methods the prepared HS particles can act 
simultaneously as reducing agent of gold salt and present low toxicity and the 
potential for the modulation of the osteoblastic cell behaviour 12. 
Considering the nanometric size of the gold particles precipitated in the present 
work, particular optical properties were foreseen for HS-AuNPs 26. Figure 5.4 
shows the UV-Vis spectra of (a) HS as prepared and of (b, c and d) HS-AuNPs 
after 5, 10 and 20 min reaction times. HS particles as prepared do not show any 
absorption band in the range of 300-800 nm (fig 5.4 (a)). Similar results were 
already reported by other authors 17,25,27. Conversely, a characteristic Surface 
Plasmon Resonance (SPR) band of gold nanoparticles (AuNPs) at 553 nm is 
clearly detected for the all studied samples (5, 10 and 20 min) confirming that 
AuNPs were precipitated. Furthermore the obtained SPR band at 553 nm 
suggests the formation of AuNPs with spherical shape by this synthesis 
method. As predicted by Gan theory, when the shape of AuNPs change from 
spheres to different morphologies like: rods, nanocages, etc, the SPR band is 
split into two bands: a strong band in the region (650-900 nm) corresponding to 
electron oscillations along the long axis, and a weak band in the visible region 
(520 nm) at a wavelength similar to that of gold nanospheres 16,28. However, the 
SPR band exhibited around 553 nm is slightly shifted away from the well-known 
value of 520 nm referred for isotropic spherical particles (<20 nm) dispersed in 
water 29,30. It can be argued that the slight shift in SPR band may be due to the 
fact that the refractive index of hydroxyapatite (1.63-1.64), i.e. the substrate, is 
higher than that of water (1.33) which is the solvent usually referred 27. A similar 
effect was reported for other materials, namely silica nanoparticles 31,32. 
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Normally this band accounts for the strong colour changes observed on the 
particles 33. As referred previously the spherical gold particles exhibit a SPR in 
visible region which is not optimal for in vivo applications because its 
attenuation by biological fluids and tissues is giant 6,34. However the presence of 
SPR effect on the synthesized HS-AuNPs could be interesting for the treatment 
of a skin-type cancer and/ or a near-surface cancer where the wavelength of the 
laser should be less intense and the effect of SPR is maximized. Another 
possible application could be to use HS-AuNPs as a targeted X-ray contrast 
agent for labelling microdamage in bone tissue 35,36. Repetitive loading of bone 
tissue can lead to the accumulation of microdamage, observed histologically as 
microcracks or diffuse damage, and to degradation of mechanical properties. 
Microdamage accumulation in bone has been implicated with clinical scenarios 
for increased risk of fracture, including stress fractures in active individuals and 
fragility fractures in the elderly. However, the role of microdamage in clinical 
bone fragility is not well understood due, in part, to limited capabilities for 
detecting microdamage non-destructively 35,36. The gold nanoparticles can be 
used as targeted X-ray contrast agent and the Hap particles will be useful in the 
calcification of this microdamage 35,36. Moreover Hap particles could be also 
functionalized through adsorption of biological molecules that exist in vivo and 
hence functionalized Hap particles can be attracted by bone mineral crystals 
exposed on the surface of microcracks and thus detect this microdamage 43,44. 
Finally, another possible application for these particles is as immunosensor, due 
to Hap high absorbing ability and other multifunctional advantages such as high 
surface area, good biocompatibility and solubility. Yanjun Ding et al. 
demonstrated this immunosensor application, preparing gold/hydroxyapatite 
hybrid nanomaterial for the detection of -Fetoprotein (AFP), an important 
indicator in the clinical diagnosis of cancers 10.  
Examples of encapsulation or functionalization of gold nanoparticles are 
recurrent in the literature, but most of them are focused on nonspherical gold 
nanoparticles (including nanorods, nanocages, stars, cubes) because they 
possess multiple plasmonic absorptions, where attenuation by biological fluids 
and tissues is minimal 6,37. Studies involving spherical nanoparticles are still of 
interest for those biomedical applications targeted to bodily surface treatments 
as is the case of skin cancer.  
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Figure 5.4-UV-Visible spectra of as prepared HS nanoparticles (a) and of HS-AuNPs 
after a reaction time of 5 min (b), 10 min (c) and 20 min (d).  
5.3. Gold precipitation and surface-characteristics of HS-
AuNPs 
The process of AuNPs growth on HS surfaces was also followed by FTIR 
spectra analysis aiming to assess the evolution of adsorbed species. Figure 
5.5-A compares the full spectrum of HS particles as prepared with those of HS-
AuNPs collected after 5, 10 and 20 min, being the details of the FTIR region 
(1350-1680 cm-1) magnified in the figure 5.5-B. It is important to remark that the 
general Hap FTIR features are detected in all samples (figure 5.5-A), although 
in those spectral region of HS particles coupled with Au some slight differences 
are remarked 38,39.This is the spectrum region where some groups derived from 
citrate decomposition are likely to be identified. Such groups as mentioned in 
chapter 3 result from citrate decomposition reactions under the used 
hydrothermal conditions 40. The more significant differences observed in the 
1350-1680 cm-1 FTIR region, (figure 5.5 B) include the band at 1384 cm-1 
assigned to –CH2- scissoring mode 41 whose intensity undergoes a drastic 
decrease in HS-AuNPs as well as the band at 1567 cm-1 corresponding to the 
antisymmetric stretching mode of carboxylate groups in bidentate configuration. 
Additionally the band at 1670 cm-1 that can be attributed to C=O stretch in 
carbonyl containing species 42 is unobserved in HS-AuNPs 39. FTIR results also 
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reveal some groups remaining regardless Au synthesis process. This is the 
case of the bands at 1402 cm-1 and 1458 cm-1 that may be attributed to the 
symmetric stretching mode of carboxylate groups in monodentate and bidentate 
configuration which indicate the species not involved in Au precipitation 
reactions. Conversely the bands affected by Au growth on the surface of the 
hydroxyapatite are interpreted either as denoting organic compounds playing 
active role in Au precipitation process or as indicating organics prone to easy 
desorption when exposed to the boiling HAuCl4 solution. 
According to S. Kumar et al. 43 gold precipitation by Turkevich method can be 
systematized in three steps: the initial step comprises the oxidation of citrate to 
acetone dicarboxylic acid after which a second step consisting of auric salt 
(AuCl3) reduction to aurous salt (AuCl) takes place. The third step involves the 
disproportionation of aurous ions (Au+) to gold atoms (Au0). The equations 
corresponding to these three steps are respectively: 
 
                                     (5.1) 
 
 
 
 
AuCl3 + 2e-           AuCl + 2Cl-                                              (5.2) 
 
3AuCl     Au0 + AuCl3                                                         (5.3) 
 
The last step (eq. 5.3) is facilitated by the acetone dicarboxylic specie that helps 
the formation of aurous species and dicarboxy acetone complexes which 
provide the combination of several aurous chloride molecules as required by 
equation (5.3). This is thus a multi-step process where series and parallel 
oxidation/reduction reactions take place. Based on the obtained results a 
mechanism of AuNPs synthesis using Hap (HS) particles as templates is here 
proposed. The following observations are worthy of mention: 
(i) in the absence of the HS nanoparticles no precipitation of gold occurs 
during the gold solution heating;  
(ii) Once HS particles are added to the heated (~100ºC) gold solution, gold 
nanoparticles start to be deposited on HS particles surfaces. This is 
Acetone dicarboxylic acid 
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detected by the modification of the particle colour that changes from light 
yellow to brown-purple after 2-3 min and to red-purple after 20 min (fig 
5.1). 
Based on these evidences the mechanism proposed is similar to that described 
by S. Kumar et al. 43. In the present work and as mentioned before, the thermal 
decomposition of citrate ions during hydrothermal synthesis of HS particles may 
originate diacids products (aconitic and/or itaconic acid, for instance). These 
acidic products could also be oxidized to dicarboxylic acids which in turn would 
play an organizing role equivalent to that of suggested by S. Kumar et al. 43 for 
the acetone dicarboxylic acid above described. Thus the assumption that citrate 
degradation derived compounds could have equivalent ability for reducing 
trivalent gold and consequently lead to the formation of gold nanoparticles is 
here confirmed. In this mechanism proposal citrate derived compounds play the 
role attributed to citrate in Turkevich method.  
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Figure 5.5- A) FTIR spectra of HS and HS-AuNPs nanoparticles; (B) Spectra 
magnification in the region of 1200-1900 cm-1 for HS (a) and for HS-AuNPs after 
different times of gold precipitation : 5 min (b),10 min (c) and 20 min (d). 
To evaluate the surface charge of the produced particles, zeta potential 
measurements were performed. The relation between the particles zeta 
potential () and the suspension pH is depicted in figure 5.6. HS nanoparticles 
have negative zeta potential in the examined pH range (fig. 5.6, curve (a)), due 
to the prevalence of negatively charged species in the Stern layer of the 
electrical double layer of Hap which are thought to include carboxylate groups, 
(A) 
(B) 
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PO43- and OH− surface ions 44-47. Zeta potential values appear practically 
unchanged in the (5.7 -7) pH interval ((fig. 5.6, curve (a)), being this behaviour 
assigned to phosphate ions buffer capability according to the studies of Dušica 
R. Vučinić et al 46 on Hap zeta potential variation within the specific pH range of 
(6-9). As pH increases from 7 to 10 the amount of OH- ions adsorbing on Hap 
surface also increases hence incrementing further the Hap negative zeta 
potential 46. Comparing HS and HS-AuNPs curves shown on figure 5.6 a main 
difference is remarked within the pH interval of (6.5-7.5) where HS-AuNPs are 
seen to bear a more negative ζ-potential than do HS particles. According to 
literature AuNPs present normally a negative zeta potential in the pH interval of 
4 to 12 48,49. In the present case it is thought that citrate derived compounds 
containing carboxylic groups participated actively on Au0 precipitation (as 
explained before) thus leaving behind newly unbound calcium ions which would 
be free for adsorbing OH- ions. This could explain the apparently higher ability 
of HS-AuNPs particles to adsorb OH- as compared to HS particles in this pH 
range. The strong negative zeta potential observed in all prepared particles 
denotes a high electrical surface charge which will protect the particles from 
aggregation and thus result in more stable dispersions of these nanoparticles 
which might be an advantage in biological tests applications. 
Figure 5.6- Zeta potential (ξ) as a function of pH for: (a) HS nanoparticles, (b) HS-
AuNPs after 5 min of synthesis and (c) AuNPs after 20 min of synthesis. The strong 
negative zeta potential is observed in all prepared particles. 
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Some recent studies reported the synthesis of Au and Hydroxyapatite, although 
so far the method proposed in the present work for growing AuNPs on the 
surface of hydroxyapatite (Hap) is being reported for the first time. It combines 
the dual role of citrate ions as complexing agents of calcium ion during the 
synthesis of hydroxyapatite particles and as reducing agent for the nucleation 
and growth of gold on hydroxyapatite surface.  
The facile strategy here reported to grow gold nanoparticles on the surface of 
the HS particles with a controlled nanometric size is a completely new approach 
in terms of AuNPs nucleation which was not used in any other kind of material 
so far. Additionally, the potential usefulness of the obtained materials for 
applications in the novel field of theragnosis is here enhanced.  
5.4. Interaction of HS-AuNps with osteoblastic cells  
The samples selected to be studied in the interaction of particles with cells were 
HS and HS-AuNPs synthesized during 5 minutes.  
In this study, as in the last chapter, human osteosarcoma-derived MG63 
osteoblastic-like cells were used. The selection of this human cell line has for 
long been applied for cytotoxicity and biocompatibility assays within the 
biological evaluation of materials, especially in those aiming for bone tissue 
repair/regeneration context. These cells, at a low density, show a characteristic 
oval to spindle-shaped morphology, with fine branching cytoplasmic cell 
processes, similar to those of human osteoblasts in culture 50. Furthermore, 
these cells express several characteristic markers of osteoblasts, being positive 
for alkaline phosphatase (ALP), osteocalcin (OC), osteonectin, osteopontin, 
osteoprotegerin (OPG), collagen type I (COL I), bone morphogenetic proteins, 
collagen type III, bone sialoprotein and decorin. They have also been shown to 
express Runx-2, the earliest known transcription regulator of osteoblast 
differentiation and consequently demonstrated the commitment of these cells 
toward the osteogenic pathway 50,51. 
In this experimental work, MG63 human osteoblast-like cells were cultured at a 
density of 104 cells/cm2 on the surface of standard tissue culture plates. After 24 
hours, the medium was removed and fresh complete culture medium, 
containing the appropriate concentration of sterilized HS or HS-AuNPs 
nanoparticles was added, and cultures were maintained for further 1, 3 and 7 
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days. The results regarding cell viability/proliferation (MTS assay) in presence 
of different concentration (1-500 m/ml) of studied particles are shown in figure 
5.7.  
 
Figure 5.7- Cell viability/proliferation of MG63 cell cultures exposed to HS, HS-AuNPs 
and HS-AuNPs-FA nanoparticles, during 1, 3 and 7 days for a nanoparticles 
concentration range between (1-500 g/ml). It can be seen that the cell viability remain 
high cells in presence of different particles. 
 
MTS is metabolized to a purple formazan salt by mitochondrial enzymes in 
living cells and the absorbance read is proportional to the number of viable cells 
in the sample. Figure 5.7 shows the viability/proliferation of MG63 cell cultures 
after being exposed to HS and HS-AuNPs for different periods (1, 3 and 7 
days). From the figure, it can be seen that the cells growing in the absence of 
nanoparticles (control) presented a high proliferation rate throughout the entire 
culture period (figure 5.7). Similarly, cultures established in the presence of HS 
or HS-AuNPs nanoparticles, at the assayed concentrations, revealed a similar 
behavior, which supports the non-cytotoxic behavior of the assayed particles, 
even to the relatively high dose of 500 μg/ml. 
For more clearly determine cell viability in contact with the HS and HS-AuNPs, 
cell morphology studies were carried out. The cell morphology was addressed 
by confocal laser scanning microscope (CLSM) following staining for F-actin 
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cytoskeleton and nucleus counterstaining. Representative images of the 
established cultures for 1, 3 and 7 days are shown in figure 5.8, 5.9 and 5.10 
respectively. Control cultures revealed, at day 1 (figure 5.8), that cells had 
spread out and presented an elongated morphology, establishing elementary 
cell-to-cell contacts; at day 3 (figure 5.9), areas of high cell density could 
already be visualized with confluent zones of intensive cell growth; at day 7 
(figure 5.10), cells were organized in continuous cell multilayers. Cultures 
established with both nanoparticles (HS and HS-AuNPs), at the assayed 
concentration range (1-500 m/ml), displayed a similar behavior to control 
regarding cell structural organization, staining intensity and morphological 
features, as addressed by CLSM (figure 5.8, 5.9 and 5.10). 
These results reveal that the interaction between cells and the nanoparticles HS 
and HS-AuNPs is similar, which suggests that differences observed in particles 
are not sufficiently expressive to cause detectable effect on MG63 cells. 
However, those data converge to substantiate the cytocompatibility of the 
assessed particles, at the tested concentrations. 
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Figure 5.8- CLSM images of MG63 cell cultures exposed to the HS and HS-AuNPs, for a nanoparticles range concentration of 1-500 g/ml, 
during 1 day. 
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Figure 5.9- CLSM images of MG63 cell cultures exposed to the HS and HS-AuNPs, for a nanoparticles range concentration of 1-500 g/ml, 
during 3 days. 
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Figure 5.10- CLSM images of MG63 cell cultures exposed to the HS and HS-AuNPs, for a nanoparticles range concentration of 1-500 g/ml, 
during 7 days.
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Additionally gene expression by reverse-transcription polymerase chain reaction 
(RT-PCR) was performed to investigate the effect of HS and HS-AuNPs 
nanoparticle incorporation at various seeding densities on osteogenic signal 
expression. The effect of both HS and HS-AuNPs particles, at 100 g/ml, was 
evaluated regarding the expression of osteoblastic-related markers, i.e., Runt-
related transcription factor 2 (Runx-2), Collagen type I (Col I), alkaline 
phosphatase (ALP), osteocalcin (OC) and osteoprotegerin (OPG), as observed 
in figure 5.11.  
 
Figure 5.11- Gene expression of RUNX-2, Collagen I, ALP, OC and OPG of MG63 cell 
cultures exposed to HS, HS-AuNPs and HS-AuNPs-FA nanoparticles, 100 g/ml, 
during three days. RT-PCR, the PCR products were subjected to a densitometric 
analysis and normalization to the corresponding GAPDH value.  
Analyses of the expression pattern of regulating genes and bone-related 
proteins revealed three sequential stages during the proliferation and 
differentiation of human osteoblasts in vitro. These are cell proliferation, 
extracellular matrix formation and maturation, and extracellular matrix 
mineralization 52. There seems to exist two check points to which the cells can 
progress but cannot develop further without additional signalization:  the first 
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one occurs when proliferation is down-regulated and gene expression 
associated with the extracellular matrix maturation is induced; and the second 
when mineralization occurs 52. Within these stages, actively proliferating Runx-
2-expressing osteoblastic cells produce high levels of type I collagen, and a 
fibronectin- and osteonectin-rich extracellular matrix 53. The down-regulation of 
the proliferation period and the up-regulation of the matrix maturation and 
mineralization are marked by a temporal sequence of events in which there is 
an enhanced expression of ALP immediately following the proliferation period, 
and an increased expression of osteopontin and OC at the onset of 
mineralization 53. It is also suggested that ALP is highly expressed during the 
early matrix formation and maturation period, followed by a decrease in its 
activity. During the mineralization period, the expression of OC and the number 
of mineralization nodules are high 52,53. 
MG63 human osteoblast-like cells exhibit many osteoblastic behaviors which 
are characteristic of bone forming cells. Assayed cultures, grown in the 
presence of 100 g/ml HS nanoparticles, were shown to enhance the ALP 
expression, while cultures established in the presence of 100 g/ml HS-AuNPs 
nanoparticles induced the expression of both Runx-2 and ALP. No significant 
differences were found regarding the expression of Col I, OC and OPG, in 
cultures established with HS particles and control (figure 5.11). However 
alterations on HS particles surface by the presence of AuNPs have shown 
major modifications on Col I and OPG expression.  
ALP is an enzyme believed to provide inorganic phosphate for osteoblastic-
mediated extracellular matrix mineralization process, and its expression is 
considered a hallmark of osteoblastic differentiation 52. Both evaluated 
nanoparticles were shown to enhance the expression of this marker. This 
observation comes in line with several studies in which the presence of distinct 
Hap-based nanoparticles, incorporated into the culture microenvironment of 
osteoblastic and osteoblastic-like cells, seems to enhance the ALP expression 
in a concentration-dependent way 54,55.  
Runx-2 is a master regulator of osteogenic gene expression and osteoblast 
differentiation, being essential for osteoblastic differentiation and bone formation 
52,56. HS and HS-AuNPs nanoparticles induced the expression of this 
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transcription factor, substantiating the enhancing role of these nanoparticles in 
the osteoblastic differentiation process.  
According to many reports AuNPs nanoparticles have been found to be 
‘‘nontoxic’’. For example using a human leukemia cell line, gold nanospheres of 
different sizes (4, 12, and 18 nm in diameter) and capping agents (citrate, 
cysteine, glucose, biotin, and cetyltrimethylammonium bromide) were found to 
be nontoxic based on the MTT assay for a concentration up to 25 M 57. Similar 
results were observed when studying immune system cell line response to 
AuNPs (spheres, 3.5 nm in diameter) 58. In this study, AuNPs entered the cell 
by (presumably) endocytosis, did not induce any toxicity and reduced the level 
of reactive oxygen species. Villiers et al. studied the toxicity of citrate-capped 
AuNPs (spheres, 10 nm in diameter) on dendritic cells (cells of the human 
immune system that process and present antigens on their surfaces to other 
cells). They found that gold nanoparticles were not cytotoxic, did not induce cell 
activation, and did not change the gene and protein expression of the cells 59. In 
contrast to these results, other research groups have found that AuNPs are 
‘‘toxic’’. For example, it was found that cationic quaternary ammonium 
functionalized gold nanospheres (2 nm in diameter) are toxic (at certain doses) 
and that the same nanoparticles when having negatively charged surface were 
not toxic at the same concentration and to the same cell line, i.e (Cos-1) 57. This 
difference was explained by the ability of the cationic nanoparticles to interact 
with the negatively charged cellular membrane and disrupt the cell membrane 
57. Pan et al. found that 1.4-nm gold nanospheres triggered necrosis, 
mitochondrial damage, and induced an oxidative stress on all examined cell 
lines (HeLa cervix carcinoma epithelial cells) 60. However the authors found no 
evidence of cellular damage for 15-nm gold nanospheres bearing the same 
surface group, i.e (with triphenylphosphine monosulfonate (TPPMS)) 60. This 
result highlights a possible size-dependent toxicity of AuNPs 60. Citrate-capped 
AuNPs (13 nm in diameter) were found to be toxic to a human carcinoma lung 
cell line but not to human liver carcinoma cell line at same dosage 61. These 
conflicting findings could arise from the variability of the studied cell lines, and 
nanoparticles chemical/physical properties. Furthermore, the dosing parameters 
and the exposure time of AuNPs to the cells in these studies vary, making it 
difficult to compare toxicity assays differently designed. 
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The promise of gold nanoparticles for many different biological applications has 
led to a strong interest to expose them to living systems. Studies involving 
AuNPs coupled with hydroxyapatite and their cellular toxicity are rare or even 
inexistent. For that reason the cellular toxicity of HS-AuNPs was addressed in 
this chapter. Though the obtained results allowed to conclude about a non-
cytotoxic behavior of the assayed particles, even at a relatively high dose of 500 
g/ml, to contrast them truly with published data was unmanageable as studies 
of MG63 cell line response to similar particles (Hap-AuNPs) or to AuNP were 
not found so far.  
5.5. Hap and Hap-AuNPs nanoparticles functionalized with 
folic acid, a cell membrane receptor 
The focal objective of this section is to discuss the design of a folic acid-
conjugated nanoparticle for the specific recognition of the soluble form of the 
folate receptor expressed at the surface of cells. The adsorption of folic acid 
(FA) on hydroxyapatite nanoparticles (HS) and hydroxyapatite-gold 
nanoparticles (HS-AuNPs 5 min) and their biological behaviour folic acid are 
here addressed.  
5.5.1. Synthesis of folic-acid conjugated HS and HS-AuNPs 
HS and HS-AuNPs are a convenient target for functionalization because they 
have a carboxylic acid-enriched surface which may provide a platform for 
efficient surface immobilization of functional molecules such as DNA, drugs, 
proteins and fluorescent molecules 62-66. The synthesis of HS and HS-AuNPs 
nanoparticles was carried out by the hydrothermal method using citric acid as a 
tailoring agent of particle morphology and simultaneously as a reducing agent of 
gold ions, as described previously. The ability of HS and HS-AuNPS surfaces 
enriched with citrate derived species for immobilizing FA is schematically 
expressed on figure 5.12. 
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Fig.5.12- Schematic representation of (a) HapNPs (HS) and (b) HapNPs with gold (HS-
AuNPs), both functionalized with folic acid (FA). 
 
Figure 5.13 ((a) and (b)) displays TEM micrographs of HS-FA and HS- AuNPs-
FA nanoparticles. As evidenced the shape and size of the particles exposed to 
folic acid were maintained. It is important in drug delivery applications that 
nanoparticles are individually dispersed, as observed in figure 5.13 ((a) and (b)), 
because aggregation of nanoparticles makes difficult the transport of drug-
loaded nanoparticles to the desired site. Additionally it is observed that gold 
nanoparticles present in the HS-AuNPs nanoparticles are kept after FA 
adsorption experiments thus suggesting that gold nanoparticles are strongly 
bonded to HS particles. 
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Figure 5.13- TEM micrographs of HS (a); HS-FA (b); HS-AuNPs (c) and HS-AuNPs-FA 
(d). 
 
The evaluation of drug loaded amounts is an important issue for the sake of 
engineering drug delivery systems able to supply the required drug dose at the 
target site. In the present work the maximum FA loaded amount was assessed 
after the time period required for the loaded particles to display a constant UV 
absorbance measured at 295 nm. The amount of loaded FA after 2 days was 
evaluated as 8.5X10-5 mol/gram FA for HS nanoparticles and as 1.09X10-4 
mol/gram FA for HS-AuNPs. As the amounts of FA loaded on HS-AuNPs are 
higher than on HS, FA binding to Hap particle surface is likely conditioned by 
the nanoparticles surface chemistry. Comparison of these loaded FA values 
with literature data is hardly feasible as the published values correspond to FA 
measurements on supernatant suspension and spectrophotometrically analyzed 
while in this work Hap particles are dissolved in acid solution in which FA is 
assayed thus allowing the FA amount effectively loaded on Hap particles to be 
determined 15,67,68. The attachment of FA to HS and HS-AuNPs was further 
assessed by FTIR analysis. 
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Figure 5.14 compares the FTIR spectrum of FA to that of unloaded (HS, and 
HS-AuNPs) and of loaded particles (HS-FA and HS-AuNPs-FA). The FTIR 
spectrum of pure folic acid displays characteristic bands at 3543, 3416, 3324, 
2959, 2924, 2844, 1694, 1640, 1605, 1484 and 1411 cm-1 69-71. The bands lying 
between 3600 and 3000 cm-1 are attributed to the hydroxyl (OH) stretching and 
NH stretching vibrations. Another two bands identified as (C-H) and s(C-H) of 
structural unit CH2 of FA are detected at 2844 cm-1 and 2959 cm-1 79,80. The 
C=O bond stretching vibration of carboxyl group is detected at 1694 cm-1, while 
the stretching vibration of the C=O bond of –CONH2 group appears at 1640 cm-
1. The band at 1605 cm-1 accounts for the bending mode vibration of NH2 while 
the stretching vibration (O-H) of OH phenyl skeleton is revealed by the band at 
1411 cm-1 69-71. Furthermore two other bands at 1346 cm−1 and 1450 cm-1 are 
assigned to the aromatic C–H in plane bending 14 and to the stretching vibration 
of C=C in the backbone of the aromatic ring, respectively 69.  
Figure 5.14- FTIR spectra of (─) HS nanoparticles, (─) HS-FA nanoparticles, (─) HS-
AuNPs-FA nanoparticles and (─) FA.  
 
As expected the main vibrations assigned to hydroxyapatite are found on all the 
spectra corresponding to the different types of particles (HS, HS-FA and HS-
AuNP-FA) (figure 5.14). The main differences are noticed in the spectral region 
of 1200-1700 cm-1 where the bands detected at 1384, 1402 and 1670 cm-1 in 
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HS FTIR spectrum become absent after exposing HS and HS-AuNPs to the FA 
solution. Such bands were previously attributed (see discussion in chapter 3), to 
the vibrations of carboxylic groups differently coordinated to Hap surface. Some 
of these species seem weakly bound to particles surface and easily desorb 
during FA loading and/ or get involved in FA conjugation process 69,71,72. That is 
the case of HS-FA and HS-AuNPs-FA that have lost the two intense bands at 
1384 cm-1 and 1670 cm-1, assigned respectively to –CH2- scissoring mode and 
to C=O stretching of carbonyl containing species.  
Looking for evidences of FA conjugation to HS particles, it is noticed that three 
characteristic bands of FA appearing at 1640, 1450 and 1346 cm-1 are detected 
on HS-FA and HS-AuNPs-FA spectra. In addition, two small bands in HS-FA 
nanoparticles at 2959 cm-1 and 2844 cm-1, and one a 1694 cm-1 in HS-AuNPs, 
both pertaining to FA are also observed. The presence of these bands is 
indicative of the successful binding of FA to nanoparticle surface. Nevertheless 
the chemical binding of FA to both HS and HS-AuNPs surfaces seems to 
involve different chemical species, probably reflecting the contribution of 
different pre-adsorbed chemical species on both Hap nanoparticles surface. 
Several reports on FA conjugation with polymer or metallic nanoparticles, as 
gold, are found in literature. However in all the reported studies and depending 
on the nature of the nanoparticles the particles are firstly functionalized with 
diverse molecules to facilitate FA uptake. In most of the cases the molecules 
used have an N group in a terminal position allowing the connection of FA to 
these nanoparticles in an easy way. In our case it was not used any molecule to 
make the attachment of folic acid to the surface of the HS or HS-AuNPs, 
although the results seem to indicate that the presence of gold at the surface of 
the HS particles facilitates the uptake of the FA. Therefore it may be suggested 
that the precipitation of the gold has resulted in a "reconstruction" or 
rearrangement of the surface of the HS particles which facilitated the FA 
attachment. This rearrangement may have been configured by the precipitation 
of the gold on the surface of HS leaving the surface of the HS particles 
chemically altered. 
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5.6. Interaction of HS-FA and HS-AuNPs-FA with osteoblastic 
cells  
Nanotoxicity is a major issue that limits the practical clinical applicability of most  
nano-contrast agents reported so far. Considering this important matter, the 
toxicity of different Hap samples on human osteosarcoma-derived MG63 
osteoblastic-like cell was tested. As previously shown HS and HS-AuNPs 
nanoparticles have no significant cytotoxicity. The cytotoxicity of the HS-FA and 
HS-AuNPs-FA was also evaluated by a MTS assay after incubation with 
nanoparticles for 1, 3 and 7 days, respectively. Figure 5.7 depicts the 
comparison of Hap nanoparticles effects on cells viability, for different particles 
concentrations. No significant cell viability difference is found on HS-FA and 
HS-AuNPs-FA nanoparticle treated cells as compared to the control (cells 
without nanoparticles). MG63 cell viability remained high after cell incubation 
with HS-FA and HS-AuNPs-FA for 7 days, implying that those particles are 
biocompatible and safe at a concentration below 500 g/mL and thus can be 
used for biomedical purposes. Anusha Ashokan et al. studied the toxicity of Hap 
nanoparticles doped with Eu3+ (hexagonal crystals) and functionalized with FA 
on primary human endothelial cells (HUVEC) and various cell lines including 
normal mouse lung fibroblast cell line (L929), human nasopharyngeal 
carcinoma (KB) and human lung cancer cell line (A549). They found that 
nanoparticles revealed no apparent toxicity even up to relatively high doses of 
500 g/mL and 48 h of incubation 73 which is in accordance with the results 
presented in this thesis. 
Following RNA extraction of MG63 cells that had been cultivated without 
nanoparticles (control) or with HS-FA and HS-AuNPs-FA, expression levels of 
Runx-2, ALP, Col I, OC, OPG gene were determined via RT-PCR (figure 5.11). 
Transcription of the housekeeping gene GAPDH was used as reference. The 
biocompatibility of HS and HS-AuNPs in absence of FA in this cell line had 
already been demonstrated previously. Comparing the gene expression of HS-
FA with the control and HS it is observed that the presence of FA stimulates 
Runx-2 but reduces the expression of Col I. The other expressed genes 
remained unchanged. Col I is an essential component of the extracellular 
matrix, constituting approximately 90% of the total organic matrix in mature 
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bone. Together with the mineral component, collagen governs the mechanical 
properties and functional integrity of the osseous tissue. From a number of in 
vitro studies, Col I had been proposed to induce osteoblast differentiation and 
facilitate mineralization 74. Additionally as mentioned previously Runx-2 is a 
master regulator of osteogenic gene expression and osteoblast differentiation, 
being essential for bone formation. The conjugation of the two opposite effects 
on genetic transcription seems not to affect the viability of the cells in presence 
of hydroxyapatite functionalized with folic acid although not contributing to an 
easy mineralization.  
When gold nanoparticles are coupled on HS surface (HS-AuNPs-FA) gene 
expression results are closer to the control with exception of OPG, as observed 
in figure 5.11. The presence of FA on HS-AuNPs stimulates the OPG 
transcription. There are few studies in literature reporting the combination of FA 
and hydroxyapatite but not its effects on genetic expression. However earlier 
studies on biosilica led to observe a stimulated OPG transcription 75. Some 
studies have shown that mice over-expressing OPG had high bone mass and 
those without OPG had very low bone mass 76. OPG has been identified to be 
one of the most crucial signaling systems that mediate and modulate bone 
resorption 75,76. Hence, the data obtained in the present study suggest that HS-
AuNPs functionalized with folic acid result in a strongly enhancement of the 
expression of genes tested, being this expression similar to or higher than that 
evidenced by particles HS. These findings point out those nanoparticles (HS-
AuNPs-FA) with a considerable biomedical potential for the treatment of 
osteoporosis disorders. 
Moreover, and in order to detail the mechanisms involved in the nanoparticle-
mediated osteogenic induction of the established cell cultures, a further step of 
this research could account for the assessment of the more relevant signalling 
pathways involved. Thus, the cellular function, in terms of functional activity, 
could be evaluated in the presence of specific inhibitors of relevant osteogenic 
signalling pathways, in order to clearly differentiate the most significant ones 
involved in the induction of the osteogenic process.  
Osteoblastogenesis and bone formation are regulated by hormones, growth 
factors, cytokines, mechanical loading and aging. Osteoblasts can sense these 
external cues, transduce the signals through various signalling pathways and 
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regulate the expression of specific genes, to determine cellular fate 77. Relevant 
cellular signalling mechanisms within the osteoblastic cell function are expected 
to include early electrophysiological signals, possibly associated with integrin 
receptors and ionic channels, followed by activation of the intracellular signalling 
pathways 78. The most relevant ones seem to be those such as mitogen-
activated protein kinase (MAPK), c-Jun N-terminal kinases (JNK), p38, nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-kB), calcium sensing 
receptor, Wnt/β-Catenin and protein kinase C 79. The activation of these 
mechanisms can then act to regulate the activity and transcription levels of 
various transcription factors (e.g., Runx-2) involved in the regulation of the cell 
survival, commitment and differentiation. The activation of these pathways has 
been found to broadly mediate the up-regulation of significant osteogenic 
markers such as collagen type I, alkaline phosphatase, osteocalcin and 
osteoprotegerin, in a process mediated, at least in part, by Runx-2 induction 77-
79.  
This mechanistic approach would allow a more complete understanding of the 
nanoparticle-mediated induction of the ostegenic phenotype and further 
enhance their potential impact on the development of therapeutic strategies to 
improve human bone health.  
From the obtained results it is worthy emphasizing that HS or HS-AuNPs 
functionalized with FA have a strong influence on osteogenic signal expression. 
Additionally the presented studies confirm that HS nanoparticles coupled with 
gold and functionalized with FA are non-toxic, apparently without adverse 
effects on the cellular functions, which is an essential pre-requisite for an ideal 
diagnostic agent. 
The present chapter allows concluding that gold (Au) nanoparticles were 
successful precipitated on HS surface. Spherical Au particles with few 
nanometers are synthesized after 5 min which size increases with the reaction 
time though keeping a spherical shape with nanometric dimension. 
Carboxylate groups remaining from HS synthesis process play a crucial role in 
the chemical reaction process involved in AuNPs nanoparticles precipitation.  
The study of the biological behaviour of the synthesized nanoparticles has 
demonstrated that HS and HS-AuNPs do not display severe cytotoxic effects on 
MG63 cells. Furthermore osteoblastic differentiation was facilitated by the 
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incorporation of Hap particles on cellular medium since a high proliferation is 
detected. It was also clearly shown that the presence of HS nanoparticles 
induce a higher proliferation rate and as well an enhancement of osteogenic 
parameters of MG63 cells compared to HS-AuNPs nanoparticles, with the 
exception of Runx-2 gene which is more pronounced in HS-AuNPs than in HS.  
Finally, a folic acid (FA) based formulation was found based on HS 
nanoparticles and HS- AuNPs through a facile technique of adsorption. UV and 
FTIR characterization confirmed the adsorption/functionalization of HS and HS-
AuNPs nanoparticles with folic acid. Moreover it was concluded that HS-AuNPs 
provide better surface conditions for FA conjugation than HS nanoparticles. 
The functionalization of nanoparticles with FA does not produce significant 
effects on cell viability even at high particle concentrations. Furthermore, it was 
established that with exception of Col I all gene expression are enhanced in 
presence of functionalized nanoparticles. Considering the osteogenic signal 
expression it can be concluded that depending on the HS functionalization (with 
gold and/or FA) an enhancement or reduction of the genes expression could be 
observed, which may condition or be a plus depending on the desired 
application.  
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It is known that nanoparticle (NP) physical-chemical properties are of 
paramount importance for the biomedical applications that expose NP to living 
cells as cellular pathways are prone to be modulated by NP morphological and 
surface attributes. Thus a pool of knowledge on the biological impacts of 
particle size, shape, crystallinity and surface properties is required in order to be 
able to predict both particle fate and elicited cell response. Therefore, the 
development of successful nano engineered particles and the clarification of NP 
properties impact on cellular interaction was here envisaged as a valuable 
contribution for this scientific field.  
Framed by this motivation, an important part of this thesis was focused on the 
synthesis of Hydroxyapatite nanoparticles (Hap NP), and on the modification of 
its physical-chemical and morphological characteristics by manipulating the 
synthesis experimental conditions. Moreover, pushed by the recent 
developments on the field of nanoparticles application as diagnosis and 
therapeutic tools, the functionalization of Hap NP nanostructures with gold and 
with folic acid was also carried out in the present work, aiming to impart imaging 
and therapeutic capacity to NP which could be particularly interesting in 
applications like cancer treatment. The cellular response to the synthesized 
nanoscale materials with diverse physic-chemical properties was also 
addressed. 
The main conclusions withdrawn from the results obtained throughout this 
research can be summarized as follows:  
- Two synthesis methods were selected for producing Hap nanoparticles with 
different characteristics: (i) precipitation from calcium/citrate/phosphate solution 
at 180ºC by an hydrothermal method (HS) under the presence of an organic 
additive, i.e. citric acid, and (ii) a second wet chemical synthesis method (WCS) 
at physiological temperature previously reported in the literature 1. 
- The morphology of the precipitated particles by HS has shown a great 
dependence on the experimental conditions, mainly on the citrate/calcium 
(Cit:Ca) molar ratio. Nanometric or micrometric Hap particles with different 
morphologies could be obtained from solution with different Cit:Ca ratios: 
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crystalline Hap particles with a well-defined prismatic shape and nanometric 
dimensions may be produced provided the ratio of the organic specie to the 
calcium ion is maintained close to 3:1. An increase in the Cit:Ca ratio origins 
hydroxyapatite particles with micrometric size. 
- The mechanism of hydroxyapatite growth seems to be controlled by the 
amount and the configuration of carboxylate groups, derived from citrate ions 
adsorbed on particles surface.  
- As compared to particles obtained by HS, Hap particles synthesized via WCS 
were seen to be thinner Hap particles, with larger specific surface area but with 
lower crystallinity, thus confirming previous literature reported results.  
- The influence of autoclaving sterilization step, which is required before 
subsequent in vivo application of Hap nanoparticles, revealed that the 
sterilization modifies markedly the shape, size and aggregation state of WCS 
nanoparticles which high surface area suffered a severe reduction during 
autoclaving. These findings pointed out the need of NP characterization after 
the sterilization step.  
- In vitro cell culture experiments revealed that both type of Hap nanoparticles 
(HS and WCS) are biocompatible since no deleterious effects on MG63 cells 
were observed. Sterilized WCS and HS nanoHap particles were readily 
internalized by MG63 osteoblastic cells, by an endocytic pathway, and exhibited 
some differences in the elicited cell response. 
- Moreover, the presence of Hap particles in cell culture induces the expression 
of ALP and BMP-2 genes and potentiates the modulation of the osteoblastic cell 
response. Low Hap concentrations, did not induce deleterious effects in the cell 
viability/proliferation, F-actin cytoskeleton organization and apoptosis rate, were 
furthermore able to increase the expression of ALP and BMP-2.  
- Deleterious effects on cell behaviour were observed only at high nanoparticles 
concentrations, probably because of the vesicular entrapment of the particles 
and their low degradability.  
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- Due to the low toxicity and the potential for the modulation of the osteoblastic 
cell behaviour, WCS and HS nanoHap particles are likely to exhibit an 
interesting profile for bone tissue applications. 
- Spherical gold nanoparticles (AuNPs) were precipitated on HS surface, using 
a Turkevich related approach. Au particle size increases with reaction time 
though keeping a spherical shape of nanometric dimension. 
- Carboxylate groups remaining from Hap precipitation by HS were found to 
play a crucial role in the chemical reaction process involved in AuNPs 
nanoparticles precipitation.  
- Biological behaviour of the synthesized nanoparticles has demonstrated that 
HS and HS with coupled AuNPs (HS-AuNPs) do not have acute cytotoxic 
effects on MG63 cells. The presence of HS nanoparticles induces highest 
proliferation rate as well as enhancement of osteogenic parameters of MG63 
cells than HS-AuNPs, with the exception for the Runx-2 gene which is more 
pronounced in HS-AuNPs than in HS. A folic acid (FA) based formulation 
targeted for theragnosis was prepared using HS-AuNPs via an adsorption 
technique. The functionalization of Hap or Hap-AuNPs nanoparticles with FA 
does not produce significant effects on cell viability even at high particle 
concentrations. Furthermore, it was established that with exception of Col I the 
remaining genes expressions are enhanced in presence of functionalized 
nanoparticles.  
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Future Work 
The results obtained in this research provide an input to the engineering of 
nanoparticles that have a potential to be an added value in the field of diagnosis 
and treatment of many diseases. However, further information is still required to 
answer some unsolved questions. Therefore the following topics should be 
addressed in future work. 
 Although synthesised hydroxyapatite particles with complex 
morphologies were explored and compared several factors related with 
the citrate effect on crystal growth and final particles morphology require 
further investigation. Such study is expected to benefit the 
understanding on Hap crystal growth and particularly, on tailoring the 
morphology of the particles. 
 
 Only a chelating molecule (citric acid) was tested in the synthesis of Hap 
particles. However, different chelating molecules, in particular some with 
biological interest, may be helpful for obtaining particles with different 
morphologies and sizes.  
 
 Different types (with a different Cit:Ca ratio) of synthesised Hap particles 
should be sterilized by different methods such as gamma-radiation and 
tested in cell culture to evaluate the effects of the sterilization method on 
morphology and therefore on biological response of the particles.  
 
 Although spherical gold nanoparticles were successfully synthesized on 
Hap surface the obtained SPR band of those particles is not the most 
adequate for several applications. For that reason the modification on 
synthesis method and, as consequence, the alterations on gold particles 
morphology, could help to achieve a better understanding on gold 
growth mechanism while diversifying the applications of the resulting 
nanoparticles. 
 
 The method here presented to conjugate folic acid to the Hap particles 
should be improved. Additionally different concentrations of folic acid 
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must be tested and the effect of its concentration on cell response 
evaluated.  
 
 Even though the synthesized particles were mainly envisaged for 
applications more closely related with bone, the study of the interaction 
behaviour of these materials with other type of cells seems to be an 
obvious requirement to improve the potentiality of these Hap particles. 
 
Based on literature reports Hyperthermia ability was suggested for the 
synthesized HS-AuNPs though not experimentally verified. The confirmation 
and, if required, the optimization of hyperthermia behaviour is thus mandatory. 
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